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Tuberculosis (TB) is a disease of global importance affecting millions of humans, livestock, and 
wildlife. Control and eventual eradication of TB depends on dedicated management actions for all 
species. Accurately diagnosing TB can be challenging in wildlife species, for which validated tests may 
be unavailable or of limited sensitivity or specificity. Managing TB in wildlife poses additional 
difficulties, requiring considerable time and resources to implement at an appropriately broad scale. Each 
unique ecosystem where TB occurs requires management interventions designed to meet the area’s 
conservation, ecological, social, and financial needs. In this dissertation, I explored the diagnosis and 
management of tuberculosis in wildlife in three different settings: free-ranging European badgers (Meles 
meles) in Ireland, working African elephants (Loxodonta africana) in Zimbabwe, and captive African and 
Asian elephants (Elephas maximus) in North America. Badgers are a reservoir of bovine TB in Ireland, 
while captive elephants around the world are at risk of TB from their human handlers. Badgers have 
historically been managed by culling, but there is a current transitioning to vaccination as the primary 
management tool. In contrast, captive elephants in high-resource settings are typically treated for TB upon 
diagnosis, although this option may be limited in low-income countries. 
The first objective of this research was to assess the impact of environmental factors in 
management of TB over three different studies. I explored how biotic and abiotic factors influence 
trapping success of badgers being managed for bovine TB in Ireland. In a second study of badgers, I 
estimated density of a population undergoing vaccination in relation to environmental variables and prior 
management history. Underlying badger density is an important driver in the TB disease dynamics 
between cattle and badgers, and can be used in predictions about and assessment of outcomes under 
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vaccination. Finally, I examined potential risk factors for TB seropositive status in working African 
elephants in Zimbabwe, and identified unique potential exposures from the environment. 
The second objective of this dissertation was to study the performance of diagnostic tests in a 
novel setting and interpret the results in the context of exposures within the ecosystem. This study 
employed two serological tests, STAT-PAK and DPP, for the first time in working African elephants in a 
range country. I interpreted the results suggestive of exposure to mycobacteria in some elephants based on 
possible interactions with the complex community of humans, livestock, wildlife, and mycobacteria. 
The third objective of this dissertation was to develop recommendations for TB management 
programs based on surveys, capture data, and consideration of individual, population, and community 
factors. The results from our badger trapping study in Ireland formed the basis of suggested conditions 
under which vaccine delivery can be increased, because captures are most likely. We used mark-recapture 
data to estimate badger density in a vaccination area, which adds an important dimension to the Irish TB 
management program that includes badgers and cattle. Population density is an important factor in 
pathogen transmission and estimating density using these methods may be a priority for other wildlife 
populations being managed for TB. Our study of TB treatment in elephants provided a compilation of 
empirical data for elephant managers and veterinarians to inform clinical decision making. It also 
underscores the need for improved diagnostics to more confidently identify when animals are no longer 
infectious. For working African elephants, we documented other wildlife species with host potential on 
and around facilities, and considered these as possible sources for mycobacterial transmission. Our 
management guidelines for TB prevention specifically include measures to reduce direct and indirect 
contact with potential host species.  
Management of TB across humans and animal species remains a challenging prospect. A One 
Health approach that incorporates data and techniques across disciplines to build a complete picture of 
disease control is ideal for TB in wildlife. I drew from ecology and epidemiology to implement a holistic 
approach to diagnosing and managing TB in species of conservation concern, provide insight into the 
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challenges of diagnosing and managing TB in free-ranging and captive wildlife, describe the benefits of a 
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Tuberculosis (TB) is a disease of global importance affecting humans, livestock, and wildlife (de 
Lisle et al. 2001; Kyu et al. 2017). It is most frequently caused by the bacteria Mycobacterium 
tuberculosis (M. tuberculosis) in humans and Mycobacterium bovis (M. bovis) in livestock and wildlife 
(Gordon and Behr 2015). M. bovis is also a zoonotic pathogen of humans (Cosivi et al. 1995), while M. 
tuberculosis is increasingly emerging in captive and free-ranging wildlife at the human-wildlife interface 
(Michel et al. 2013; Miller and Olea-Popelka 2013). Several countries have TB control programs in 
livestock, but these are often hampered by the presence of wildlife reservoirs (de Lisle et al. 2002). 
Successful control of TB in any species will require a coordinated effort to control the disease in all host 
species (Miller and Olea-Popelka 2013). 
Disease management is desirable for maintaining livestock health, preventing zoonotic disease in 
humans, and benefitting wildlife conservation (Wobeser 2002). Diagnosis is the first step to managing the 
disease at all scales, from identifying disease in individuals to monitoring populations (Maas et al. 2013). 
Validating diagnostic tests for wildlife species, however, proves challenging when known positive or 
negative samples are often difficult to acquire or otherwise in short supply (Cousins and Florisson 2005). 
Once a diagnosis is confirmed, management of TB takes various forms depending on local factors. 
Prevention is key where the disease is not present, while eradication may be a goal for established 
disease, and control is often desirable in endemic areas (Wobeser 1994). Approaches for controlling 
established disease differ between free-ranging and captive wildlife populations. Free-ranging populations 
may be manipulated through culling or widescale vaccination efforts, while endangered or valuable 
captive wildlife such as elephants can feasibly be treated for TB (de Lisle et al. 2002; Fitzgerald and 
Kaneene 2013). Both free-ranging and captive wildlife can benefit from modification of human activities 
that increase TB risk for animals (Fitzgerald and Kaneene 2013). 
The goal of my dissertation was to use principles from epidemiology and ecology to analyze field 
data to improve our understanding of diagnosis and management of TB in wildlife. Each system contains 
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a unique group of hosts, mycobacterial pathogens, and environmental conditions that call for different 
management strategies adapted to the circumstances. In chapter 2, I review literature pertaining to 
common diagnostic assays and management strategies for TB in both captive and free-ranging wildlife 
around the world. Chapters 3–6 describe studies of wildlife species at risk of TB in three different settings 
(Figure 1.1): free-ranging European badgers (Meles meles) in Ireland, where they are a reservoir for M. 
bovis and hinder eradication of bovine TB from cattle; working African elephants (Loxodonta africana) in 
Zimbabwe that interact with humans in this high TB (M. tuberculosis) burden area; and captive African 
and Asian elephants (Elephas maximus) in North America, where they continue to become infected with 
M. tuberculosis despite routine testing. 
 
Figure 1.1: Map of the world showing each of the study areas in this dissertation: Ireland, where free-ranging 
badgers were studied (Chapters 3 and 5); Zimbabwe, where working African elephants were studied (Chapter 4); 




The studies in Ireland were designed to use badger capture data from the Kilkenny Vaccine Trial 
in County Kilkenny to provide wildlife managers with new information to support the country’s move to 
replace badger culling with vaccination as a control strategy for M. bovis. My objectives were to 
investigate environmental factors that maximize badger trapping success, and to estimate the density of 
badgers within a vaccination area as a baseline. Chapter 3 is a manuscript published in the European 
Journal of Wildlife Research, describing biotic and abiotic factors associated with successful trapping of 
badgers as part of an intramuscular vaccination program used in Ireland’s bovine TB management. 
Improving trapping success is vital for delivery of vaccines. Chapter 5 is a manuscript describing the 
density of badgers within the Kilkenny vaccination area in Ireland, using spatially explicit capture-
recapture methods. Badger density is an important driver of transmission dynamics among badgers and 
cattle. The density estimates will be used in conjunction with data from cattle for a coordinated approach 
to assessing the success of vaccination in controlling TB. 
The objective of the study in Zimbabwe was to use survey data from working African elephants 
at ecotourism facilities in the Victoria Falls area of Zimbabwe to assess potential exposure to M. 
tuberculosis from humans in this high human TB burden area. Chapter 4 is a manuscript published in 
Transboundary and Emerging Diseases, describing TB serological status of these working elephants and 
potential risk factors for seropositive status. This study is the first to examine TB in African elephants in a 
range country, where facility conditions and local community ecology differ considerably from those of 
either working Asian elephants in range countries or captive elephants in zoos and private collections. 
Two surveys were distributed to elephant facilities in North America: one survey covered 
demographics, management, and potential risk factors for TB (caused by M. tuberculosis) in captive 
elephants, and the other covered results from diagnostic assays for TB and protocols from elephants 
treated for TB. Chapter 6 is a manuscript describing TB treatment protocols, serum drug concentrations, 
and adverse effects associated with TB treatment in elephants in North America. This chapter is the first 
compilation of treatment protocols for TB in a wildlife species, which have previously been limited to a 
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various case reports. Finally, chapter 7 contains final conclusions about the contributions of this 





CHAPTER 2: A REVIEW OF DIAGNOSIS AND MANAGEMENT OF TUBERCULOSIS IN FREE-





A rapidly changing world poses many threats to wildlife conservation. The increasing human 
population and expansion of agriculture lead to continued encroachment on wildlife habitat and changes 
in land use (Foley et al. 2005). Alteration of global climate promotes disease emergence and spread to 
new areas (Daszak et al. 2001; Cunningham et al. 2017). Human activity may also result in increased 
stress on wildlife (Baker et al. 2013), which can compromise immune function (Cohen and Williamson 
1991), making animals more susceptible to disease (Hofer and East 2012). Globalization has resulted in 
rapid movement of people, animals, and pathogens around the world, with major potential consequences 
for human and animal health (Daszak et al. 2001). Increasing interactions among humans, livestock, and 
wildlife have real risks for increased pathogen transmission across species (Daszak et al. 2001).  
Disease is a ubiquitous process in organisms of all types, and a normal constituent of ecosystems 
(Delahay et al. 2009). Changing conditions may create a perfect storm of risk factors that allow for 
disease to occur at a scale that threatens wildlife populations. Sylvatic plague, caused by the bacteria 
Yersinia pestis, and canine distemper virus wreaked havoc on black-footed ferret (Mustela nigripes) 
populations and brought the species to the brink of extinction (Santymire et al. 2014). Devil facial tumor 
disease, a newly emerging disease caused by a transmissible tumor, has led to a precipitous decline of 
Tasmanian devils (Sarcophilus harrisii), resulting in a loss of top-down control via alterations in trophic 
cascades (Hollings et al. 2014). North American bats are being decimated by white nose syndrome (Frick 
et al. 2010), a devastating disease resulting from infection with the fungus Pseudogymnoascus 
destructans (Minnis and Lindner 2013). Mass mortality events and species declines need not occur only 
from emerging infectious diseases, which tend to capture public interest and funding priority (Wiethoelter 
et al. 2015), but under the right confluence of circumstances, enzootic pathogens also have the ability to 
devastate wild animal populations. A staggering 200,000 critically endangered saiga antelope (Saiga 
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tatarica) – 62% of the global population – died off in 3 weeks as a result of opportunistic Pasteurella 
multocida overgrowth, precipitated by high humidity and higher-than-typical ambient temperature (Kock 
et al. 2018). Disease can also play a more insidious role in population declines outside of mass mortality 
events, by altering population dynamics or behavior (Preece et al. 2017), or contributing to host mortality 
and sterility (Grogan et al. 2018).  
Management intervention for diseases of wildlife may be motivated by the intrinsic value of 
wildlife, threats to beneficial wildlife populations (particularly populations with value for harvest or 
tourism), or the need to control diseases in wildlife that threaten human or livestock health (Wobeser 
1994; de Garine-Wichatitsky et al. 2013). Controlling animal diseases can confer significant economic 
benefits through increased opportunities for trade; for example, African livestock exports are limited by 
endemic diseases in these countries, which have served as a barrier to entering profitable international 
markets (Kock 2005). Study of wildlife diseases is becoming increasingly relevant in both wildlife 
conservation and various health fields with the resurgence of the concept of One Health (Cunningham et 
al. 2017). One Health stipulates an inherent connection between animal, human, and environmental 
health, and underscores the importance of a multidisciplinary approach to studying diseases (Osburn et al. 
2009; Cumming and Cumming 2015). The concept of “One Medicine,” or a link between human and 
veterinary medical sciences, was once more widely acknowledged, and is again being embraced by newer 
generations of professionals across health disciplines (Kahn et al. 2007). One Health has roots in both 
epidemiology and ecology (Cumming and Cumming 2015). Epidemiology has a foundation of 
investigating disease determinants associated with so-called epidemiologic triad of host, agent, and 
environment (Thrusfield 2005), while disease ecology is based on interactions at all biological scales, 
from individual to ecosystem, involved in disease (Tompkins et al. 2011). Wildlife disease research and 
management can benefit from a more holistic approach that considers human and domestic animal health 





2.2 Management of Wildlife Diseases 
2.2.1 Mathematical Principles 
Underlying infectious disease management are basic mathematical principles of disease dynamics 
and population biology. All infectious diseases have a basic reproductive rate, 𝑅𝑅0, which describes the 
average number of secondary cases produced by a primary case in a susceptible population, assuming 
homogeneous mixing of hosts (Anderson and May 1991). 𝑅𝑅0 dictates the behavior and persistence of a 
pathogen in the host population where 𝑅𝑅0 > 1 is required to maintain a disease in a population and 𝑅𝑅0 <
1 will result in the disease dying out (Anderson 1991). This behavior is based on the assumption of 
intraspecific transmission within a single host species; in multi-host systems, interspecific transmission 
can “top up” 𝑅𝑅0, creating a more complex dynamic (Nugent 2011). In such a system, pathogens persist in 
maintenance or reservoir hosts without transmission from other sources (Thrusfield 2005), and 
maintenance hosts can transmit pathogens to non-maintenance hosts in spillover transmission events 
(Nugent 2011). Spillover hosts have the potential to transmit pathogens back to the maintenance host 
species, a process which is called spillback (Nugent 2011). 
Host populations can be defined into simple states of susceptible, infected, and recovered or 
resistant (Figure 2.1), and a variety of mathematical interpretations of disease dynamics can be assembled 
using so-called SIR models, as originally described by Kermack and McKendrick (1927; 1932; 1933). 
Deterministic SIR models provide a theoretical background to understand population-level disease 
dynamics and the influence of different management interventions on each disease class.  
 
Figure 2.1: Basic population model of disease, including susceptible (S), infected (I), and recovered/resistant (R) 
classes. The transition from S to I is governed by the transmission rate, β, and the transition from I to R is governed 




In the basic SIR model example in Figure 2.1, modified from Anderson and May (1979) 




= −𝛽𝛽𝑑𝑑𝛽𝛽 (2.1) 
where S is the susceptible class, I is the infected class, and β is the transmission coefficient, and 
𝑑𝑑𝛽𝛽
𝑑𝑑𝑑𝑑
= 𝛽𝛽𝑑𝑑𝛽𝛽 − 𝛾𝛾𝛽𝛽 (2.2) 
𝑑𝑑𝑅𝑅
𝑑𝑑𝑑𝑑
= 𝛾𝛾𝛽𝛽 (2.3) 
where R is the resistant/recovered class, and γ is the recovery rate. 
The SIR framework provides a starting point for understanding and analyzing population 
dynamics of disease and the potential impact of management interventions, but has limitations that are not 
reflective of the complexity of natural systems. SIR models are based on the tenuous assumption of 
homogeneous mixing of individuals, which is unsupported by natural human and animal behaviors and 
spatial distribution (Anderson and May 1991). Basic SIR models are deterministic, and do not account for 
individual heterogeneity in factors such as immunity or bacterial shedding intensity. Individual-based 
models can be used to incorporate stochasticity into disease simulation models (e.g., Smith et al. 2001; 
Shirley et al. 2003; Ramsey 2007). SIR models can be modified to include disease latency, maternal 
antibodies (Anderson and May 1991), and demography (e.g., age class, sex, births, and deaths; see 
Anderson and Trewhella 1985; Smith et al. 2001; Shirley et al. 2003; Graham et al. 2013; Brooks-Pollock 
and Wood 2015; Abdou et al. 2016). Lastly, basic SIR models are designed for a single host, but can be 
modified to include multiple hosts (Cox et al. 2005; Brooks-Pollock and Wood 2015). Substantially more 
complex variations of the simple SIR structure can be constructed to more accurately represent 
transmission dynamics for a specific system, but doing so expands the number of parameters and model 
equations required to define the system. Empirical data to quantify model parameters may be sparse or 
non-existent for the population of interest. 
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Different disease management strategies manipulate populations of different classes to influence 
the transitions between different states, most importantly the transmission coefficient; under the 
assumption of density-dependence, the contact rate of individuals increases with host density, as does the 
per capita force of infection (Begon et al. 2002) Disease management takes the form of four major 
categories: prevention, control, eradication, and laissez-faire, or doing nothing (Wobeser 2002). This last 
option has been applied in many situations where disease management is not feasible or justifiable in 
wildlife (Wobeser 2002; Gortazar et al. 2015). Prevention of disease is often important for wildlife 
because diseases are difficult to eradicate once established (Wobeser 1994). Eradication of diseases may 
be desirable, but is not always an attainable goal (Wobeser 1994). Thus disease control, which 
acknowledges some level of ongoing commitment to disease management, is extremely important to 
successful management of disease in wildlife (Wobeser 1994).  
Disease control may be further subdivided into six categories: management of the disease agent 
and/or vector, manipulation of the host population, treatment, immunization, environmental modification, 
and influencing human activities (Wobeser 1994). Directly addressing the disease agent and/or its vector, 
modifying the environment or human activities, and treating animals all decrease the I class within the 
SIR framework. Managing the host population may reduce the I class in the case of selective culling or 
fertility control, or both S and I classes if general depopulation is used. Immunization transitions animals 
from the S class to the R class.  
 
2.2.2 Unintended Ecological Consequences 
Disease control is intended to benefit wildlife populations, but wildlife managers must consider 
unintended ecological consequences of control programs in their long-term management strategies. 
Management approaches that promote survival (e.g., vaccination and treatment) might be considered 
more benign than other approaches (e.g., culling), but complex host and pathogen communities are 
susceptible to altered dynamics when diseases are controlled.  
10 
 
At the pathogen level, Lloyd-Smith (2013) suggests that pathogen eradication results in a vacated 
niche, which may be filled by other pathogens as a form of competitive release. This phenomenon has 
been observed in the recent rise of peste des petits ruminants (PPR) in the wake of rinderpest eradication 
(Banyard et al. 2014). Vaccination against rinderpest virus, a relative of the PPR virus, ended once the 
disease was globally eradicated; PPR has become more prevalent as hosts lose the cross-protective 
benefits of rinderpest vaccination (Banyard et al. 2014; Libeau et al. 2014).  
Interventions may have opposite effects at the levels of individual host and host population. 
African buffalo coinfected with helminths and Mycobacterium bovis, the causative agent of bovine 
tuberculosis (TB), treated with an anthelmintic experienced reduced mortality from TB, which is 
beneficial to the individual (Ezenwa and Jolles 2015). The population level effect, however, was harmful, 
because surviving infected buffalo continued shedding M. bovis and infecting herd members, resulting in 
an eightfold increase in 𝑅𝑅0 in the host population (Ezenwa and Jolles 2015).  
At the community level, when disease acts to regulate the population, increased survival of one 
species may have negative consequences for other species. Simulation models of vaccinating lions against 
canine distemper virus showed negative impacts on survival and increased likelihood of local extinction 
for cheetahs (Chauvenet et al. 2011). Management intended to promote conservation of one threatened 
species could compromise conservation of other threatened species within the community (Chauvenet et 
al. 2011). 
 
2.3 Disease at the Wildlife-Livestock-Human Interface  
Complex interactions between species are often pertinent in diseases of wildlife. Contact between 
livestock and wildlife creates an important interface in pathogen transmission, as seen in Texas, where 
cattle (Bos taurus) died of wildebeest-associated malignant catarrhal fever – a form of the disease not 
typically found in the United States – after being on a mixed-use operation with exotic game, including 
wildebeest (USDA APHIS 2008). Keeping wildlife in captivity, such as in game ranching or zoological 
institutions, can also result in increased opportunities for transmission given close contacts between 
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multiple species, including humans. An outbreak occurred at a zoo after an Asian elephant (Elephas 
maximus) infected with Mycobacterium tuberculosis transmitted the bacteria to a chimpanzee (Pan 
troglodytes) and several (human) zoo staff (Stephens et al. 2013). Wildlife are implicated in the 
epidemiology of most zoonoses (Kruse et al. 2004), making the human-wildlife interface one with major 
risks for human health. 
Human activities can also indirectly influence disease dynamics in wildlife. Settlers in nineteenth 
century Africa brought cattle with them, evidently infected with rinderpest, which spread throughout the 
continent in the following decades (Mack 1970). The naïve cattle and wildlife of Africa were 
subsequently devastated, with an estimated 80–90% of African buffalo (Syncerus caffer), eland 
(Taurotragus oryx), giraffe (Giraffa spp.), wildebeest (Connochaetes spp.), kudu (Tragelaphus spp.), and 
antelope perishing, and approximately 2.5 million cattle lost in South Africa alone (Mack 1970). Disease 
threats can also result when extenuating circumstances disrupt normal preventive measures. Political 
unrest in Zimbabwe led to a dramatic reduction in vaccination of domestic dogs (Canis familiaris) against 
rabies; canine rabies incidence subsequently increased, resulting in spillover to wildlife reservoirs and 
establishment of enzootic rabies in jackals (Lawrence et al. 1980).  
The economic and epidemiological consequences of the wildlife-livestock-human interface in 
disease transmission have contributed to increasing interest in managing disease in free-ranging wildlife. 
However, diagnosing and managing disease in wildlife can be particularly challenging, as effective 
diagnostic tools are often lacking, and management options tend to be limited and/or resource-intensive. 
 
2.4 Tuberculosis as a Case Study of Disease Management 
2.4.1 Background 
Tuberculosis (TB) is a useful case study for exploring the challenges of disease management at 
the wildlife-livestock-human interface. TB is one of the oldest known diseases of humans and animals, 
with written references to its existence in humans (Steele and Ranney 1958) and captive wildlife (Iyer 
1937) from thousands of years ago, and evidence of its presence in livestock and free-ranging wildlife 
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dating from prehistory (Rothschild and Laub 2006; Rothschild and Martin 2006). Most infected humans 
develop latent TB, without clinical signs of disease (Rengarajan et al. 2015), but ~10% of infected 
individuals develop active clinical disease that includes non-specific signs such as fever and cough 
(American Thoracic Society 2000). TB in cattle has a chronic progression without distinct stages (Waters 
et al. 2015). TB is classically characterized by development of caseonecrotic granulomas (Waters et al. 
2015), formed by T cells and macrophages to contain mycobacteria (American Thoracic Society 2000). 
Transmission is most frequently by aerosol, but can also occur by ingestion of contaminated animal 
products, feed, or water, as well as indirectly by contact with fomites (Waters et al. 2015).  
TB remains a global health threat despite decades of control efforts (Kyu et al. 2017). 
Approximately one quarter of the world’s human population is infected with Mycobacterium tuberculosis, 
the causative agent of human TB (World Health Organization 2018). The burden of TB in wildlife has not 
been formally estimated, but the burden in cattle worldwide is estimated to be > 50 million head infected, 
costing billions of dollars annually (Waters et al. 2012). TB control costs to governments and producers 
include testing costs, labor, indemnity payments, depopulation, and repopulation (Wolf 2005). The 
economic impact of TB control programs is considerable: for example, the European Union spends an 
estimated €537 million controlling human TB (Diel et al. 2014), while the UK spends £91 million 
annually on bovine TB control (Department for Environment, Food and Rural Affairs 2011). Controlling 
TB does have considerable economic returns (Amanfu 2006), as demonstrated by the United States 
bovine TB eradication program from 1917–1962, which is estimated to have cost approximately $258 
million, but resulted in $3.2 billion (in 1918 dollars) of benefits for the livestock sector alone (Olmstead 
and Rhode 2004). Other benefits of control relate to trade: states with accredited TB free status are not 
subject to testing, movement, or quarantine restrictions that other states may impose on animal exports 
(Wolf 2005). 
Species in the M. tuberculosis complex (MTBC) cause TB in a variety of species. TB in humans 
is most frequently the result of infection with M. tuberculosis, while TB in animals is often the result of 
infection with M. bovis (Gordon and Behr 2015). The MTBC also includes the human-adapted strains M. 
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africanum and M. canetti (Gordon and Behr 2015). The animal-adapted strains are named for the host 
species in which they were first or most frequently isolated, but may be found in other host species 
(Gordon and Behr 2015); these include M. caprae, found in domestic goats (Capra aegagrus hircus), M. 
microti, found in field voles (Microtus agrestis; Gordon and Behr 2015), M. pinnipedi, found in marine 
mammals (Cousins et al. 2003) and the as yet unnamed “Dassie bacillus” of rock hyrax (Procavia 
capensis; Smith 1960). The past decade has seen three new members added to the animal-adapted MTBC 
strains: M. mungi, found in banded mongoose (Mungos mungo; Alexander et al. 2010); M. orygis, found 
in oryxes (Oryx spp.; van Ingen et al. 2012), and M. suricattae, found in meerkats (Suricata suricatta; 
Parsons et al. 2013). Other mycobacteria (known as non-tuberculous mycobacteria [NTM], mycobacteria 
other than tuberculous mycobacteria [MOTT], or atypical mycobacteria) can cause clinical disease, but 
not the classic lesions of TB (American Thoracic Society 1997). 
 
2.4.2 Tuberculosis at the Wildlife-Livestock-Human Interface 
It is important to note the zoonotic and reverse zoonotic potential of some MTBC members. M. 
bovis is primarily an animal pathogen, but it does cause zoonotic TB cases in humans – the true burden of 
which is likely underestimated due to a lack of testing and reporting (Cosivi et al. 1998; Olea-Popelka et 
al. 2017). Zoonotic TB is most prevalent in developing countries, in those handling or consuming 
contaminated products such as unpasteurized milk, and in agricultural workers (Cosivi et al. 1998). Those 
infected with human immunodeficiency virus (HIV) are particularly at risk, as TB is the most commonly 
found co-infection with HIV (Cosivi et al. 1998). M. tuberculosis and M. bovis may be an occupational 
hazards to zoo staff and veterinarians (Dalovisio et al. 1992; Davis 2001) and M. bovis a recreational risk 
to hunters (Wilkins et al. 2003). Other MTBC species can also infect humans, as has been reported for M. 
pinnipedii (Kiers et al. 2008), M. orygis (Dawson et al. 2012), and even archeological evidence for an 
MTBC ancestor from seals over 1,000 years ago (Bos et al. 2014). 
The human-wildlife interface has been a source of reverse zoonoses for some time, as M. 
tuberculosis has long been reported in captive wildlife (Fox 1923). While M. bovis has a wide host range 
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and affects a large variety of species (de Lisle et al. 2001), some non-domestic ungulates appear to be 
more susceptible to M. tuberculosis than their domestic counterparts (Lomme et al. 1976). M. 
tuberculosis infection in elephants, particularly Asian elephants (Elephas maximus), has become 
problematic in zoos and other captive facilities (Mikota et al. 2000; Mikota and Maslow 2011), and new 
outbreaks continue to emerge despite surveillance (Vogelnest et al. 2015; Zlot et al. 2015; Ghielmetti et 
al. 2017; Simpson et al. 2017). M. tuberculosis is increasingly recognized as a pathogen in free-ranging 
wildlife as well (Alexander et al. 2002; Michel et al. 2013). Case reports from free-ranging Asian and 
African elephants (Loxodonta africana) raise conservation concerns about this human pathogen becoming 
endemic in threatened wildlife populations (Obanda et al. 2013; Perera et al. 2014; Chandranaik et al. 
2017; Zachariah et al. 2017). M. tuberculosis appears to be spilling over into wildlife in areas of high 
human TB prevalence, with potential for spillback to humans (Michel et al. 2013; Zachariah et al. 2017), 
highlighting the risks of pathogen transmission at species interfaces.  
The livestock-wildlife interface can result in transmission of M. bovis to wildlife species, and 
wildlife reservoirs may be established (Miller and Sweeney 2013), with the potential for spillback to 
livestock (Fitzgerald and Kaneene 2013). Wildlife maintenance hosts can maintain the agent 
independently, and so have the potential to reinfect livestock, which makes them problematic for 
eradication efforts in livestock (de Lisle et al. 2001). Current global TB hotspots involve cattle and at 
least one free-ranging wildlife species, varying by location. North American wildlife TB hosts include 
white-tailed deer (Odocoileus virginianus) in Michigan in the US (Schmitt et al. 1997), and wood bison 
(Bison bison athabascae) in Wood Bison National Park and elk (Cervus elaphus) and white-tailed deer in 
Riding Mountain National Park in Canada (Wobeser 2009). European wildlife TB hosts include European 
badgers (Meles meles) in Ireland and the UK (de Lisle et al. 2001), and wild boar (Sus scrofa), red deer 
(Cervus elaphus), and fallow deer (Dama dama) in the Iberian peninsula (Gortázar et al. 2015). African 
wildlife TB hosts include African buffalo in South Africa, and lechwe (Kobus leche) in Zambia 
(Fitzgerald and Kaneene 2013). Brushtail possums (Trichosurus vulpecula) are maintenance hosts in New 
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Zealand (de Lisle et al. 2001). Eradication of TB requires management from all hosts, but eradication 
from an established, free-ranging wildlife host is extremely difficult (Michel et al. 2006).  
Managing wildlife for TB becomes more complex when taking into account conservation of 
protected reservoir species (de Lisle et al. 2001), as lethal control of diseases in indigenous free-ranging 
wildlife is often contentious (Bengis et al. 2002). Badgers are a protected species in Ireland and the UK, 
therefore management for TB by culling them has been controversial due to concerns about conservation 
and welfare (White and Whiting 2000). In south Asia, M. orygis is emerging at the wildlife-livestock-
human interface, with infections reported in captive spotted deer (Axis axis) and blue bull (Thapa et al. 
2015), and a free-ranging greater one-horned rhinoceros (Rhinoceros unicornis) in Nepal (Thapa et al. 
2016), cattle and rhesus monkeys (Macaca mulatta) in Bangladesh (Rahim et al. 2017), and a woman 
from India who infected a cow (Dawson et al. 2012). The burden of this pathogen in wildlife is unclear 
(Thapa et al. 2017), but greater one-horned rhinoceros and other protected species such as Asian 
elephants and Bengal tigers (Panthera tigris) may be at risk (Thapa et al. 2016). Culling iconic protected 
species is unlikely to be a culturally acceptable proposal. 
One of the most complex systems of TB in free-ranging wildlife is Kruger National Park (KNP) 
in South Africa, home to an ongoing epidemic of bovine TB. Cattle around the park are assumed to be the 
source of M. bovis in African buffalo within the park, first detected in 1990 (Bengis et al. 1996). TB 
subsequently spread to other species in the park, including cheetah (Acinonyux jubatus), lion (Panthera 
leo), chacma baboon (Papio ursinus; Keet et al. 1996), greater kudu (Keet et al. 2001), common warthog 
(Phacochoerus aethiopicus), leopard (Panthera pardus; Renwick et al. 2007), and black rhinoceros 
(Diceros bicornis; Miller et al. 2017). The population-level effects of TB go beyond mortality from TB 
infection; for instance, buffalo in high prevalence herds have worse body condition and increased fecal 
endoparasite egg counts (Caron et al. 2003). Bovine TB in KNP has resulted in restricted movement of 
animals outside the park for national and international translocation efforts, which challenges 
conservation of endangered species (Michel et al. 2006) and financial viability of the park itself 
(Geoghegan 2012). M. bovis has continued moving through wildlife in the park to buffalo in neighboring 
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Gonarezhou National Park in Zimbabwe, highlighting the need for disease control (de Garine-Wichatitsky 
et al. 2010; Caron et al. 2016). 
  
2.5 Diagnosis of Tuberculosis in Wildlife 
The first step in disease management is to determine what disease is affecting the population. 
Once identified, any simulation modeling using an SIR framework for predictions depends in part on 
realistic estimates of the membership of each disease class (e.g., an estimate of prevalence to determine 
the size of the I class). Correctly identifying individuals as infected or not is crucial to developing an 
accurate depiction of the disease dynamics. Diagnostic test characteristics such as sensitivity (the ability 
of a test to correctly classify infected animals) and specificity (the abilty of a test to correctly classify 
uninfected animals; Dohoo et al. 2009) are informative in understanding how reliable prevalence 
estimates may be. Some diagnostic modalities have the ability to inform estimates of exposure (e.g., 
antibody tests that suggest immune response due to exposure), while others can inform estimates of 
infection (e.g., culture, which shows growth of live organisms).  
Disease diagnosis may not be straightforward in wildlife given a lack of established diagnostic 
tests for non-domestic species. Validation of diagnostic tests according to the World Organisation for 
Animal Health (OIE) requires a specific test purpose, type of diagnostic specimen, and target species 
(Maas et al. 2013). Acquiring known positive and negative samples from wildlife species poses serious 
difficulties for test development and validation (Cousins and Florisson 2005). For some wildlife species, 
it may be difficult to test sufficient numbers of animals to estimate sensitivity and specificity (Cousins 
and Florisson 2005). Published sensitivity and specificity estimates may not reflect these values under all 
circumstances, as testing generally occurs under less than ideal circumstances (Cousins and Florisson 
2005). Test development is unlikely to be a profitable enterprise for many wildlife species. 
When tests are available, additional practical constraints may limit their use. Animals must first 
be available for testing, which can make antemortem diagnosis of free-ranging wildlife difficult or 
impossible in certain scenarios (Wobeser 1994). Large and highly mobile species may require physical 
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capture and chemical immobilization for handling and collection of sample for testing (Wobeser 1994). 
Immobilization drugs, capture crews, and capture equipment (e.g., traps, helicopters) all add to the cost of 
the investigation. In cases of mortality events, finding carcasses may be difficult (Wobeser 1994), 
particularly before decomposition has advanced to the point of excluding some diagnostic 
modalities.Diagnosing TB as early as possible, particularly in captive wildlife, is desirable as infected 
animals become infectious before developing clinical signs (de la Rua-Domenech et al. 2006). A wide 
variety of tests have been developed to address the needs for diagnosing TB. These modalities approach 
diagnosis from three pathways: direct detection of TB organisms or the pathological response to them, 
humoral immune response to infection, or cell-mediated immune response to infection (Cousins and 
Florisson 2005). Commonly used methods for TB screening and diagnosis in wildlife species are 
described below, but this list is not exhaustive, and some assays that have been used less frequently are 
not discussed.  
 
2.5.1 Direct Detection 
Direct antemortem confirmation of infection with TB is desirable, particularly in captive animals 
where treatment might be applied. Even establishing whether disease is present may not be 
straightforward, as clinical signs of TB are rarely seen in wildlife (Montali et al. 2001). Most clinical 
signs are non-specific, with weight loss most frequently reported (Lécu and Ball 2011). Cough and 
dyspnea, if present, are signs of end-stage disease (Lécu and Ball 2011). Several diagnostic methods for 
direct detection of TB organisms have been developed, with culture being the most important. 
 
2.5.1.1 Culture 
Mycobacterial culture is considered the gold standard diagnostic for confirmation of TB (de Lisle 
et al. 2002), as it demonstrates the presence of live mycobacteria within the host. Culture for 
mycobacteria should be performed in suspected TB cases because of its improved sensitivity over 
microscopy, and for species identification, genotyping, and drug susceptibility testing if treatment is to be 
18 
 
pursued (American Thoracic Society 2000). Culture can be used as a postmortem diagnostic to confirm 
infection in free-ranging or captive wildlife, but may also be used as an antemortem diagnostic in captive 
wildlife (Montali et al. 2001). Collecting antemortem samples for culture generally involves a veterinary 
procedure under sedation (Hermes et al. 2018) to obtain sputum, gastric lavage, and bronchial lavage 
(Thoen et al. 2006), or specialized training to perform unsedated, as with elephant trunk washes (Mikota, 
Lyashchenko, et al. 2015). Culture has several major limitations: it may take up to eight weeks for results, 
appropriate antemortem samples may be difficult to collect from wildlife, and antemortem samples may 
be contaminated and result in bacterial or fungal overgrowth (Mikota, Lyashchenko, et al. 2015). Animals 
shed mycobacteria intermittently, which necessitates repeated sampling for antemortem culture (Mikota, 
Lyashchenko, et al. 2015) and contributes to suboptimal test sensitivity.  
 
2.5.1.2 Direct Microscopy 
Samples may also be evaluated by direct microscopic examination for more rapid preliminary 
results. Mycobacteria have a cell wall containing mycolic acid, which can uptake dyes, and such acid-fast 
bacilli (AFB) can be identified using stains such as Ziehl-Neelsen or Kinyoun (Thoen et al. 2009). 
However, other acid-fast organisms, including NTM and Nocardia spp., can be confused for tuberculous 
mycobacteria, and further workup is required (Lécu and Ball 2011; Mikota, Lyashchenko, et al. 2015). A 
lack of AFB does not rule out the possibility of TB, as lesions may have few organisms present (de Lisle 
et al. 2002) and approximately 5000 bacilli/ml are required for positive identification (Lécu and Ball 
2011). 
 
2.5.1.3 Gross Pathology and Histopathology 
Some species develop characteristic TB lesions that can be used to make a presumptive 
postmortem diagnosis, but lesions in wildlife vary considerably by species in appearance and distribution 
(de Lisle et al. 2002). Traditional granulomatous lesions are yellow, have a caseous core, and may be 
calcified in late infections (Adugna et al. 2014). Generalized lesions in carnivores are distinctly different 
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than those in herbivores and omnivores, appearing proliferative or cavitational, with no abscessation, 
caseation, or calcification (de Lisle et al. 2002). Lesions are typically associated with the route of 
transmission: animals infected via respiratory route most commonly have lesions in the lungs (e.g., 
brushtail possum, European badgers) and thoracic lymph nodes (e.g., lechwe, African buffalo), while 
animals infected orally most commonly have lesions in the head lymph nodes (e.g., greater kudu, 
warthog) and the mesenteric and peripheral lymph nodes (e.g., lion, leopard; de Lisle et al. 2002).  
Histopathology is useful for examining suspected TB lesions, particularly if tissues are not 
suitable for culture (de Lisle et al. 2002). Classic lesions in cattle have central necrosis with 
mineralization, a surrounding granulomatous response with macrophages, and an outer capsule of fibrous 
connective tissue, but lesions in wildlife vary (de Lisle et al. 2002). Histopathology can be used to 
exclude a TB diagnosis for another differential diagnosis (de Lisle et al. 2002), but alone it is not specific 
enough to definitively diagnose TB (Cousins and Florisson 2005). 
 
2.5.1.4 Radiography and Computed Tomography 
Radiography or computed tomography studies can be a useful non-invasive tool for determining 
whether pulmonary lesions characteristic of TB are present in some species, including carnivores, marine 
mammals, and non-human primates (Morris et al. 1996; de Lisle et al. 2001; Jurczynski et al. 2011). 
Calcified lesions may not appear on radiographs if relatively small (Capuano et al. 2003). Detecting 
extrapulmonary TB lesions is more challenging, and radiological signs such as splenomegaly or 
mesenteric lymphadenopathy are non-specific (Bushmitz et al. 2009). Radiological methods require the 
appropriate equipment, anesthesia for proper immobilization, and are not suitable for species with a large 
thoracic cage, such as ungulates > 250 kg (Lécu and Ball 2011).  
 
2.5.1.5 Polymerase Chain Reaction (PCR) 
Polymerase chain reaction (PCR) testing of biological samples can detect small amounts of 
mycobacteria without the long wait required with culture (de Lisle et al. 2002). PCR has been widely used 
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in wildlife species to differentiate MTBC mycobacteria from NTM (Maas et al. 2013). PCR can be used 
on fresh samples, cultured bacteria, or formalin-fixed tissues if fresh tissue is not available for culture (de 
Lisle et al. 2002). Its use on suspect samples rather than cultured samples requires a higher bacterial load 
(Maas et al. 2013), as inhibitors may be present in biological samples and impair PCR detection (de Lisle 
et al. 2002; Lécu and Ball 2011). One drawback to PCR is that it amplifies any genetic material present, 
which includes live bacteria, dead bacteria, and extracellular DNA (Rogers et al. 2010), and does not 
confirm the presence of live organisms as in culture. PCR for TB diagnosis has been used in studies of 
free-ranging African ungulates (Cleaveland et al. 2005), and captive non-human primates (Alfonso et al. 
2004), carnivores (Miller 2008), camelids and ungulates (Pate et al. 2006), pinnipeds (Kriz et al. 2018), 
and small mammals, rodents, and lagomorphs (Miller and Lyashchenko 2015). 
 
2.5.1.6 Genotyping 
Genotyping of mycobacteria is a continually evolving field, with numerous methods available to 
differentiate strains. IS6110 restriction fragment length polymorphism (RFLP) is the oldest commonly 
used genotyping method, and is based on fingerprinting repetitive DNA elements known as IS6110 in 
MTBC species (van Embden et al. 1993). RFLP is a labor- and time-intensive process that takes weeks 
for culture and DNA purification (Supply et al. 2006). Spacer oligotyping, or spoligotyping, is a 
technique that exploits DNA polymorphism in the direct repeat locus of MTBC bacteria (Kamerbeek et 
al. 1997). Spoligotyping is easy to perform, and can be used on clinical specimens or fixed tissues for 
more rapid results than culture (Kamerbeek et al. 1997). Mycobacterial interspersed repetitive unit–
variable number of tandem repeats (MIRU-VNTR) (Frothingham and Meeker-O’Connell 1998; Supply et 
al. 2006) also makes use of polymorphisms, and can be applied up to 24 loci (Roetzer et al. 2013). MIRU-
VNTR is faster than IS6110 RFLP (Supply et al. 2006) and can be performed on killed bacteria, which 
minimizes biohazards to laboratory personnel (Frothingham and Meeker-O’Connell 1998). Whole 
genome sequencing (WGS) provides detail on all genetic information rather than specific polymorphic 
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targets (Roetzer et al. 2013), and is superior to other genotyping methods for differentiating between 
relapse and re-infection in TB cases (Bryant et al. 2013). 
Genotyping is particularly valuable as an epidemiological tool for investigating outbreaks and 
understanding transmission patterns (de Lisle et al. 2002), as well as identifying laboratory cross-
contamination (Frothingham and Meeker-O’Connell 1998). Genotyping methods are often used in 
combination: for example, an investigation in zoo elephants used MIRU-VNTR, spoligotyping, and WGS 
to determine the source of infection and route of transmission among animals (Ghielmetti et al. 2017). 
WGS is increasingly used in multi-host epidemiological investigations of outbreaks in free-ranging 
wildlife and cattle to determine strains involved, directionality of transmission, and persistence (Biek et 
al. 2012; Trewby et al. 2015; Glaser et al. 2016; Crispell et al. 2017).  
 
2.5.2 Humoral Immune Response Detection 
The humoral response allows for assessment of TB status from a blood sample, but the immune 
response of many species to mycobacterial infection is not well described (Chambers 2013). The 
serological response is generally only elevated in the latter part of the disease (Cousins and Florisson 
2005; Maas et al. 2013; Bezos et al. 2014), although elephants have an unusually robust antibody 
response that can be detected years before positive cultures (Greenwald et al. 2009). Humoral antibody 
tests are generally considered poor indicators of TB infection (Cousins and Florisson 2005), as the 
humoral response may be absent in early infection (Bezos et al. 2014). The main drawback to serological 
assays is that they are an indirect measure of disease status, with the potential for cross-reaction, and may 
represent exposure or past infection but cannot be interpreted to indicate a current infection (Gilbert et al. 
2013).  
 
2.5.2.1 Immunochromatographic Assays 
Immunochromatographic assays are simple tests that result in a color change when antigen-
antibody binding occurs (Sakamuri et al. 2015). Disposable point-of-care commercial tests have been 
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developed for wildlife; these tests are relatively inexpensive, simple to use, can be performed patient-side, 
and deliver results within 15–20 minutes, and are valuable for use in diagnosis of captive and free-ranging 
wildlife (Lyashchenko et al. 2008). The rapid test or VetTB STAT-PAK test was adapted for a variety of 
species (Lyashchenko et al. 2008), including elephants (ElephantTB STAT-PAK; Lyashchenko et al. 
2006; Greenwald et al. 2009; Lyashchenko et al. 2012), primates (Lyashchenko et al. 2007 PrimaTB 
STAT-PAK), badgers (BrockTB STAT-PAK; Chambers et al. 2008), and cervids (CervidTB STAT-
PAK; Gowtage-Sequeira et al. 2009). STAT-PAK testing of elephants was a mainstay of annual TB 
testing of elephants when previously mandatory testing was required by the US Department of 
Agriculture (United States Animal Health Association 2010).  
The STAT-PAK was known to result in false positive reactions, likely due to NTM infections 
(Lacasse et al. 2007; Greenwald et al. 2009), and has been discontinued. It was replaced by the more 
specific Dual-Path Platform (DPP) VetTB assay, which uses the same antigens (ESAT-6, CFP10, and 
MPB83) as the STAT-PAK but two nitrocellulose strips to independently deliver the test sample and 
reagent (Greenwald et al. 2009; Lyashchenko et al. 2012). DPP results can be quantified using an optical 
reader device (Greenwald et al. 2009). DPP has been used in elephants (Greenwald et al. 2009; 
Lyashchenko et al. 2012; McGee et al. 2014; Yakubu et al. 2016), lions (Miller et al. 2012), fallow deer 
(Boadella et al. 2012), wild boar (Che’Amat et al. 2015), warthogs (Miller et al. 2015), and banded 
mongoose (Brüns et al. 2016). 
 
2.5.2.2 Enzyme-linked Immunosorbent Assay (ELISA) 
The enzyme-linked immunosorbent assay (ELISA) or enzyme immunoassay (EIA) is a laboratory 
test that detects antibodies to a specific MTBC antigen(s) (Sakamuri et al. 2015). ELISA assays have been 
developed or modified in a number of wildlife species, including in elephants to screen for M. 
tuberculosis (Larsen et al. 2000), and to detect M. bovis in farmed red deer (Griffin et al. 1994), badgers 
(Kampfer et al. 2003; Aznar et al. 2014), lions (Cleaveland et al. 2005), wild boar (Aurtenetxe et al. 2008; 
Boadella et al. 2011), fallow deer (Boadella et al. 2012), and warthogs (Roos et al. 2016). However, 
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results must be interpreted with caution when ELISAs have not been validated for the individual species 
tested (Maas et al. 2013). ELISA testing has been used in Spain for immunosurveillance of wild boar to 
MTBC bacteria (Chambers 2013), but has been found to be poorly sensitive in other wildlife species, 
limiting its utility (de Lisle et al. 2002). It is also unsuitable in resource-poor settings where laboratory 
facilities and/or testing funds are insufficient (Sakamuri et al. 2015). 
 
2.5.2.3 Multiantigen Print Immunoassay (MAPIA) 
The multiantigen print immunoassay (MAPIA) is a laboratory test to immobilize a cocktail of 
serum antigens onto nitrocellulose membranes (Lyashchenko et al. 2000). MAPIA is a more cost-
effective and reproducible method with greater responses than observed in ELISA assays (Lyashchenko 
et al. 2000). MAPIA binds serum IgG antibodies using 12 mycobacterial antigens, which may include 
recombinant ESAT-6, CFP10, Mtb8, Mtb48MPB64, MPB59, MPB70, MPB83, α-crystallin [Acr1], and 
38 kDa protein; protein fusions TBF10, CFP10/ESAT-6, and Acr1/MPB83; and native antigens bovine 
protein purified derivative [PPD-B], and M. bovis culture filtrate [MBCF] (Lyashchenko et al. 2008). 
MAPIA has been useful in characterizing species-specific responses to mycobacterial antigens; for 
instance, red deer infected with M. avium subsp. paratuberculosis registered as false positives on the 
CervidTB STAT-PAK and cross-reacted with MPB83 on MAPIA (Buddle et al. 2010), while ESAT-6 is 
strongly recognized in sera from culture-positive elephants (Lyashchenko et al. 2006). One advantage of 
this test is its ability to quantify the animal’s antigen recognition patterns (Lyashchenko et al. 2006; 
Lyashchenko et al. 2008), which may be valuable for monitoring antibody response during treatment 
(Lyashchenko et al. 2006; Duncan et al. 2009). It can also be used as a confirmatory test, given its use of 
antigens specific to the MTBC (Lyashchenko et al. 2006). 
 
2.5.3 Cellular Immune Response Detection 
Tests of cellular immunity can be used in some species (e.g., cattle) to diagnose animals earlier 
than antibody assays (de la Rua-Domenech et al. 2006). During mycobacterial infections, a T-helper type 
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1 (Th1) response occurs and results in production of cytokines, in particular interferon-γ (de la Rua-
Domenech et al. 2006; Adugna et al. 2014). Tests of cellular immunity are based on the reactions of these 
Th1 cells, either in their release of interferon-γ or a delayed hypersensitivity response from Th1 memory 
cells when stimulated by tuberculin, a crude antigen mixture of mycobacterial extracts (Tizard 2009).  
 
 2.5.3.1 Tuberculin Skin Test (TST) 
The tuberculin skin test (TST; also known as the Mantoux test or intradermal test) is commonly 
used as a routine screening diagnostic test in humans and cattle around the world (Cousins and Florisson 
2005). Intradermal testing is simple and inexpensive to perform, and detects a delayed-type 
hypersensitivity reaction in infected animals (Monaghan et al. 1994). To perform the test, bovine PPD is 
inoculated intradermally in either the caudal fold at the base of the tail (for a caudal fold test [CFT]) or the 
mid-cervical region (for a single intradermal cervical test [SIT]; Buddle et al. 2015). The injection site is 
assessed for an increase in skin thickness 72 hours post-inoculation, and any increase in skin thickness is 
considered a positive response (Buddle et al. 2015). The CFT is used as a routine screening test in cattle 
in North America and throughout the southern hemisphere, while the SIT is used in cattle in continental 
Europe (Buddle et al. 2015). The single intradermal comparative cervical test (SICCT), an alternative 
approach to increase specificity, uses PPD-B and avian PPD from M. avium, inoculated in the mid-
cervical region approximately 12.5 cm apart (Buddle et al. 2015). Skin thickness, as measured with 
calipers, is assessed pre- and 72 hours post-inoculation, and increases are compared between the avian 
and bovine PPD sites (Buddle et al. 2015). One advantage of the SICCT is higher specificity as compared 
to the CFT or SIT based on the ability to better determine whether a response is due to infection with M. 
bovis or NTM such as the M. avium complex (de Lisle et al. 2002), as a larger reaction would be expected 
at the corresponding PPD site (Palmer et al. 2015).  
TST is used as a screening test in certain taxa in captivity, including cervids and other ungulates, 
as well as primates, with some species-specific modifications (Miller and Lyashchenko 2015). Captive 
deer in the US are tested using SIT, and suspects or reactors re-tested using SICCT (Palmer et al. 2015). 
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Primates are screened using TST, although in these species the test is generally performed with 
mammalian old tuberculin (MOT; Chambers 2013) on the upper eyelid (Miller and Lyashchenko 2015). 
The test does present complications when used in free-ranging wildlife, as animals must be immobilized 
twice over a period of three days to both administer the tuberculin and then evaluate the test site. TST has 
been applied in free-ranging African buffalo in southern Africa (le Roex et al. 2015), but capture and 
testing requires significant effort and cost.  
Drawbacks to TST are subjectivity in measuring the response (Sakamuri et al. 2015), uncertainty 
in optimal dosing of tuberculin depending on species (de Lisle et al. 2002), and variable testing 
frequency, type and site of tuberculin administration, and interpretation guidelines among species (Miller 
and Lyashchenko 2015). NTM can cause cross-reaction, and TST has been found to be of poor diagnostic 
value in camelids (Miller and Lyashchenko 2015) and elephants (Mikota, Lyashchenko, et al. 2015). In 
some animals, anergy or stress may result in a false negative test (Schiller et al. 2010).  
 
2.5.3.2 Interferon-γ (IFN-γ) Assay 
The interferon-γ assay (also known as IFN-γ or interferon gamma release assay [IGRA]) is 
another useful diagnostic technique that has been used as an ancillary test to the TST in cattle (Bezos et 
al. 2014). Blood samples are incubated in the presence of test antigens – usually PPD-A and PPD-B, and 
a negative control – to stimulate release of IFN-γ, which is then quantified using an ELISA (de la Rua-
Domenech et al. 2006). IFN-γ, similar to the SICCT, can differentiate between tuberculous and NTM 
infections based on the response to either bovine or avian antigens (de la Rua-Domenech et al. 2006). 
IFN-γ testing is not as cost-effective as serology (Schiller et al. 2010), and requires a laboratory setup, 
which is less feasible in low-resource settings (Sakamuri et al. 2015). The assay is also ineffective in 
anergic animals (de la Rua-Domenech et al. 2006). 
The commercial IFN-γ assay developed for cattle, BOVIGAM (Wood and Jones 2001), has also 
been used in free-ranging buffalo (Michel et al. 2011) and wood bison (Koller-Jones et al. 2006). Another 
commercial assay, PRIMAGAM, was developed for use in non-human primates (Lerche et al. 2008). The 
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QuantiFERON-TB Gold (In-Tube Method) stimulation platform (to replace PPDs in the BOVIGAM) has 
been used in buffalo (Parsons et al. 2011), chacma baboons (Parsons et al. 2009), and black rhinoceros 
(Miller et al. 2017), and along with the IFN-γ ELISA in lions (Sylvester et al. 2017). Assays specific to 
elephants have also been developed (Angkawanish et al. 2013; Paudel et al. 2016).  
 
2.6 Control of Tuberculosis in Wildlife 
Understanding management strategies for TB within the SIR framework requires revision of the 
model to a modified SEIR model (Figure 2.2), again modified from Anderson and May (1979), which 
incorporates an additional class representing exposed animals. The E class then represents animals with 
latent TB infection, where no shedding occurs (Ernst 2012). In this model, the R class represents 
vaccinated animals rather than those that have acquired immunity from natural infection, and for this 
reason, the transition occurs from animals in the S class.  
 
Figure 2.2: A modified SEIR model describing a basic system of tuberculosis for management purposes, 
representing susceptible (S), exposed (E), infected (I), and recovered/resistant/vaccinated (R) classes. The transition 
from S to E is governed by the transmission rate, β; the transition from E to I is governed by the rate of disease 
progression, α; and the transition from S to R is governed by the vaccination rate, γ. 
 
The SEIR model in Figure 2.2 is governed by the following equations: 
𝑑𝑑𝑑𝑑
𝑑𝑑𝑑𝑑
= −𝛽𝛽𝑑𝑑𝛽𝛽 − 𝛾𝛾𝑑𝑑 (2.4) 
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where S is the susceptible class, I is the infected class, β is the transmission coefficient, and γ is the 
vaccination rate, and 
𝑑𝑑𝑑𝑑
𝑑𝑑𝑑𝑑
= 𝛽𝛽𝑑𝑑𝛽𝛽 − 𝛼𝛼𝑑𝑑 (2.5) 
𝑑𝑑𝛽𝛽
𝑑𝑑𝑑𝑑
= 𝛼𝛼𝑑𝑑 (2.6) 
𝑑𝑑𝑅𝑅
𝑑𝑑𝑑𝑑
= 𝛾𝛾𝑑𝑑 (2.7) 
where E is the exposed class, R is the vaccinated class, and α is the rate of progression to active TB, 
Management of TB in wildlife is typically undertaken to mitigate transmission to livestock or to 
protect valuable wildlife species (de Lisle et al. 2002). A laissez-faire approach has been demonstrably 
harmful in some cases: for instance, the devastating foot-and-mouth disease outbreak in the UK 
necessitated that veterinarians suspend routine cattle TB testing, and as a result, TB prevalence increased 
in both cattle and badgers (Woodroffe et al. 2006). Effective management of TB includes components of 
all active forms of disease management: prevention, eradication, and control (Figure 2.3). The strategies 
used or proposed for TB control in wildlife include culling, fertility control, immunization, treatment, and 
alteration of human activities (Figure 2.3). The strategies that are feasible and used frequently differ by 
species and location, and between free-ranging and captive wildlife populations. 
 
Figure 2.3: Tuberculosis management strategies addressing susceptible (S), exposed (E), infected (I), and 





Areas that are currently free of TB in free-ranging wildlife have disease prevention as their 
ultimate goal (de Garine-Wichatitsky et al. 2013; Michel et al. 2015). Prevention is intended to disallow 
transmission between susceptible and infected individuals in populations, often by limiting contact. If 
there is no opportunity for contact between susceptible and infected animals, the product βSI in equations 
2.4 and 2.5 is 0, and no transition occurs. TB prevention in captive wildlife is dependent on adequate 
post-arrival quarantine procedures and routine surveillance (Montali et al. 2001), and in free-ranging 
wildlife, is partially dependent on management and movement of livestock, given the risk of transmission 
from infected herds. A short- to medium-term strategy for containing diseases and preventing 
transmission between infected and uninfected populations is the use of barriers (Bengis et al. 2002). 
Fencing to separate livestock and free-ranging wildlife is an important management strategy that has been 
applied widely across Africa, but has considerable ecological impacts by limiting movements of free-
ranging wildlife (Ferguson and Hanks 2012). Fencing is expensive to purchase and place, and requires 
ongoing maintenance (Ferguson and Hanks 2012), but is unlikely to be completely eliminated in areas 
where negative impacts have been observed.  
Translocation of wildlife is also a risk factor for movement of pathogens. Movement of zoo 
animals and free-ranging wildlife in other countries sometimes requires certification of the animals’ 
freedom from TB, but there is no consistent protocol in place for how certification of TB-free status for 
individual animals is made (Lécu and Ball 2011; Maas et al. 2013). Pre-transport TB testing of captive 
wildlife is recommended to minimize potential exposure at the facility (Bushmitz et al. 2009), but all 
potentially susceptible animals should be quarantined until a TB test has been performed (de Lisle et al. 
2001). The risks of translocation were demonstrated in an outbreak of TB at a private South African game 
reserve after introduction of free-ranging wildlife that were not TB tested (Hlokwe et al. 2016). African 
buffalo are the only wildlife species in South Africa that require TB testing prior to translocation, but 
these practices would be beneficial in all susceptible host species to limit movement of infected animals 




Countries may seek to eradicate bovine TB to facilitate trade of livestock with high standards of 
animal health and food safety (Reviriego Gordejo and Vermeersch 2006). Complete eradication is an 
ideal but typically elusive long-term management goal once TB is present (Bengis et al. 2002). 
Eradication in the strictest sense results in extinction of the E and I classes, with the entire population free 
of disease or infection. Instead, the goal may be to reduce the I class to a negligible number rather than 
zero, as with the OIE’s definitions regarding countries’ TB status: to qualify as a country officially free 
from TB (OTF) in bovids, TB must be a notifiable disease; a surveillance program testing all herds must 
be in place, with at least 99.8% of herds (representing at least 99.9% of bovids in the country) uninfected; 
ante- and postmortem surveillance and regulatory measures for early detection must be in place; and 
imported bovids and semen must meet strict criteria to minimize the likelihood of disease transmission 
(World Organisation for Animal Health 2017). Similar regulations are defined for OTF certification for 
captive cervids (World Organisation for Animal Health 2017). Eradication in captive wildlife facilities is 
similarly difficult, and requires testing throughout the collection to identify infected animals (de Lisle et 
al. 2001).  
Eradication at the national scale has had limited success and is highly dependent on country-
specific circumstances. Australia was successful in eradicating TB from cattle, in part due to the fact that 
there was no native wildlife reservoir (More et al. 2015). Feral water buffalo (Bubalus bubalis) were 
culled extensively during the eradication process (Cousins and Roberts 2001; Radunz 2006); more 
extreme control measures like this are generally only accepted in feral or non-native species (Bengis et al. 
2002). The United States has dramatically reduced its cattle TB over the last century from 5% to 
<0.001%, and is considered a major success in TB control (Schiller et al. 2010). A persistent reservoir of 
white-tailed deer and TB in imported cattle from Mexico have thwarted complete eradication in the US, 
however (Schiller et al. 2010). Ireland, the United Kingdom, and New Zealand are working towards 
eradication but are met with similar challenges with wildlife reservoirs (Schiller et al. 2010). Disease 
eradication is most feasible on islands (Kaneko et al. 2000), where host populations are limited and 
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movements of incoming livestock and wildlife can be more strictly controlled than in countries sharing 




 2.6.3.1 Culling 
Culling host populations is the most practical method for controlling TB in free-ranging wildlife, 
and culling animals with clinical disease or reactive test results is the most effective approach in captive 
wildlife (de Lisle et al. 2001). Culling has varying levels of social acceptability based on the setting, and 
may be problematic in species of conservation concern. For instance, there has been considerable public 
opposition to culling of badgers in the UK, where they are a native protected species (White and Whiting 
2000) with intrinsic value (O’Brien et al. 2011). Interference in badger culling operations is lower in 
Ireland, while compliance and participation from landowners is higher (Sheridan 2011). Proactive culling 
to reduce populations of certain species, such as African buffalo, may be beneficial but socially 
unpalatable (Renwick et al. 2007). In contrast, culling is less controversial in non-native brushtail 
possums in New Zealand, where dairy and beef exports are of great importance to the economy (O’Brien 
et al. 2011). Opposition to the use of the chemical toxicant sodium monofluoroacetate (1080) for lethal 
control of possums has centered on ecological effects of environmental contamination (Eason et al. 1992) 
rather than conservation concerns. Public acceptance of culling may also be improved when it has had 
noticeable positive outcomes for disease control. Simulation modeling of outcomes prior to implementing 
these management strategies may be valuable, as models of targeted removal of white-tailed deer in 
Michigan in the US did not result in reduced TB prevalence (Cosgrove et al. 2012). 
The theory behind culling is based on principles of density-dependence and 𝑅𝑅0; for a disease to 
be maintained endemically in a population (𝑅𝑅0 > 1), the population of susceptible animals, 𝐾𝐾, must 




(𝜎𝜎 + 𝑎𝑎)(𝛼𝛼 + 𝑎𝑎)
𝛽𝛽𝜎𝜎
(2.8) 
where β is the transmission coefficient, 1
𝜎𝜎
 is the average latent period, α is the death rate of infected 
animals, and a is the average per capita birth rate (Anderson et al. 1981). If a constant quota of animals, 
Λ, is to be removed to maintain a set population density, and 𝐾𝐾𝑇𝑇 >
1
2
𝐾𝐾, then it is possible to control 





where r is the per capita population growth rate (Anderson et al. 1981). The population cannot be 
maintained stably by quota culling if  𝐾𝐾𝑇𝑇 <
1
2
𝐾𝐾, however (Anderson et al. 1981). The other approach for 







where Δb is additional mortality due to culling (Anderson et al. 1981). The goal of such widescale 
removals is to reduce β such that remaining susceptible animals are partly protected from infection 
(Swinton et al. 1997). 
Culling may include both susceptible and infected individuals, resulting in decreased population 
densities, or can be selective to specifically target infected animals. The scale of culling varies by species 
and setting. For invasive brushtail possums, removing both susceptible and infected individuals is 
acceptable, so widescale removal efforts using 1080 have been implemented (Eason et al. 1992). Culling 
has shifted to a “systematic overkill” policy to reduce possum numbers far below the calculated threshold 
for disease persistence, to more rapidly eliminate M. bovis from the possum population (O’Brien et al. 
2011). More targeted culling of infected animals occurs in other landscapes such as Hluhluwe-iMfolozi 
Park, South Africa, where African buffalo are mass captured and tested using TST, and reactors are culled 
under a trial test and cull program (le Roex et al. 2015). A selective culling program has also been 
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proposed for wood bison in Canada (Shury et al. 2015). Such intensive targeted programs have significant 
costs and are therefore only feasible in certain settings with adequate investment (Geoghegan 2012).  
The outcomes of culling have been variable depending on the setting. The success of culling in 
brushtail possums is indicated by a > 92% reduction in the number of infected herds during intensive 
culling operations from 1994–2009 (O’Brien et al. 2011). However, conflicting findings from the UK and 
Ireland have been a source of controversy in management of badgers for TB. In the UK, the Randomized 
Badger Culling Trial (RBCT) employed both reactive culling (localized culling to reduce TB in cattle but 
minimizing badgers culled) and proactive culling (widespread, repeated culling) of badgers (Donnelly et 
al. 2003). The results showed increased TB risk in cattle in reactively culled areas, and lower TB risk in 
cattle in proactively culled areas, with an increased TB risk in cattle in the areas surrounding proactive 
culling (Donnelly et al. 2005). These results have been proposed to be due to a social perturbation effect, 
in which culling disrupts badger territories and social behavior, increasing ranging behavior and 
interspecific contact with cattle (Woodroffe et al. 2006). The Easy Offaly Badger Research Project in 
Ireland found lower TB incidence in cattle herds where badgers were removed (Ó Máirtín et al. 1998; 
Eves 1999), and the Four Areas Project found that TB incidence in cattle was lower in areas of proactive 
than reactive badger culling (Griffin et al. 2005). The conflicting results between the UK and Ireland led 
to divergent opinions on management practices; scientists in the UK concluded that badger culling was 
not a viable strategy for bovine TB control (Bourne et al. 2007), while Ireland implemented a national 
badger culling program (Good and Duignan 2017).  
The differences in the results from the RBCT and the Irish studies have been hypothesized to 
occur due to various differences in each countries’ cattle or badger populations, or study implementation 
(O’Connor et al. 2012). Larger cattle herd sizes in the UK may have allowed for more infection 
persistence, and the 𝑅𝑅0 value in cattle may differ between the UK and Ireland (O’Connor et al. 2012). 
Higher badger density in the UK may have resulted in increased perturbation from culling, prevalence in 
badgers may have been increasing in the UK, or previous culling in the UK may have contributed to 
badger social instability (O’Connor et al. 2012). Study implementation also differed between countries: a 
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larger proportion of land in the UK went un-culled and may have created a source-sink dynamic; the 
period of culling was less consistent in the UK; badgers in the UK were trapped using a less effective 
method than in Ireland, meaning residual populations may have existed; and badger movements back into 
study areas in the UK were less restricted by natural barriers (O’Connor et al. 2012).  
 
2.6.3.2 Fertility Control 
Fertility control has been explored as an alternative method of controlling free-ranging host 
populations, by reducing population density by limiting the birth rate rather than through increased 
mortality rates as in culling. Fertility control is less effective than culling at reducing population density 
in the short term, and only removes susceptible animals from joining the population (Swinton et al. 1997; 
Tuyttens and Macdonald 1998), and is therefore unsuitable for controlling outbreaks in naïve or captive 
populations. It has been proposed as a control strategy in brushtail possums (Ramsey et al. 2006; Ramsey 
2007) and badgers (Swinton et al. 1997; White et al. 1997; Tuyttens and Macdonald 1998). Simulation 
modeling studies in badgers have had varying results: one suggested that fertility control would not be 
effective alone, but could be effective if combined with culling (White et al. 1997), while another found 
that fertility control could be as effective as culling if used in combination with vaccination or as a 
standalone measure if deployed as a permanent contraceptive (Smith and Cheeseman 2002). Suppressing 
reproductive behavior can reduce contacts between individuals and will reduce population density over 
time, albeit more slowly than with culling (Killian et al. 2007). However, fertility control may have 
complex effects on population dynamics, social behavior, and 𝛽𝛽 (Caley and Ramsey 2001).  
There are several approaches to controlling fertility in wild populations, but all have drawbacks: 
surgical sterilization would not be practical on a wide scale (Tuyttens and Macdonald 1998); developing 
effective and safe fertility control agents is likely to be a high cost endeavor (White et al. 1997); and 
abortifacients have logistical and welfare concerns (Tuyttens and Macdonald 1998). Field trials have been 
conducted in brushtail possums, where fertility control has been shown unlikely to negatively impact their 
social behavior (Ramsey 2007). The effectiveness for disease control is less clear, with evidence for 
34 
 
increase of pathogen transmission in one study (Caley and Ramsey 2001), but reduced contact and 
pathogen transmission rates in sterilized populations in another (Ramsey et al. 2006; Ramsey 2007). A 
management program involving multiple approaches may be more efficient than a single control strategy; 
one study found that an initial brushtail possum cull combined with BCG vaccination and a fertility 
control vaccine with at least 50% efficacy applied every 3 years was the most cost-effective option for 
local eradication modeled (Ramsey and Efford 2010). 
 
2.6.3.3 Immunization 
Immunization is becoming an increasingly relevant approach to TB control in certain countries, 
particularly Ireland, the UK, Spain, and New Zealand (Waters et al. 2012). The goal of immunization is to 
reduce individuals in the 𝑑𝑑 class by transitioning them to the R class, or to lower 𝛽𝛽. The success of any 
vaccination program hinges on the ability to induce herd immunity, the principle that once a significant 
proportion of the population is vaccinated, there are not enough susceptible individuals to maintain an 
𝑅𝑅0  ≥  1, and unvaccinated individuals are protected from infection (Anderson and May 1985). The level 
of vaccination required to eradicate a pathogen is defined by 𝑝𝑝 > 1 − � 1
𝑅𝑅0
�, where 𝑝𝑝 is the proportion of 
hosts that must be vaccinated (Anderson and May 1982); however, this value is also dependent on the 
efficacy of the vaccine. Population density and prevalence of infection influence the success of wildlife 
vaccination programs (Abdou et al. 2016). 
The only available vaccine against M. tuberculosis and M. bovis is the Bacille Calmette-Guerin 
(BCG) vaccine, which is derived from an attenuated M. bovis strain (Andersen and Doherty 2005). BCG 
has been used in humans since 1921, with billions of doses delivered, but only has a protective effect of 
50% against TB infection (Colditz 1994; Brewer 2000). Individuals without active TB who are vaccinated 
are significantly more likely to react on TST, therefore infected and vaccinated individuals cannot be 
differentiated using TST (Wang 2002). The European Union has prohibited vaccination of cattle against 
TB (EU Council Directive 78/52/EEC) for this reason, and captive wildlife are also typically not 
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vaccinated to allow for routine TST testing (OIE 2009). Development of a differentiating infected from 
vaccinated animals (DIVA) test and DIVA vaccine for use in livestock and wildlife is underway (Waters 
et al. 2012). 
 BCG vaccination of free-ranging wildlife is allowable. Public attitudes towards vaccination of 
wildlife vary, but it is generally seen as acceptable to favorable (Warren et al. 2013; Enticott 2015) and 
less controversial than culling. Vaccine efficacy varies widely by species. A study of African buffalo 
found that intramuscular BCG vaccination conferred no protection from infection or disease (de Klerk et 
al. 2010). Oral BCG vaccination did not result in protection from infection, but did result in reduced 
disease severity in brushtail possums (Aldwell et al. 2003), white-tailed deer (Nol et al. 2008), and wild 
boar (Garrido et al. 2011). In badgers, oral BCG vaccination reduced seroconversion, disease, and the 
number of lesions (Gormley et al. 2017), while intramuscular BCG vaccination resulted in a decreased 
risk of infection (Carter et al. 2012) and reduced disease severity and bacterial shedding when 
administered at 10 times the human dose (Lesellier et al. 2011). The intent of vaccination against TB 
using BCG is not to eliminate new infections, but to lessen morbidity and mortality and most importantly, 
limit transmission (Wobeser 2002).  
The nature of BCG alters the structure of the SEIR model and adds complexity by lending the R 
class several special characteristics. First, unlike in the traditional SIR model, animals do not recover 
from disease (i.e., the I class) and gain immunity, but rather move directly from the S class to the R class 
via vaccination. Second, in the case of TB, the R class is not a true resistant class, as BCG does not 
deliver sterilizing immunity that completely protects from infection, but reduces the severity of disease 
(Aldwell et al. 2003; Nol et al. 2008; Garrido et al. 2011; Lesellier et al. 2011). Vaccinated animals 
effectively function as a second class of susceptibles, and infected vaccinated animals have decreased 
shedding, resulting in a lower transmission coefficient associated with this class. Third, assuming that 




These characteristics could be modeled with a modified SEI model (Figure 2.4). Here, in lieu of 
an R class, the other disease classes are modeled separately based on vaccination status, with the subscript 
v indicating vaccinated animals. There are two transmission coefficients, β and η, to represent the 
different bacterial shedding rates of unvaccinated and vaccinated infected animals. The rate of disease 
progression, α, is also defined differently based on vaccination status. Vaccinated animals can also 
transition back to the unvaccinated susceptible class with loss of immunity over time, δ. 
 
Figure 2.4: A modified SEI model based on vaccination against tuberculosis in wildlife, representing susceptible (S), 
exposed (E), and infected (I) classes for both unvaccinated and vaccinated animals (designated by subscript v). The 
transition from S to E classes is governed by the transmission rates from different groups, β and η; the transition 
from E to I is governed by the rate of disease progression, α; the transition from S to Sv is governed by the 
vaccination rate, γ, and the transition from Sv to S is governed by the rate of lost immunity, δ. 
 




= 𝛿𝛿𝑑𝑑𝑣𝑣 − 𝛽𝛽𝑑𝑑(𝛽𝛽 + 𝛽𝛽𝑣𝑣) − 𝜂𝜂𝑑𝑑(𝛽𝛽 + 𝛽𝛽𝑣𝑣) − 𝛾𝛾𝑑𝑑 (2.11) 
where S is the unvaccinated susceptible class, Sv is the vaccinated susceptible class, I is the unvaccinated 
infected class, Iv is the unvaccinated infected class, δ is the rate of loss of immunity, β is the transmission 
coefficient for shedding from unvaccinated animals, η is the transmission coefficient for reduced shedding 





= 𝛽𝛽𝑑𝑑(𝛽𝛽 + 𝛽𝛽𝑣𝑣) + 𝜂𝜂𝑑𝑑(𝛽𝛽 + 𝛽𝛽𝑣𝑣) − 𝛼𝛼1𝑑𝑑 (2.12) 
𝑑𝑑𝛽𝛽
𝑑𝑑𝑑𝑑
= 𝛼𝛼1𝑑𝑑 (2.13) 
where E represents the expose unvaccinated class, α1 represents the rate of disease progression for 
unvaccinated animals, and 
𝑑𝑑𝑑𝑑𝑣𝑣
𝑑𝑑𝑑𝑑
= 𝛾𝛾𝑑𝑑 − 𝛿𝛿𝑑𝑑𝑣𝑣 − 𝛽𝛽𝑑𝑑𝑣𝑣(𝛽𝛽 + 𝛽𝛽𝑣𝑣) − 𝜂𝜂𝑑𝑑𝑣𝑣(𝛽𝛽 + 𝛽𝛽𝑣𝑣) (2.14) 
𝑑𝑑𝑑𝑑𝑣𝑣
𝑑𝑑𝑑𝑑
= 𝛽𝛽𝑑𝑑(𝛽𝛽 + 𝛽𝛽𝑣𝑣) + 𝜂𝜂𝑑𝑑(𝛽𝛽 + 𝛽𝛽𝑣𝑣) − 𝛼𝛼2𝑑𝑑𝑣𝑣 (2.15) 
𝑑𝑑𝛽𝛽
𝑑𝑑𝑑𝑑
= 𝛼𝛼2𝑑𝑑𝑣𝑣 (2.16) 
where Ev represents the exposed vaccinated class, and α2 represents the rate of disease progression for 
vaccinated animals.This model set demonstrates the complexity in attempting to simulate population 
dynamics when using an imperfect vaccine. An additional component to consider with vaccination is how 
to deliver vaccines to free-ranging wildlife populations. Widescale vaccine delivery to wildlife poses 
several logistical challenges. Parenteral delivery requires individual capture and handling, which is time- 
and labor-intensive (Wobeser 2002). Despite these challenges, intrasmuscular vaccination has been used 
in trials in Ireland (Aznar et al. 2014) and the UK (Brown et al. 2013; O’Connor 2016) using 
BadgerBCG, which has been licensed specifically for use in badgers (Brown et al. 2013). Oral 
vaccination programs using widespread dispersal of vaccine baits are the most commonly implemented 
wildlife vaccination strategy, and have been used successfully to control rabies in carnivores in North 
America and Europe (Sterner et al. 2009; Freuling et al. 2013). Oral vaccines have unique considerations: 
they must be able to survive the gut and induce immunity when ingested, not be pathogenic if ingested by 
non-target species, and be stable and remain immunogenic in the environment (Wobeser 2002). Implicit 
safety concerns with use of oral vaccines include reversion to virulence, oncogenecity, excretion from 
vaccinated animals, and public health risks (Stöhr and Meslin 1997). Consumption of baits by non-target 
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species, especially cattle, is a particularly relevant concern, as oral BCG vaccine can result in positive 
TST in cattle (Buddle et al. 2005). An ideal DIVA vaccine alternative would not produce disease in hosts 
or non-target species, provide long-lasting immunity and protection against all local TB strains, be 
incapable of reversion to virulence, and be inexpensive and stable (Wobeser 2002). Improved vaccine 
options are an area of ongoing research (Buddle et al. 2013). 
 
2.6.3.4 Treatment 
Treatment of TB is designed to transition individuals from the 𝛽𝛽 class back to the susceptible class 
rather than removing them from the population. This can be shown in a simple SEI model (Figure 2.5), 
where the only difference from the SEI component of the model in Figure 2.3 is the addition of a 
transition, ε, that represents cure of infected animals and return to the S class. 
 
Figure 2.5: A modified SEI model based on treatment of tuberculosis in wildlife, representing susceptible (S), 
exposed (E), and infected (I) classes. The transition from S to E classes is governed by the transmission rate, β; the 
transition from E to I is governed by the rate of disease progression, α; and the transition from I to S is governed by 
the cure rate, ε. 
 
The model in figure 2.5 can be represented by the following model set: 
𝑑𝑑𝑑𝑑
𝑑𝑑𝑑𝑑
= 𝜀𝜀𝛽𝛽 − 𝛽𝛽𝑑𝑑𝛽𝛽 (2.17) 









= 𝛼𝛼𝑑𝑑 − 𝜀𝜀𝛽𝛽 (2.19) 
where E is the exposed class, and α is the rate of disease progression. 
While on a mathematical level treatment is a simple intervention to reduce the number of infected 
animals, in practice it is difficult to implement. TB treatment in elephants involves a costly (e.g., $20,000-
60,000/elephant/year; Dumonceaux and Mikota 2006; Mikota 2008; Simpson et al. 2017) multi-drug 
regimen administered over a long period of time, and is therefore not a practical option for free-ranging 
wildlife. Captive collections with rare species or charismatic megafauna may choose to administer 
treatment to infected animals rather than euthanize (de Lisle et al. 2001), but treatment of clinical TB in 
laboratory non-human primates is not recommended (Montali et al. 2001). Infected animals pose a disease 
risk to other animals within the collection, and a potential public health risk to employees. Some 
outbreaks in zoos have involved multiple species (Lewerin et al. 2005), although the transmission routes 
in these cases were not always clear. There have been reported cases of TB in human handlers of 
elephants and rhinoceros with TB (Murphree 2011; Miller and Olea-Popelka 2013), but the risk of 
transmission is considered low for those with brief contact (e.g., members of the public viewing animals; 
Michalak et al. 1998). 
Successful treatment of infected animals in captivity has been recorded in elephants (Mikota et al. 
2001; Vogelnest et al. 2015), black rhinoceros (Mann et al. 1981; Duncan et al. 2009), bongo 
(Tragelaphus eurycerus; Auclair et al. 2002), Arabian oryx (Oryx leucoryx; Greth et al. 1994), 
chimpanzees (Stephens et al. 2013), and Matschie’s tree kangaroo (Dendrolagus matschiei; Miller and 
Lyashchenko 2015). Treatment of non-domestic species is fraught with difficulties in determining 
appropriate drug doses, which are extrapolated from human recommendations, length of treatment, and 
delivery routes (Stakeholders Task Force on Management and Research Priorities of Tuberculosis in 
Elephants 2017). Drugs most commonly used in treatment of animal TB include isoniazid (INH), 
rifampin (RIF), pyrazinamide (PZA), ethambutol (EMB), amikacin, and levofloxacin (Bush et al. 1990; 
Greth et al. 1994; Auclair et al. 2002; Stakeholders Task Force on Management and Research Priorities of 
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Tuberculosis in Elephants 2017). The mainstays of treatment for elephants are INH, RIF, PZA, and EMB, 
and general guidelines for treatment protocols have been published for elephants (Stakeholders Task 
Force on Management and Research Priorities of Tuberculosis in Elephants 2017). Drugs may be 
administered orally directly or disseminated in feed or water, but oral delivery may be complicated by 
poor acceptance (Auclair et al. 2002). Some rectal formulations have been developed for elephants 
(Maslow, Mikota, Zhu, Isaza, et al. 2005; Zhu et al. 2005), and amikacin, EMB, and INH were delivered 
intramuscularly or subcutaneously in bongo (Auclair et al. 2002). Some species may have sensitivities to 
drugs, and fatal drug reactions have been reported, as with INH toxicity in Bactrian camels (Bush et al. 
1990). Adverse effects of treatment are not uncommon and may be severe, resulting in interruption of 
treatment and risking promotion of drug resistance (Dumonceaux et al. 2011). In worst case scenarios, 
uncertainty over antemortem diagnostic results to confidently determine disease status, adverse drug 
effects, and public health concerns may make euthanasia the only viable option (Bush et al. 1990; 
Dumonceaux et al. 2011). 
 
2.6.3.5 Alteration of Human Activity 
Altering human activities or enterprises that modify the natural landscape can be used to control 
TB in wildlife, often by reducing β by removing factors that promote clusters of artificially high animal 
density. Effecting changes or garnering support for enforcing changes in human activities to mitigate 
diseases in free-ranging wildlife can prove extremely challenging, however. As an example, badgers in 
the UK have been shown to visit farmyards and exploit resources from feed troughs, sheds, haystacks, 
and other areas, and to defecate and urinate onto cattle feed; these activities represent clear opportunities 
for pathogen transmission (Garnett et al. 2002). Simple exclusion measures such as aluminum sheet gates 
and fencing are highly effective at preventing badger entry into feed storage and cattle housing areas, but 
in one study, willingness of farmers to deploy these measures (which were purchased and installed at no 
cost to them) was highly variable (Judge et al. 2011). In Michigan, white-tailed deer tend to congregate at 
artificially high densities due to feeding and baiting practices, which aids in transmission (Schmitt et al. 
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1997). A majority of local stakeholders support the TB eradication goal, in principle (Dorn and Mertig 
2005). However, when asked about specific strategies for managing TB in deer in this area – banning 
baiting and feeding and reducing deer numbers – those in opposition outweighed those in support for all 
proposed interventions (Dorn and Mertig 2005). Surveys in Spain showed more encouraging results, with 
some potential interventions – separation of wildlife and livestock access to waterholes, increased testing 
of cattle on farms with a positive TB case, and removing gut-piles after hunting – ranked as practical by 
various stakeholder groups (Cowie et al. 2015). Interestingly, stopping supplemental feeding was 
considered the most effective potential intervention by experts, yet was not considered practical by any 
stakeholder groups (Cowie et al. 2015). 
Introducing short-term management changes to control small TB outbreaks may be more socially 
acceptable than long-term interventions. A TB outbreak in white-tailed deer in Minnesota was contained 
by using a multifaceted approach: increased hunting opportunities, permits for private landowners to 
remove unlimited numbers of deer from their property as long as carcasses were tested for TB, and a 
feeding ban with strong enforcement (Carstensen et al. 2011). This outbreak appears to have been a 
spillover event that was managed aggressively with good compliance from the public, and the disease did 
not become established as in Michigan (Carstensen et al. 2011). A TB outbreak in a troop of chacma 
baboons was associated with the troop sleeping in an abandoned building, which facilitated accumulation 
of feces and other potentially infectious material, and aerosol transmission among troop members 
sleeping at high density in an enclosed space (Keet et al. 2000). This outbreak resolved without further 
intervention after access to the building was restricted and the baboons returned to sleeping in trees (Keet 
et al. 2000). 
 
2.7 Conclusions 
Virtually all of earth’s ecosystems have been modified by human activity (Vitousek et al. 1997), 
which has complex and variable impacts on disease prevalence in wildlife (Brearley et al. 2013). Wildlife 
diseases impact not only individuals and populations, but through their interactions with other species, 
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wildlife disease impacts communities and ecosystems as well (Tompkins et al. 2011). TB has an 
extraordinary global burden in millions of wildlife, livestock, and humans (Waters et al. 2012; World 
Health Organization 2016). Although veterinary TB control is a daunting task, it is essential to livestock, 
wildlife, and human health. The World Health Organization End TB Strategy aims for a 90% reduction in 
human TB deaths and 80% reduction in TB incidence by 2030 (World Health Organization 2016). This 
ambitious plan cannot succeed without a One Health approach, and must address both zoonotic TB in 
humans and bovine and human TB in animals (World Health Organization et al. 2017). However, disease 
managers are often fragmented across agencies, including public health officials for human disease, 
agricultural officials for livestock disease, and wildlife or natural resource officials for wildlife disease. 
An integration of data and strategies among these groups is required to fully explore the multi-host 
dynamics of TB (Gebreyes et al. 2014; Thirunavukkarasu et al. 2017). Ignoring or underestimating 
interspecific transmission and the environmental component of One Health are likely to be hampering TB 
control. This gives rise to the first objective of this dissertation: to assess the impact of environmental 
factors affecting wildlife populations and TB management strategies. Three studies compose the 
contributions to this objective: exploring weather and other environmental factors in trapping success of 
European badgers being managed for bovine TB; estimating population density of badgers, relative to 
habitat variables, within a BCG vaccination area; and identifying potential risk factors for TB seropositive 
status in working African elephants stemming from demography, intra- and interspecific contact. 
Estimating the burden of TB in a population and the impact of management in reducing TB 
depends on the accuracy of diagnostic tools. Diagnostic modalities for TB have advanced considerably in 
the last decades, and improved assays are continually being developed (Schiller et al. 2010; Chambers 
2013). The uncertainty that remains in diagnostic testing for TB has troubling implications for successful 
disease control. TB cannot be controlled without identifying both actively infected individuals and 
latently infected individuals, who have the potential to develop active disease and transmit bacteria. While 
treatment is possible, cure is difficult to define without being able to confidently determine a change in 
infection state. Tests for TB exposure or infection have variable sensitivity and specificity in different 
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wildlife species (Maas et al. 2013), and the predictive value of positive or negative test results is 
dependent on population prevalence (Dohoo et al. 2009), making interpretation subject to local 
prevalence. Management decisions depend on understanding test results in light of the local disease 
scenario, which leads to the second objective of this dissertation: to study the performance of diagnostic 
tests in a novel setting and interpret the results in the context of exposures within the ecosystem. This 
study employed two serological tests, STAT-PAK and DPP, for the first time in working African 
elephants in a range country with a complex community of humans, livestock, wildlife, and mycobacteria. 
The diversity in wildlife TB settings necessitates a management approach tailored to the local 
conditions and host communities (Johnson et al. 2015). The varying success of a management strategy 
applied in the same species in relatively similar habitats – for instance, culling badgers in England 
compared to Ireland – points to additional ecological components that play a role in disease dynamics. 
The biology and ecology of the host species involved, host species immune responses, and the community 
ecology of hosts and mycobacterial pathogens are all features that should be considered. Feasibility and 
social acceptance of implementing proposed interventions, as well as financial resources are other factors 
that vary widely around the world but have considerable influence on management success. Control of TB 
in wildlife is evolving as options for vaccination become more available and feasible (Buddle et al. 2011), 
but the long-term effects of newer control strategies for wildlife such as BCG vaccination remain unclear. 
The challenges of adapting management to local ecology and needs form the basis of the final objective 
of this dissertation: developing recommendations for TB management programs based on surveys, 
capture data, and consideration of individual, population, and community factors. This objective 
comprises the studies listed above, as well as a retrospective compilation of treatment data for captive 
elephants in North America. The results of these studies using prevention, culling, vaccination, and 
treatment are framed within the context of the long-term success of each locality’s management goals and 
extenuating circumstances.  
TB is a complex multi-host–pathogen system that requires a management approach tailored to its 
unique local dynamics. Managing diseases in the context of an integrated One Health approach that 
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incorporates human, animal, pathogen, and environmental factors is necessary to fully address complex 
interactions (Osburn et al. 2009; Cumming and Cumming 2015). TB has far-reaching impacts beyond 
health, including livestock productivity, producer livelihoods, international trade, and wildlife 
conservation (Geoghegan 2012); therefore, its effective control has tremendous economic and social 
benefits (Olmstead and Rhode 2004). Controlling TB at the wildlife-livestock-human interface must 
occur through a coordinated interdisciplinary approach to be successful (de Garine-Wichatitsky et al. 
2013; Miller and Olea-Popelka 2013).The projects in this dissertation represent highly collaborative 




CHAPTER 3: WEATHER INFLUENCES TRAPPING SUCCESS FOR TUBERCULOSIS 





European badgers (Meles meles) in Ireland and the United Kingdom are a reservoir for 
Mycobacterium bovis, the causative agent of bovine tuberculosis (TB). A number of interventions have 
been evaluated in attempts to control bovine TB within badger populations, many of which rely on the 
capture of badgers. One strategy being implemented within Ireland is intramuscular vaccination using 
Bacille Calmette Guerin (BCG), as an alternative to badger culling. The success of vaccination as a 
disease control strategy depends on the ability to capture badgers and administer vaccines, thus trapping 
success is crucial to effectively vaccinate the population (maximize vaccine coverage). A field vaccine 
trial was conducted in County Kilkenny, Ireland, from 2010–2013. We used data from this trial to 
evaluate the association between weather (precipitation and temperature data), badger sett characteristics, 
and badger trapping success. Approximately 10% of capture efforts resulted in a badger capture. Our 
results indicate that badger captures were highest in drizzle, rain, and heavy rain weather conditions, and 
when minimum temperatures ranged from 3–8 °C. Badger captures were highest at main setts (large 
burrow systems) and when sett activity scores were high (qualitative classes 4 or 5). Using local 
precipitation and temperature data in conjunction with observed sett characteristics provides wildlife 
managers with guidelines to optimize trapping success. Implementing capture operations under optimal 
conditions should increase the trapping success of badgers and allow for increased delivery of vaccines to 
manage bovine TB. 
 
  
                                                     
1 Originally published as: Martin LER, Byrne AW, O’Keeffe J, Miller MA, Olea-Popelka FJ. 2017. Weather 
influences trapping success for tuberculosis management in European badgers (Meles meles). European Journal of 




Managing endemic diseases in free-ranging wildlife relies on interventions intended to control or 
eradicate the disease (Wobeser 2002). When controlling disease, vaccination of wildlife is considered 
under certain circumstances, particularly in offering protection against diseases that threaten livestock 
production or wildlife species of conservation concern (Cross et al. 2007). Vaccination programs may be 
useful in the control of wildlife diseases such as bovine tuberculosis (TB). Bovine TB affects livestock 
and a number of wildlife species around the world, and is an important disease of cattle in the Republic of 
Ireland (More and Good 2015). The European badger (Meles meles) is an important wildlife reservoir 
implicated in bovine TB persistence, which hampers disease eradication efforts. In Ireland, badgers are 
listed as a protected species under the Irish Wildlife Act, thus their conservation is an important 
consideration in disease management (Byrne, Sleeman, et al. 2012). Bovine TB management in Ireland 
has included targeted culling of badgers in areas of cattle TB outbreaks (O’Keeffe 2006). Culling is not a 
long-term sustainable management strategy of a protected species, thus vaccination of badgers against 
bovine TB has been proposed as an alternative. Vaccination has the dual benefits of controlling disease 
without reducing badger populations, while lessening the morbidity and mortality in badgers due to TB 
disease. The Bacillus Calmette-Guérin (BCG) vaccine has been shown to be safe (Lesellier et al. 2006) 
and efficacious (Chambers et al. 2011; Lesellier et al. 2011) in badgers. However, a considerable portion 
of a given badger population must be immunized for vaccination to effectively replace culling as a 
management strategy (Wilkinson et al. 2004; Byrne, O’Keeffe, et al. 2012). 
An intramuscular BCG vaccine is currently available for use in badgers, which requires capture 
and handling for administration. Maximizing trapping success will therefore be crucial to an effective 
vaccination program. Live-capture rates are low among carnivores. Capture success of red foxes (Vulpes 
vulpes) has been reported in the range of 1.5–1.8 captures/100 trap-nights (Baker et al. 2001) or 0–3.4 
captures/100 trap-nights (Ruette et al. 2003), and for stone martens (Martes foina) and pine martens 
(Martes martes), 0.6–7.8 captures/100 trap-nights (Ruette et al. 2003). Badgers are nocturnal and 
fossorial, which further reduces capture opportunities. A study in Atlantic Spain showed that a minimum 
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of 40 traps had to be set per sampling period per sett to trap 93.18% of adult badgers (Acevedo et al. 
2014). Byrne et al. (2012) showed mean badger trappability during a vaccine trial in County Kilkenny, 
Ireland to be 34–35% across the population, with variation by season and age-class. Examining specific 
factors that improve trapping success of badgers can provide wildlife managers with information to 
optimize trapping efforts and, in doing so, guide wise allocations of resources to protect badgers and 
livestock from TB.  
Trapping success is influenced by factors related to trapping methods, environmental variables, 
and species characteristics (Pawlina and Proulx 1999; Tuyttens et al. 1999). Few mammal trapping 
studies have examined the role of weather. Temperature and time since rainfall affected trapping success 
of Valley pocket gophers (Cox and Hunt 1992), and rainfall and lower temperatures were positively 
correlated with captures of Western Red-backed voles (Maguire 1999). In the United Kingdom (UK), 
temperature and precipitation have been shown to influence the efficiency of cage-trapping badgers 
(Noonan et al. 2015). However, that study in the UK was conducted over a small area with a discrete, 
systematically trapped population using bait and a different trap style than that employed in Ireland. Thus, 
the objective of this study was to examine the effect of local weather (temperature and precipitation), 
season, as well as sett type and sett activity, on badger trapping success in disease management in Ireland.  
 
3.3 Methods 
3.3.1 Study Area 
This study used data from the Kilkenny Vaccine Trial; the study area and capture protocol have 
been previously described by Byrne et al. (2012). Briefly, the study area is approximately 755 km2 
located in the northwest of County Kilkenny, Ireland, and encompasses pasture land with extensive 
hedgerows (Figure 3.1). This area was divided into three zones (A, B, and C) for different treatments of 




Figure 3.1: Map of badger vaccine trial area and zones with County Kilkenny, Ireland. Black dots are main setts and 





3.3.2 Capture Protocol 
Badgers were captured in six sessions from February 2010 – December 2013. Trapping occurred 
during all months of the year, but most heavily from March–June and October–November and 
infrequently during July–August. Badgers were captured using stopped wire restraints (for details on 
these restraints and their impact on trapped badgers see: Byrne et al. 2015b). In each zone, active setts 
were targeted each week for trapping, and 1–35 restraints were laid at each sett. The number of restraints 
laid was subjectively determined by signs of activity, number of openings available, and badger passes or 
paths available for restraints to be set. Setts were classified as main setts (those used for breeding and 
over-wintering; Smal 1995) or non-main setts. Starting in February 2011, at the beginning of the week, 
setts were assigned activity scores ranging from 0–5 (Table 3.1). Trapping was conducted at setts with 
activity scores ≥ 3. Trapping occurred at selected setts over a period of 8 nights. A sett-night is defined as 
all trapping effort at one sett over one trap night. All traps were checked daily prior to 12 pm.  
Table 3.1: Standardized badger sett activity scoring system used in Ireland. 
Score Description 
0 No activity; openings closed or partly closed by clay, leaves, etc. No fresh paths or tracks are visible 
leading to, or between openings. Old existing paths are overgrown and beginning to disappear. Grass or 
scrub growing around openings and on the spoil heap. 
1 Beginning of movement; first signs of activity, with paths leading to the openings. Openings however are 
not cleaned out. Could not be sure if paths are badger or non-target species. 
2 Possible badger activity; distinctive paths leading to openings. Openings may or may not be cleaned out. 
No fresh spoil heap. Possible footprint. Impression is that the badger is travelling around different setts 
rather than setting up home. 
3 Badger activity; opening cleaned out but spoil heap not fresh. Paths can be visibly seen leading to and 
from openings. Bottom of opening is clean where animal is moving in and out of the sett. 
4 Definite badger activity; paths can be clearly seen leading to and between openings. Openings cleaned 
out with fresh spoil heaps, possibly with or without bedding. Bottom and side of openings are clean and 
shiny in appearance where badger is moving in and out of the sett. Fresh latrine pits in the vicinity of the 
openings. 
5 Definite badger activity; as above at number 4 but at a main sett. 
 
In each zone, minimum and maximum temperatures were recorded using a maximum/minimum 
thermometer (AgriHealth, Monaghan, Ireland) for each 24 hour period from morning to the time when 
traps were checked the following morning. Precipitation scores were assigned on a scale of 1–6, where 1 
= dry, 2 = drizzle, 3 = light rain, 4 = rain, 5 = heavy rain, and 6 = snow. A single precipitation score, 
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representative of conditions overnight when badgers were expected to be active, was assigned by the field 
staff for each 24-hour period.  
  
3.3.3 Statistical Analyses 
Descriptive statistics (counts, frequencies, proportions, means and standard deviations) were 
calculated to evaluate the data distribution. The temperature data revealed a non-linear relationship 
between minimum and maximum temperature and badger trapping success. To further explore this 
relationship, minimum and maximum temperatures were separated into four categories based on quartiles. 
Logistic regression modeling was used to assess trapping success, which was considered as a binary event 
(badger captured or not) in a given sett/night. 
Univariable logistic regression models were used to assess the association between variables (sett 
type, sett activity score, precipitation score, minimum and maximum temperature categories, number of 
traps per sett, season, year, and zone) and whether or not a badger was captured. All variables found to be 
significant (using a significance threshold of p < 0.15) in the univariable analysis were considered for 
inclusion in a multivariable model. Continuous variables were assessed for collinearity using pairwise 
Pearson correlation, and categorical variables were assessed for collinearity using Spearman correlation. 
When collinearity was detected in a pair of variables, only the variable with higher correlation to badger 
trapping success was retained. 
A series of ten logistic regression candidate models were developed using variables from the 
univariable analysis. Two-way interaction terms between weather and season were also investigated in 
some candidate models. Using a full fixed effects logistic regression model, model fit was assessed using 
the Hosmer-Lemeshow goodness-of-fit test and a receiver operating characteristic curve. To control for 
lack of independence from repeated observations within setts, the candidate model set was tested using 
three-level mixed logistic regression models with setts nested within zones. An information-theoretic 
approach with Akaike’s Information Criterion (AIC) was used to perform model selection (Burnham and 
Anderson 2002). The model with the lowest AIC (and highest weight) was considered the preferred 
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model, and models with ΔAIC < 2 were considered equally parsimonious. The candidate model set is 
shown in Table 3.2. All candidate models contained season, year, and number of traps set as controls. To 
ensure comparability of AIC values by using the same number of observations for all models (Burnham 
and Anderson 2002), model selection was performed on a subset of the data (13,860 of 19,196 total sett-
nights) for which no covariate data was missing. All analyses were performed in Stata 13.1 (StataCorp 
2013). 
Table 3.2: Candidate models and model statistics for mixed effects logistic regression models of badger trapping 
success.  
Model LL K AIC ΔAIC wi 
Main Activity Weather MinTemp Traps Season Year -4028.453 20 8096.906 0 0.79 
Activity Weather MinTemp Traps Season Year -4031.012 19 8100.025 3.12 0.17 
Main Weather MinTemp Traps Season Year -4134.651 18 8305.301 208.40 0.00 
Main Activity Weather Traps Season Year -4034.823 17 8103.646 6.74 0.03 
Activity Weather Traps Season Year -4037.215 16 8106.429 9.52 0.01 
Main Activity MinTemp Traps Season Year -4039.411 15 8108.821 11.92 0.00 
Activity MinTemp Traps Season Year -4041.986 14 8111.971 15.07 0.00 
Main Activity Traps Season Year -4051.036 12 8126.073 29.17 0.00 
Main Activity Weather MinTemp Traps Season Year 
Weather*Season 
-4024.328 30 8108.656 11.75 0.00 
Activity Weather MinTemp Traps Season Year 
Weather*Season 
-4026.878 29 8111.756 14.85 0.00 
K: number of parameters; LL: log likelihood; AIC: Akaike’s information criterion; ΔAICc: difference in AIC from 




Trapping occurred at 561 unique setts over 19,196 sett-nights from 2010-2013.  The number of 
trapping events at main and non-main setts was approximately equal, with 9,316 trap-nights at main setts 
and 9,880 at non-main setts. Number of restraints per sett ranged from 1–35 (mean 7.8, SD 3.3). Sett 
activity was not quantified in 2010 or early 2011 (before February). Of the 14,272 sett-nights where sett 
activity was recorded, 54.5% were scored 3, 24.2% were scored 4, and 21.3% were scored 5. Using 
observer precipitation scores, there were 7,526 sett-nights with dry weather, 2,721 sett-nights with drizzle, 
2,848 sett-nights with light rain, 3,274 sett-nights with rain, 1,941 sett-nights with heavy rain, and 262 
sett-nights with snow. Minimum temperature ranged from -12 to 16 °C (mean 5 °C, SD 4.5). Maximum 
temperature ranged from -3 to 30 °C (mean 12.4 °C, SD 4.9). The majority of sett-nights (17,394/19,196; 
91%) did not result in capture of any badgers. A total of 1,802 sett-nights resulted in trapping success; 
52 
 
most successful sett-nights (1,623) resulted in one badger captured, but 167 sett-nights resulted in two 
badgers captured and 12 sett-nights resulted in three badgers captured. The overall trapping success rate 
was 9.5 badgers/100 sett-nights. 
Univariable logistic regression analysis indicated significant (at p < 0.15) differences in badger 
trapping success for sett type, sett activity, precipitation score, minimum temperature category, maximum 
temperature category, number of traps set, season, and year (Table 3.3). Minimum and maximum 
temperature were highly correlated, and minimum temperature was retained for inclusion in multivariable 
models based on its higher correlation with badger trapping success. Analysis of Spearman correlation 
coefficients for categorical variables did not show strong correlations (ρ > 0.7). 
Table 3.3: Results from univariable logistic regression analysis of sett characteristics, weather variables, and other 
predictors of badger trapping success in Co. Kilkenny, Ireland 2010–2013. 
Variable Category  OR 95% CI p-value 
Main Non-main  REF – – 
 Main  1.79 1.62–1.97 < 0.001 
Sett activity  3  REF – – 
 4  2.64 2.28–3.06 < 0.001 
 5  4.56 3.97–5.24 < 0.001 
Weather  1 (dry)  REF – – 
 2 (drizzle)  1.37 1.18–1.59 < 0.001 
 3 (light rain)  1.17 1.00–1.36 0.041 
 4 (rain)  1.52 1.33–1.74 < 0.001 
 5 (heavy rain)  1.63 1.39–1.91 < 0.001 
 6 (snow)  0.70 0.41–1.18 0.178 
Minimum temperature ≤ 2 °C  REF – – 
 3–5 °C  1.36 1.19–1.55 < 0.001 
 6–8 °C  1.08 0.94–1.23 0.26 
 ≥ 9 °C  0.74 0.63–0.86 < 0.001 
Maximum temperature ≤ 9 °C  REF – – 
 10–12 °C  1.07 0.94–1.22 0.28 
 13–16 °C  0.88 0.77–1.00 0.049 
 ≥ 17 °C  0.62 0.53–0.72 < 0.001 
No. Traps N/A  1.13 1.12–1.15 < 0.001 
Season Spring  REF – – 
 Summer  0.47 0.38–0.57 < 0.001 
 Autumn  1.01 0.89–1.14 0.92 
 Winter  1.36 1.20–1.53 < 0.001 
Year 2010  REF – – 
 2011  1.14 1.00–1.31 0.06 
 2012  1.06 0.92–1.22 0.42 
 2013  0.92 0.80–1.07 0.29 
REF = reference 
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The full logistic regression model had adequate performance under the ROC curve (AUC = 0.71), 
and the Hosmer-Lemeshow goodness-of-fit test did not reveal a lack of fit in the model (p = 0.70). AIC of 
the mixed effects logistic regression models revealed a single most parsimonious model, the full model 
containing sett type, sett activity, precipitation score, and minimum temperature (Table 3.2, Figure 3.2). 
When controlling for the combined effect of all other variables, there was a difference in badger trapping 
success between sett types, with captures more likely to occur at main setts than non-main sett (OR = 
1.23, 95% CI 1.03–1.48). Badger captures were more likely at setts with activity scores of 4 (OR = 2.58, 
95% CI 2.18–3.06) and 5 (OR = 3.04, 95% CI 2.54–3.64), compared to setts with an activity score of 3. 
Captures were only marginally higher at setts with activity scores of 5 compared to 4 (OR = 1.18, 95% CI 
0.95–1.46). Captures were more likely in drizzle (OR = 1.20, 95% CI 1.00–1.43), light rain (OR = 1.08, 
95% CI 0.89–1.3), rain (OR = 1.29, 95% CI 1.29–1.53), and heavy rain (OR = 1.47, 95% CI 1.21–1.79), 
compared to dry weather. Captures were less likely in snow than dry weather (OR = 0.41, 95% CI 0.13–
1.31). Badger captures were more likely in minimum temperatures of 3–5 °C (OR = 1.33, 95% CI 1.12–
1.59), 6–8 °C (OR = 1.20, 95% CI 1.01–1.43), and ≥ 9 °C (OR = 1.05, 95% CI = 0.86–1.30) compared to 
minimum temperatures ≤ 2 °C. As the number of restraints set increased by 1, the odds of capturing a 
badger increased 6% (OR = 1.06, 95% CI 1.04–1.08). Badger captures were more likely in spring (OR = 
1.78, 95% CI 1.38–2.31), autumn (OR = 1.9, 95% CI 1.46–2.42), and winter (OR = 2.4, 95% CI 1.81–
3.13), compared to summer. Badger trapping success varied little in 2012 (OR = 0.98, 95% CI 0.84–1.14) 
and 2013 (OR = 0.98, 95% CI 0.83–1.13) compared to 2011.  
 
3.5 Discussion 
In this study, the proportion of trapping events resulting in capturing at least one badger was low 
with < 10% of sett-nights resulting in a badger captured, highlighting the importance of determining 
factors associated with trapping success for implementing a vaccination program. Our results indicate that 





Figure 3.2: Forest plot of odds ratios and associated 95% confidence intervals for variables in the top logistic 
regression model of badger capture success in County Kilkenny, Ireland. Values for odds ratios and 95% confidence 
intervals are reported on the right side of the plot. Reference groups for variables (given in parentheses) are as 
follows: non-main sett (sett type); activity score 3 (sett activity score); dry (precipitation); ≤ 2 °C (minimum 
temperature); spring (season); 2011 (year) 
 
Sett characteristics proved to be important predictors of trapping success. Badger captures were 
more likely at main setts than non-main setts (Byrne et al. 2013a). Main setts are typically larger and 
more active than non-main setts (Smal 1995), and therefore have more badgers present or more entrances 
available for trapping (Byrne et al. 2013a). Trapping success also increased marginally with each 
additional restraint set, which is related to some degree to the number of sett entrances and paths available 
for trapping. Badger captures were more likely at setts with higher activity scores, and previous work has 
shown sett activity can provide a crude indication of badger presence (Wilson et al. 2003). Although the 
relationship between trapping success and sett activity was not surprising, the magnitude of the 
differences in capture odds among activity scores was notable. It is clear that setts with a score of 4 or 5 
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should be prioritized for maximizing trapping success, given odds ratios 2.6–3 times higher for scores of 
4 or 5 as compared to 3. Sett activity was the most important factor (highest odds ratios) contributing to 
badger captures in this study. 
Anecdotal reports in Ireland indicated badger captures might increase after nights with rain or 
wind. Our analysis supports this idea, with all but one category of rainy weather associated with increases 
in badger captures. Two factors may be driving the relationship between rainfall and trapping success. 
First, earthworms are an important food source for badgers and are reported in numerous studies of 
badger diet in Ireland (reviewed by Byrne, Sleeman, et al. 2012) and elsewhere (reviewed by Goszczyński 
et al. 2000). Badgers are likely to emerge after rainfall to take advantage of emerging earthworms, an 
abundant and easily obtained protein source. Elliott et al. (2015) reported that badgers in a study site in 
Ireland tended to make smaller foraging trips during wet weather. This was interpreted to mean that food 
resources (primarily earthworms) were more plentiful, and thus badgers did not have to forage as far from 
their setts to find prey. Indeed, recently research from Ireland has found that badger body mass is 
significantly, and positively, affected by precipitation (Byrne et al. 2015). Badgers appear to gain weight 
in the months following above long-term average rainfall, indicating that badgers are indeed gaining 
physiologically through increased access to food resources (Byrne et al. 2015). The second hypothesis 
relates to badgers having a strong sense of smell and typically being wary of human scent, some to the 
point of failing to emerge from a sett overnight if the sett has been visited by a person during the day 
(Roper 2010). Rain may reduce human scent outside setts and around restraints, making badgers less 
wary of emerging from setts or approaching restraints. Frequent rainfall in Ireland offers ample 
opportunities for improved trapping success.  
Badgers were most likely to be captured when minimum temperatures were in the 3–8 °C range, 
and during winter compared to other seasons. The 3–8 °C temperature range comprised the interquartile 
range of the observed minimum temperature data in our study, indicating a preference for cooler and 
moderate temperatures. This observation is supported by anecdotal evidence from field staff, who 
reported poor perceived trapping success in warm weather and weather cold enough to produce frost or 
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snow. Badgers do not hibernate in Ireland, but their activity levels are known to decrease during winter in 
northern latitudes, consistent with a type of torpor or winter lethargy (Fowler and Racey 1988; Roper 
2010; Newman et al. 2011). It may be difficult for badgers to forage in frozen soils. Badgers experience a 
net negative energy balance and increased heat loss (Fowler and Racey 1988) despite a decrease in resting 
metabolic rate (McClune et al. 2015), with weight dramatically decreasing during winter months (Byrne 
et al. 2015). Badgers may reside outside of the sett and sleep above ground during high temperatures 
(Roper 2010). Badgers may become less trappable during warm nights when they are away from their 
setts, as stopped restraints are predominantly set near sett entrances (Byrne et al. 2013b).  
In a study of badgers in Wytham Woods, England, time-lagged temperature and precipitation 
contributed to trapping efficiency (Noonan et al. 2015). Noonan et al. (2015) also found a non-significant 
positive effect of rain on trapping efficiency during summer months, but a significant negative effect 
during spring trapping. Our data did not provide strong support for models with an interaction between 
weather and season. Season has been shown to affect badger trappability elsewhere (Tuyttens et al. 1999; 
Byrne, O’Keeffe, et al. 2012; Byrne et al. 2013a). Badgers in our study were most likely to be captured in 
winter, followed by autumn and spring. This finding is in agreement with prior studies in Ireland that 
found more badgers captured in autumn/winter (Byrne, O’Keeffe, et al. 2012) or winter/spring (Byrne et 
al. 2013a), and with field staff perceptions of optimal badger trapping during November–March. In 
England, trappability was found to be lowest in autumn (Tuyttens et al. 1999), with some evidence of low 
trappability in winter from another study (Wilson et al. 2003). It is likely that the differences in seasonal 
trappability between Britain and Ireland relate to the predominant trap used (stopped restraints in Ireland 
and cage traps in Britain; Byrne, O’Keeffe, et al. 2012) and how these traps operate. Restraints rely on the 
ability to go undetected by the badger, and are placed near sites through which badgers are known to 
move (sett entrances and along runs; Byrne et al. 2013a). In Ireland, restraints are not used very 
frequently during summer months, as vegetation growth can obscure badger setts (Byrne et al. 2013b; 
Byrne et al. 2013a). Restraints have been specifically designed to capture adults, not cubs (Sleeman et al. 
2009), and in the spring, cubs may emerge from setts and disturb restraints, preventing adults from being 
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captured. In contrast, cage traps are baited (typically with peanuts), so badgers are drawn towards the trap 
and can be placed away from badger setts, for example near border latrines.  
Trapping a significant proportion of badger populations is essential for reaching herd immunity 
via vaccination, the threshold where the infection is unable to establish in the susceptible population 
(Begon 2009). The basic reproductive ratio of a disease (R0) must be less than one for disease eradication, 
although the entire population need not be vaccinated to achieve this (Begon 2009). The exact number of 
badgers that must be vaccinated to induce herd immunity is currently unknown. Simulations of an oral 
vaccination strategy based on data from England suggested at least 40% of badgers needed to be 
immunized annually to eradicate TB (Wilkinson et al. 2004), and benefits of vaccination are most likely 
with long-term annual vaccination programs (Hardstaff et al. 2013). Another simulation study using data 
from Ireland suggested that vaccination success depends on population density and prevalence of TB in 
badgers (Abdou et al. 2016). Trapping efforts must be prioritized at setts and under conditions most likely 
to yield badger captures.  
We conclude that efforts should be concentrated on main setts and setts with activity scores of 4 
or 5, and under rainy weather conditions when minimum temperatures range from 3–8 °C. The factors 
investigated in this study are advantageous in that all can be determined easily and inexpensively, 
allowing managers to make informed decisions about when and where to prioritize trapping efforts. 
Tailoring capture operations to optimal conditions should increase the trapping success of badgers and 
allow for increased vaccine delivery. An effective badger vaccination program will move Ireland closer to 






CHAPTER 4: TUBERCULOSIS SEROSURVEILLANCE AND MANAGEMENT PRACTICES OF 
CAPTIVE AFRICAN ELEPHANTS (LOXODONTA AFRICANA) IN THE KAVANGO-ZAMBEZI 





Transfrontier conservation areas represent an international effort to encourage conservation and 
sustainable development. Their success faces a number of challenges, including disease management in 
wildlife, livestock, and humans. Tuberculosis (TB) affects humans and a multitude of non-human animal 
species and is of particular concern in sub-Saharan Africa. The Kavango-Zambezi Transfrontier 
Conservation Area encompasses five countries, including Zimbabwe, and is home to the largest 
contiguous population of free-ranging elephants in Africa. Elephants are known to be susceptible to TB, 
thus understanding TB status, exposure, and transmission risks to and from elephants in this area is of 
interest for both conservation and human health. To assess risk factors for TB seroprevalence, a 
questionnaire was used to collect data regarding elephant management at four ecotourism facilities 
offering elephant-back tourist rides in the Victoria Falls area of Zimbabwe. Thirty-five working African 
elephants were screened for Mycobacterium tuberculosis complex antibodies using the ElephantTB Stat-
Pak and the DPP VetTB Assay for elephants. Six of 35 elephants (17.1%) were seropositive. The risk 
factor most important for seropositive status was time in captivity. This is the first study to assess TB 
seroprevalence and risk factors in working African elephants in their home range. Our findings will 
provide a foundation to develop guidelines to protect the health of captive and free-ranging elephants in 
the southern African context, as well as elephant handlers through simple interventions. Minimizing 
exposure through shared feed with other wildlife, routine TB testing of elephant handlers, and regular 
serological screening of elephants are recommended as preventive measures. 
 
                                                     
2 Originally published as: Rosen LE, Hanyire TG, Dawson J, Foggin CM, Michel AL, Huyvaert KP, Miller M, Olea-
Popelka FJ. 2018. Tuberculosis serosurveillance and management practices of captive African elephants (Loxodonta 
africana) in the Kavango-Zambezi Transfrontier Conservation Area. Transboundary and Emerging Diseases 




Transfrontier conservation areas (TFCAs) in Africa incorporate large tracts of adjacent private, 
communal, and public land between neighboring countries and represent a broad-scale approach to 
improving biodiversity conservation and socioeconomic development of local communities (Hanks 
2003). One goal of TFCAs is to increase connectivity of an otherwise fragmented landscape for wildlife, 
while boosting nature-based tourism (Osofsky et al. 2008). An inherent challenge in the transboundary 
landscape of TFCAs is disease management, given movement and interfaces among wildlife, livestock, 
and humans in countries with varying disease prevalence and management strategies (Osofsky et al. 
2008). A variety of diseases, including zoonoses, have been identified as threats to human and animal 
health within TFCAs (Cumming 2011). Movement of diseases within TFCAs is a major concern: for 
example, work by Caron et al. (2016) has documented the spread of bovine tuberculosis (TB) and other 
diseases in African buffalo (Syncerus caffer) within the Great Limpopo TFCA.  
Sub-Saharan African countries are particularly affected by TB in livestock, wildlife, and humans 
(Corbett et al. 2006; de Garine-Wichatitsky et al. 2013). Human TB, caused by Mycobacterium 
tuberculosis (M. tuberculosis), has high prevalence in the region as a result of high incidence of human 
immunodeficiency virus (HIV) and limited healthcare infrastructure and disease control measures 
(Corbett et al. 2006; World Health Organization 2015). Sub-Saharan African countries feature 
prominently in the high-burden country lists for TB, TB/HIV coinfection, and multidrug-resistant (MDR) 
TB (World Health Organization 2016). Angola, Botswana, Namibia, Zambia, and Zimbabwe all appear 
on at least one of these three lists, and both Angola and Zimbabwe appear on the lists for high TB, 
TB/HIV, and MDR-TB burden (World Health Organization 2016). These five countries contribute land to 
the Kavango-Zambezi (KAZA) TFCA (Figure 4.1), the largest proposed TFCA at approximately 520,000 
km2 (Anonymous 2014).  
The KAZA TFCA supports the largest contiguous population of African elephants in the world 
(Loxodonta africana) (Van Aarde et al. 2006), concentrated in Botswana and Zimbabwe (Anonymous 
2014). Threats to conservation of elephants include disease epidemics, human-elephant conflict, and 
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illegal killing for ivory (Sukumar 2003). Illegal killing of elephants for ivory has driven a steep decline in 
African elephant populations (Wittemyer et al. 2014), with overall population declines of 8% per year 
(Chase et al. 2016). Elephants are among the top-ranked species that visitors are interested in viewing 
(Lindsey et al. 2007), and the loss of elephants due to poaching results in an estimated $25 million of lost 
tourism revenue to African countries annually (Naidoo et al. 2016). Declining elephant numbers appear to 
drive tourism losses rather than vice versa (Naidoo et al. 2016), thus further losses of elephants will only 
exacerbate tourism losses and concomitant economic impacts.  
 
Figure 4.1. Map of the Kavango-Zambezi Transfrontier Conservation Area. The black star indicates Victoria Falls, 
Zimbabwe. 
 
Investing in the sustainable conservation of elephants is therefore of economic benefit to range 
countries in addition to promoting biodiversity. As a result, diseases affecting elephants, including TB, 
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are of particular interest within the TFCA. Elephants in zoological collections around the world have been 
diagnosed with TB (Mikota et al. 2001; Lewerin et al. 2005; Vogelnest et al. 2015; Zlot et al. 2015), 
primarily caused by M. tuberculosis or, more rarely, M. bovis (Mikota and Maslow 2011). Infections with 
zoonotic pathogens transmitted from humans to animals (reverse zoonosis or zooanthroponosis) are more 
frequently reported in captive animals than their wild counterparts (Epstein and Price 2009). A case of TB 
caused by M. tuberculosis has been documented in a wild African elephant in Kenya, and, although the 
source of that animal’s infection could not be definitively traced, it had known extended prior contact 
with humans (Obanda et al. 2013). In 2016, an elephant was found dead in Kruger National Park and, at 
necropsy, evident TB lesions were found in the lungs with subsequent culture and identification of M. 
tuberculosis (M. Miller, pers. comm. 2017). Spillover of M. tuberculosis from humans has been 
documented in free-ranging and captive wildlife in South Africa (Michel et al. 2013). 
Elephants are used as working animals in logging camps or tourist resorts in some countries 
where they are native (Sukumar 2003). Working elephants have close contact with humans, providing a 
potential interface for bidirectional pathogen transmission. Tuberculosis infection or seroconversion has 
been documented in working Asian elephants (Elephas maximus) in Thailand (Angkawanish et al. 2010; 
Angkawanish et al. 2013), India (Verma-Kumar et al. 2012), Malaysia (Ong et al. 2013; Yakubu et al. 
2016), Laos (Lassausaie et al. 2014), and Nepal (Mikota, Gairhe, et al. 2015). In contrast, the health of 
working African elephants has only been studied in the contexts of stress response (Millspaugh et al. 
2007) and animal welfare governance (Duffy and Moore 2011), not their risk of TB or other diseases. 
Transmission of M. tuberculosis has been documented both from humans to elephants (Michalak et al. 
1998) and vice versa (Murphree 2011), thus the interface between humans and working elephants 
presents a risk for pathogen transmission to both species. 
 Approximately 50–60 captive African elephants are used in ecotourism facilities in the KAZA 
TFCA for the purpose of elephant-back safaris, and may therefore be at higher risk of exposure to M. 
tuberculosis than their wild counterparts. Standard practices at these facilities allow elephants to freely 
forage during the day, with the potential for contact with wild elephants. Thus, these captive elephants 
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represent an important human-wildlife interface scenario, having contact with both humans in a high-
burden M. tuberculosis area as well as an important population of free-ranging African elephants.  
The goals of this study were twofold: 1) to screen this population of elephants to determine the 
seroprevalence of TB antibodies and 2) to explore associations between elephant demographics and 
management characteristics (risk factors) and seropositivity among captive African elephants in the 
Victoria Falls area of Zimbabwe in the KAZA TFCA. Based on our findings, management 
recommendations are provided to mitigate risk of M. tuberculosis exposure to captive elephants, as well 
as free-ranging wildlife and humans. 
 
4.3 Materials and Methods 
4.3.1 Study Population and Potential Risk Factors Questionnaire  
Four ecotourism facilities offering elephant-back safaris in the Victoria Falls area of Zimbabwe 
consented to participate in the study. To maintain confidentiality of participating facilities, each facility 
was designated as A, B, C, or D. A questionnaire was developed to gather information about elephant 
demographics and management through in-person interviews, and survey responses were used to define 
potential risk factors for seropositive status. The survey (Appendix A) included 45 closed- and open-
ended questions regarding the working elephants, including questions about: (1) demographics (sex, age, 
birthplace); (2) breeding status (sexual maturity, pregnancies, and births); (3) management style (free vs. 
protected contact with handlers); (4) social structure (housing, social grouping, contact with wild 
elephants); (5) public contact; and (6) staff numbers, type (full-time, part-time, or volunteer), and TB 
testing frequency. Staff at each facility were interviewed in English, Tonga, Ndebele, or Shona during 
September–October 2014. All survey responses were recorded in English. Follow-up interviews to clarify 






4.3.2 Serologic Testing 
Seroprevalence was determined by testing elephant blood samples for antibodies to 
Mycobacterium tuberculosis complex (MTBC) bacteria using two serologic assays used for elephants. A 
total of 35 African elephants were sampled at the four facilities in September 2014. Five animals were not 
sampled because they could not be sampled safely. Blood samples were collected from the auricular or 
saphenous vein, and allowed to clot at room temperature before testing, then centrifuged to separate 
serum. Each serum sample was tested using two serologic tests for MTBC antibodies that have been 
validated for elephants, the ElephantTB STAT-PAK® (no longer commercially available; Chembio 
Diagnostic Systems, Inc., Medford, NY, USA) and the DPP® VetTB Assay for Elephants (Chembio 
Diagnostic Systems, Inc., Medford, NY, USA), according to manufacturer’s instructions. STAT-PAK 
detects antibodies to ESAT-6, CFP10, and MPB83 (Lyashchenko et al. 2006) and DPP detects antibodies 
to MPB83 and a CFP10/ESAT-6 fusion (Lyashchenko et al. 2012). Each STAT-PAK and DPP test result 
was interpreted as reactive (clearly visible test line), suspect (a faint color change response), or negative 
(no visible test line). During January 2015, blood samples were collected as part of another study from a 
subset of eight of the original 35 elephants, and STAT-PAK and DPP tests were repeated. In February 
2016, 10 of the original elephants were tested again using STAT-PAK. If the STAT-PAK was reactive on 
this occasion, the sample was also tested using DPP.  For each sampling period, STAT-PAK and DPP 
results were interpreted in parallel, such that if an elephant had any reactive result to either the STAT-
PAK or DPP, it was considered seropositive.  
All serological testing was performed with the written consent of elephant owners. Approval for 
this study was obtained from the animal ethics committee at the University of Pretoria, the Department of 
Livestock and Veterinary Services, and the Division of Research, Diagnostics and Technical Services in 





4.3.3 Statistical Analysis 
Descriptive statistics including counts, frequencies, 95% confidence intervals, mean, standard 
deviation, and ranges were calculated to assess seropositivity and the data distribution for potential risk 
factors. For each facility, seroprevalence was calculated as the proportion of seropositive elephants 
among the total number of elephants tested during each sampling period. For the risk factor analysis, a 
group of factors/characteristics from the survey data were selected based on potential to serve as 
biological risk factors. Risk factors were assessed as categorical variables, and included the following: 
sex, time in captivity (< 15 years or ≥ 15 years), overnight contact with other elephants (yes or no), 
contact with wild elephants (yes or no), birthplace (captive or wild-born), shared feed with wildlife (yes 
or no), and facility (A, B, C, or D). To evaluate potential associations between data collected under 
different survey questions, correlation between variables was assessed using Spearman’s correlation, with 
correlation values of ρ ≥ 0.6 being considered correlated. When a strong correlation between variables 
was found, the decision about which of the variables to use for the risk factor analysis was made based on 
biological plausibility. For the risk analysis, a candidate model set of 6 models was built using a simple 
univariable logistic regression model for each factor and an intercept-only model to represent a null 
model; serological status (positive or negative) was the outcome variable in this analysis. Akaike’s 
Information Criterion adjusted for small sample sizes (AICc) was calculated for each model and was used 
to select the best model where the highest-ranked model carries the lowest AICc value and highest Akaike 
weight (Burnham and Anderson 2002). All analyses were performed using the AICcmodavg package 
(Mazerolle 2016) in R 3.3.2 (R Core Team 2016). 
 
4.4 Results 
4.4.1 Survey Results 
The number of elephants at each facility ranged from 2–17 throughout the study. The sex ratio of 
sampled elephants was approximately equal (17 females, 18 males). The mean reported age of the 
elephants was 22.0 years (SD 11.4, range 4–41 years), and 51% of the population sampled had reached 
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breeding age. However, some ages were approximate, because ages for wild-born elephants were 
estimated and the majority (83%) of elephants were wild-born. The average estimated time under human 
management was 13 years, but actual time under human management for older animals was greater given 
that history at any previous facility may be unknown. 
Wild-born elephants at the facilities originated from within Zimbabwe. Elephants were routinely 
used for morning and evening rides for tourists, lasting approximately 45–60 minutes each. In addition, 
tourists had the opportunity to feed, touch, and take photos with the elephants for periods of 5–25 
minutes. During the day, elephants were allowed to forage on the facilities’ property under the 
supervision of staff. Wildlife within the Victoria Falls National Park had access to the facilities (Figure 
4.2), and free foraging during the day could bring working elephants into contact with species including 
wild elephants, buffalo, greater kudu (Tragelaphus strepsiceros), impala (Aepyceros melampus), 
bushbuck (Tragelaphus scriptus), waterbuck (Kobus ellipsiprymnus), common duiker (Sylvicapra 
grimmia), common warthogs (Phacochoerus africanus), Burchell’s zebra (Equus quagga burchellii), 
giraffe (Giraffa camelopardalis), banded mongoose (Mungos mungo), chacma baboons (Papio ursinus), 
and vervet monkeys (Chlorocebus pygerythrus). 
 




Elephants at all four facilities were kept in conditions that allowed for natural breeding. All 
facilities had at least one breeding bull elephant, and three facilities had at least one previous known 
elephant pregnancy. Three facilities used gonadotropin-releasing hormone (GnRH) vaccine to prevent 
musth and aggressive behavior in bulls. Elephants at two facilities were permitted overnight contact with 
other elephants in the herd, while overnight contact was restricted at the other two facilities. There were 
no indoor elephant enclosures at any of the facilities. During the day when foraging, elephants had direct 
and close contact with the other elephants and caretakers. In addition to foraging, the elephants’ diet was 
supplemented with one or more of the following items: additional browse, local hay (with molasses or salt 
additives), commercial game cubes, green bana grass (Pennisetum hybrid), commercial horse feed, or 
vegetables. At three facilities, warthogs were reported to have contact with elephant feed or were 
observed in close contact with elephants, especially during feeding in stable areas, including sharing game 
cubes and vegetables from feeding containers (Figure 4.2). Baboons and mongoose were also reported or 
observed to have contact with elephant feed. Potential contact with other wildlife was indirect through 
shared foraging areas. At three facilities, contact with wild elephants was possible but discouraged. 
Elephants at all facilities were managed using unprotected contact. Handlers were not assigned to 
work with the same individual elephants but rotated through the herd. Full-time elephant handlers ranged 
from 8–14 per facility; part-time or volunteer staff were not used. Staff testing for TB was not required at 
any facility. 
 
4.4.2 Serological Test Results 
Thirty-five elephants were tested with both STAT-PAK and DPP (Table 4.1) during the first 
round of sampling in September 2014. Six elephants were reactive to STAT-PAK (17.1% seroprevalence, 
95% CI: 4.7–29.6%), but none were reactive to DPP. In the second round of sampling during January 
2015, eight of the 35 elephants were re-tested using both STAT-PAK and DPP. All eight elephants had 
been seronegative during the first round of sampling, and all STAT-PAK and DPP tests were non-reactive 
during the second round of sampling. In the third round of sampling during February 2016, 10 of the 35 
67 
 
elephants were re-tested using STAT-PAK. Two of these elephants had been seropositive in the first 
round of sampling, and an additional four elephants had also been tested during the second round of 
sampling. Nine of the tested elephants had a non-reactive STAT-PAK, and one was reactive. The reactive 
elephant, which had previously had a reactive STAT-PAK in the first round of sampling, was tested using 
DPP and that result was negative. In total, six out of 35 (17.1%; 95% CI 4.7–29.6%) elephants were 
classified as TB seropositive based on parallel interpretation of STAT-PAK and DPP results. One of these 
elephants was classified as seropositive during two sampling sessions. All other elephants were classified 
as TB seronegative. 
Table 4.1. Seroprevalence of Mycobacterium tuberculosis complex (MTBC) antibodies in captive elephant facilities 
in Zimbabwe across sampling periods. 






















A 16 12 1 (8.3) 17 4 0 (0.0) 17 5 0 (0.0) 
B 4 4 0 (0.0) 2 1 0 (0.0) 2 0 0 (0.0) 
C 9 8 3 (37.5) 4 0 0 (0.0) 3 2 0 (0.0) 
D 11 11 2 (18.2) 11 3 0 (0.0) 11 3 1 (33.3) 
Total 40 35 6 (17.1) 34 8 0 (0.0) 33 10 1 (10.0) 
 
4.4.3 Risk Factors 
Proportions of seropositive elephants and associated 95% confidence intervals, calculated for 
each risk factor, are shown in Figure 4.3. Strong correlations were noted between time in captivity and 
birthplace (ρ = 0.67), and between contact with wild elephants and facility (ρ = 0.86). Based on their 
perceived biological relevance, time in captivity and contact with wild elephants were included in the 
logistic regression analyses and models were ranked using Akaike weights (Table 4.2). The top-ranked 
model (w = 0.41) was for time in captivity, with elephants that had spent a shorter time in captivity (<15 
years) having higher seroprevalence (36.4%) compared to elephants that spent >15 years in captivity 
(8.3%). The intercept-only model ranked second (w = 0.18) suggesting some model selection uncertainty,  
and the model for shared feed with warthogs or other wildlife (w = 0.13) ranked third, with elephants 




Figure 4.3. Proportions of captive African elephants that were Mycobacterium tuberculosis complex (MTBC) 
seropositive, reported for five potential risk factors: A) time in captivity, B) shared feed with warthogs or other 
wildlife, C) contact with wild elephants, D) overnight contact with other elephants, and E) sex. Error bars indicate 
95% confidence intervals. 
 
 
Table 4.2. Candidate logistic regression models for Mycobacterium tuberculosis complex (MTBC) seropositivity in 
captive elephants in Zimbabwe.  
Model LL K AICc ΔAICc w 
Time in captivity -14.09 2 32.56 0 0.41 
Intercept only -16.04 1 34.19 1.63 0.18 
Shared feed -15.23 2 34.84 2.27 0.13 
Contact with wild elephants -15.48 2 35.34 2.78 0.10 
Overnight contact with elephants -15.65 2 35.68 3.12 0.09 
Sex -15.69 2 35.76 3.20 0.08 
K: number of parameters; LL: log likelihood; AICc: Akaike’s information criterion; ΔAICc: difference in AICc 
from minimum AICc model; wi: Akaike weight 
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with wild elephants, overnight contact with elephants, and sex ranked approximately equally (w = 0.08–
0.10). For these variables, seroprevalence was higher in elephants that had contact with wild elephants 
(21.7% compared to 8.3%), no overnight contact with other captive elephants (25% compared to 13%), or 
were female (22% compared to 11%).  
 
4.5 Discussion 
This study provides the first assessment of TB seroprevalence in captive African elephants in a 
range country and investigates factors associated with positive serological responses. At the facilities 
under study, 17.1% of 35 elephants tested were seropositive during the first round of sampling. 
Seroprevalence in later sampling sessions, where a subset of elephants were tested, ranged from 0–10%. 
In addition, this study describes management of captive African elephants in Zimbabwe and explores 
potential factors associated with TB seropositive status. The risk factor most strongly associated with 
seropositive status was time in captivity. Models for contact with wild elephants, sex, and overnight 
contact with other captive elephants carried less weight. 
It is important to note that this study only screened elephants for antibody responses to MTBC 
antigens, thus, a seropositive result cannot be considered equivalent to a diagnosis of clinical TB. 
Accurate and affordable tests for diagnosing mycobacterial infection are needed for elephants and other 
non-domestic species. However, serological testing provides a valuable starting point for screening 
elephants potentially at risk for MTBC exposure. Other immunoassays, such as the interferon gamma 
release assay, for detecting TB in elephants have been developed and show promise for antemortem 
diagnosis (Angkawanish et al. 2013; Paudel et al. 2016). However, these assays require special processing 
of blood samples and a laboratory with the expertise to run ELISAs, which can be a significant constraint 
to using these tests in areas with limited resources. While mycobacterial culture is considered the gold 
standard for TB diagnosis in elephants (Mikota and Maslow 2011), there are also major challenges to 
obtaining samples for culture among elephant populations under human care in range countries. First, 
elephants must be trained to perform a trunk wash procedure to collect samples for culture (Mikota and 
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Maslow 2011). Trunk wash training is not a routine procedure at ecotourism facilities in Africa, and 
requires specialized training of both elephants and their handlers. This training is under way at the four 
study facilities in order to be able to perform trunk washes in the future. Mycobacterial culture is also 
time-consuming, requires sample submission to a laboratory capable of growing and differentiating 
mycobacterial species, and may have a reduced sensitivity because samples frequently can be 
contaminated. Because elephants constantly interact with their environment using their trunks, trunk wash 
samples in culture are prone to overgrowth of environmental microorganisms (Mikota and Maslow 2011). 
At ecotourism facilities, where elephants are housed outdoors in natural habitat, environmental 
contamination is more likely to interfere with culture.  
In lieu of culture, serology allows for simplified and expedited routine testing of elephants that 
may be at risk of TB. Blood samples can be obtained more easily than trunk washes, tests can be 
performed on site in the field, and results are obtained quickly (within approximately 20 minutes). STAT-
PAK and DPP have high reported sensitivity (100%) and specificity (95% and 100%, respectively) in 
isolated studies in captive elephants in the US and Europe (Greenwald et al. 2009). However, 
interpretation of test results must take into consideration differences in host species, local factors (e.g., 
presence of cross-reacting non-tuberculous mycobacteria), and true disease prevalence (Dohoo et al. 
2009). Serologic tests may not conclusively identify infected elephants; for example, captive Asian 
elephants in Thailand that were confirmed to have M. tuberculosis infection had one or more negative 
STAT-PAK tests, including an individual that died of severe clinical disease hours after testing 
(Angkawanish et al. 2010). Species differences between Asian and African elephants may influence 
serologic test performance, given that only the immune response of Asian elephants to TB has been 
characterized in other studies (Landolfi et al. 2010; Landolfi et al. 2014). Conversely, STAT-PAK false 
positives are known to occur in cases of non-tuberculous mycobacterial infection (Lacasse et al. 2007; 
Greenwald et al. 2009) and with chronic inflammatory conditions like arthritis (Greenwald et al. 2009). 
Infection with non-tuberculous mycobacteria may alter the antibody profile that elephants produce 
(Lyashchenko et al. 2012). The elephants in this study may be more likely than zoo elephants to be 
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exposed to both tuberculous mycobacteria, due to their location in a high TB burden country, and non-
tuberculous mycobacteria, given their outdoor housing and foraging behavior. These factors should be 
taken into consideration when interpreting serological test results, which can still provide important 
information that, when used in combination with other diagnostics, can inform prevention and control 
strategies for reducing the risk of MTBC transmission. 
Interestingly, all seropositive elephants in this study were reactive to STAT-PAK but not DPP. 
The STAT-PAK positive results could indicate early infections, as STAT-PAK uses a larger volume of 
serum than DPP (30 μl compared to 5 μl; Greenwald et al. 2009), and therefore has a lower threshold of 
detection. Based on the lower specificity of STAT-PAK compared to DPP, these results could also 
indicate false positive STAT-PAK results in this population, possibly as the result of factors such as non-
tuberculous mycobacteria or inflammatory conditions. One elephant that was seropositive during the first 
round of testing became seronegative on the third round of testing. In this case, the elephant may have 
cleared a TB infection, as was hypothesized for elephants with intermittent borderline reactive DPP 
results after exposure to a TB-infected elephant (Vogelnest et al. 2015). In addition, there was one 
seroreactive elephant that remained seroreactive on the third round of testing; although DPP was 
nonreactive, this finding may increase suspicion of a true MTBC infection. 
In humans, a positive serological test result without accompanying clinical disease or detection of 
M. tuberculosis is interpreted as a latent infection, but it is unclear if elephant serological responses 
should be interpreted similarly (Ong et al. 2013). Given their apparent predilection toward strong humoral 
responses to mycobacterial infection, elephants may become persistently seropositive years before M. 
tuberculosis or M. bovis are isolated from trunk wash culture samples (Greenwald et al. 2009; 
Lyashchenko et al. 2012; Vogelnest et al. 2015). Increased monitoring with DPP (as STAT-PAK is no 
longer available) can show persistent reactions or those of increasing intensity that are suggestive of 
active TB disease (Vogelnest et al. 2015). Elephants with positive serological tests results should be 
monitored for clinical signs associated with TB, and subjected to increased TB diagnostic testing such as 
more frequent serological assays and trunk wash cultures.  
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Potential risk factors in this population may differ from other elephant populations where 
epidemiological studies have identified risk factors because of contrasts in environment and elephant 
management practices. For example, working Asian elephants with an assigned mahout (elephant 
handler) have an increased risk of TB seropositivity (Yakubu et al. 2016), but elephants at the African 
facilities do not have assigned handlers. Close and prolonged contact between humans and elephants, 
such as spending hours indoors with infected elephants (Zlot et al. 2015), or cleaning barns and 
aerosolization during pressure washing (Miller and Olea-Popelka 2013) have been implicated in human 
cases of TB at animal facilities. However, indoor elephant housing does not exist at the facilities in this 
study, nor are pressure washers in use. Determining risk factors for transmission of TB among elephants 
and between elephants and humans at ecotourism facilities is crucial to enacting preventive measures to 
protect both elephants and humans. 
In this analysis, time in captivity was the most important variable associated with higher risk for 
seropositive status in elephants based on AICc weight. The association of seropositive status with a 
shorter time in captivity is somewhat counterintuitive, as increased time in captivity would be expected to 
be associated with increased human exposure and therefore risk of TB. This may be in part due to the 
correlation observed between age and time in captivity, as elephants that have spent less time in captivity 
are generally young. Young elephants could be more curious in exploring the environment with their 
trunks, leading to an increased exposure to environmental organisms. Young elephants or those that have 
spent less time in captivity may be handled more for training purposes, and increased handling time could 
increase risk of exposure to human TB if handlers are infected. One major potential factor not explored in 
this study is the TB status of elephant handlers, and TB transmission is most likely to occur from humans 
to elephants in high TB burden countries (Lassausaie et al. 2014). Alternatively, seropositive results may 
have been more likely in elephants that have been exposed or infected but have not had time to observe a 
waning humoral response. In cattle, antibody responses to mycobacteria can wane over time (Waters et al. 
2010), thus if older elephants or those in captivity for longer were exposed to mycobacteria in the distant 
past, they may no longer have a robust antibody response. 
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The null or intercept only model, ranked second, serves as a comparison point for the models 
evaluated in this study. That the intercept-only model was highly ranked and all of the models were 
within 3-4 AICc units of each other suggests that there is some model selection uncertainty and that other 
factors that were not evaluated may be involved. With the relatively small sample size in our study, it was 
not possible to adequately investigate multivariable logistic regression models that could better reflect the 
multifactorial etiology of TB and allow for potential compounding or interactive effects among different 
factors. Nonetheless, the relative Akaike weights of the evaluated models for risk factors may allow for 
prioritization of variables to explore in future studies. 
Interactions with other wildlife through shared feed may also be important in elephant 
seropositive status. All seropositive elephants were housed at facilities that reported having warthogs or 
other wildlife around their stables. At one facility in this study, a banded mongoose colony appeared to 
use a hay barn as a semi-permanent refuge. Warthogs are known spillover hosts of TB (Renwick et al. 
2007), and wildlife having access to stored food may be a factor worth further investigation, given the 
importance of shared feed in other ecosystems in which TB is present and transmitted across species. For 
instance, European badgers (Meles meles) are known to consume cattle feed, and indirect contact through 
shared feed or direct contact during feeding may be important for M. bovis transmission between badgers 
and cattle (Garnett et al. 2002). In North America, supplemental feeding of wildlife is considered a risk 
factor for M. bovis transmission (Miller and Sweeney 2013), and indirect transmission through feed 
sharing has been documented from experimentally infected white-tailed deer (Odocoileus hemionus) to 
cattle (Palmer et al. 2004). Securing food from free-ranging wildlife and preventing wildlife contact while 
elephants are feeding would reduce the potential risk of pathogen transmission via shared feed. 
Seroprevalence was higher among elephants that had contact with wild elephants. It is unknown 
whether wild elephants in the area are infected with mycobacteria and could serve as a source of infection 
to captive elephants. However, this finding has important conservation implications, as seropositive 
captive elephants have the potential to transmit pathogens when in contact with wild elephants. Although 
contact between captive and wild elephants is discouraged, interactions between them have occurred. 
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Such interactions have included captive elephants mating with wild elephants, captive elephants taken 
into a wild herd, and an orphaned wild-born elephant being adopted into a captive herd. These 
interactions demonstrate the potential for close contact between captive and free-ranging populations that 
could put elephants at risk for pathogen transmission.  
The remaining factors carried less weight in terms of importance to seropositive status indicating 
that they are less important in shaping seroprevalence. Seroprevalence was higher among elephants 
without overnight contact with other captive elephants. Again, this finding is somewhat counterintuitive, 
as higher seroprevalence might be expected in elephants with overnight contact, given the opportunity for 
transmission via direct contact. This finding may be associated with other management differences 
between facilities that contribute to variation in risk but were not measured in this study. Seroprevalence 
was higher among female elephants (22.2%) than males (11.8%), which is in contrast to trends reported in 
working Asian elephants (Lassausaie et al. 2014; Yakubu et al. 2016). Most of the male elephants in this 
study were housed at facilities that reported using GnRH vaccine to suppress musth. High testosterone 
levels during musth may result in immunosuppression (Sukumar 2003), thus suppressing musth might 
indirectly benefit bull elephant immunity.  
The captive elephants at the facilities under study are present in a unique community of 
mycobacteria and other wildlife. Humans in these communities are hosts to M. tuberculosis, and M. bovis 
is present in cattle in neighboring Zambia (Phiri 2006; Munyeme et al. 2009; Munyeme et al. 2010; 
Muma et al. 2013). An emergent MTBC species, M. mungi (Alexander et al. 2010), has been identified in 
banded mongoose in northwest Zimbabwe (Alexander et al. 2016). Banded mongoose in South Africa 
were recently found to be hosts of M. bovis (Brüns et al. 2016), and nearly all of the other wildlife species 
reportedly seen on the facilities are known natural hosts of M. bovis or other tuberculous mycobacteria 
(Mukundan et al. 2015). A variety of non-tuberculous mycobacteria have been cultured from tissues of 
South African wildlife species, including elephants (Botha et al. 2013), and non-tuberculous mycobacteria 
can induce cross-reaction to MTBC antigens (Gcebe and Hlokwe 2017). Relatively little is known about 
movement of mycobacteria among humans, wildlife, and domestic species, especially in southern Africa. 
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Deceased working elephants and, when possible, other susceptible wildlife hosts should have a post-
mortem examination conducted and any tuberculous lesions cultured for mycobacteria. Post-mortem 
examinations are a critical surveillance tool; however, implementation may be limited by finding fresh 
carcasses and the logistics associated with sampling large animals in field settings.  
Better understanding the dynamics of infection among and between species will be crucial to 
effectively preventing and controlling diseases within animal populations within TFCAs. In addition, 
ecotourism facilities in the area can take steps to limit risks to their elephants and staff. An important first 
step would be implementation of routine TB screening for elephant handlers at the time of hiring and 
annually, allowing timely treatment of TB infected handlers. Elephants should be screened for TB using 
serologic testing with the DPP; elephants reactive on serology should receive increased monitoring for TB 
and increased testing frequency using serologic tests or culture. Additionally, other screening and 
diagnostic tests (e.g., interferon gamma assay and mycobacterial culture) should be evaluated and 
considered to continuing monitoring this population of African elephants in the KAZA TFCA. Securing 
feed sources from other wildlife would eliminate a known route for TB transmission. Continuing to 
explore potential risk factors, including others we did not evaluate, is warranted in future studies. 
Elephant facility owners should be proactive in working with local public health authorities, veterinarians, 
employees, and other stakeholders in creating an informed management plan to mitigate risk of pathogen 




CHAPTER 5: ESTIMATING DENSITY OF EUROPEAN BADGERS (MELES MELES) IN IRELAND 





Diseases shared between livestock and wildlife, such as bovine tuberculosis, are challenging to 
manage. Ireland is one of many countries with a bovine tuberculosis control program, which has been 
hampered by the presence of a wildlife reservoir, the European badger (Meles meles). Badgers have 
historically been culled for tuberculosis management, but are now being vaccinated as part of the 
country’s eradication plan. Badger population density is an important factor in rates of tuberculosis in 
cattle, therefore determining the effectiveness of vaccination as a control strategy depends on the 
underlying density of badger populations. We implemented spatially explicit capture-recapture models 
using data from a multi-year vaccination trial in County Kilkenny, Ireland, to estimate badger population 
density according to environmental and management covariates. We found that soil drainage determined 
badger density, with an estimated 0.8 badgers/km2 in the moderately drained soil present in most of our 
study area (range 0.49–1.24 badgers/km2 for all soil types). We also found evidence of considerable trap-
wariness, with the baseline probability of capture decreasing from 0.141 in naïve badgers to 0.045 in 
previously captured badgers. The magnitude of the behavioral response to trapping we observed has 
important implications for management using vaccination. Our results provide a baseline density estimate 
at the start of the vaccination program, and a framework for use in estimating badger densities elsewhere 
and over time as disease management continues. Monitoring host population density is important for 






The interface between livestock and wildlife inherently creates a pathway for pathogen 
transmission in both directions (Bengis et al. 2002), and diseases shared between livestock and wildlife 
are a source of human-wildlife conflict (Woodroffe et al. 2005). These diseases can have dramatic 
socioeconomic impacts from lost livestock production, and may create concerns for wildlife conservation 
as well (Cleaveland et al. 2001; Gortázar et al. 2007; Caron et al. 2013). Livestock-wildlife interactions 
are increasingly relevant as growing global demand for meat protein increases livestock production 
(Tilman and Clark 2014). 
A multi-host approach is required to manage diseases at the livestock-wildlife interface, involving 
control measures in both livestock and wildlife populations combined with prevention of transmission 
(Miller et al. 2013). Once a disease has been introduced into a wildlife population, disease control in 
wildlife typically takes the form of host population control or vaccination (Gortazar et al. 2015). 
Reducing population density of a host species is a common disease control method, based on the general 
principle that infectious diseases often function as density-dependent processes (Wobeser 1994). 
However, vaccination has the benefits of being non-destructive to the target species and typically being a 
more socially acceptable management strategy, although delivery at a broad spatial scale is challenging 
(Gortazar et al. 2015). Disease management programs should include a measurement of efficacy to assess 
progress towards achieving the program’s objectives (Wobeser 1994). 
Countries around the world have programs aimed at controlling or eradicating bovine tuberculosis 
(TB), a disease of economic importance and zoonotic potential that affects livestock and wildlife (Thoen 
et al. 2006). Bovine TB, caused by Mycobacterium bovis, is particularly relevant in Ireland, one of the 
world’s largest beef exporters (Bord Bia 2017), where annual costs of managing the disease may exceed 
€60 million (Abernethy et al. 2013). Ireland has actively managed TB in cattle since 1950, with rigorous 
annual test and slaughter regulations currently in place, resulting in considerable reduction but not 
eradication of the disease (Good 2006). Failure to eradicate TB in cattle despite strict testing points to a 
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reservoir for infection; in this setting, the European badger (Meles meles) is considered the wildlife 
reservoir for bovine TB (Noonan et al. 1975).  
Historically, badgers have been culled locally in response to TB “breakdowns” (outbreaks) in 
cattle if an introduced cattle source or residual infection from a prior breakdown could not be identified, 
with the goal of reducing badger density (Good and Duignan 2017). Badger removal has been shown to 
reduce TB incidence in cattle in Ireland during two major field trials, the East Offaly Project (Ó Máirtín et 
al. 1998; Eves 1999) and the Four Area Project (Griffin et al. 2005). The status of badgers as a protected 
species in Ireland necessitates a more sustainable approach to disease management, such as vaccination, 
going forward. The goal of a vaccination program in badgers is to maintain a badger population that is 
more resistant to bovine TB, and limit the transmission of M. bovis between cattle and badgers (and vice 
versa) . Experiments using the Bacille Calmette-Guerin (BCG) vaccine have showed it to be safe and able 
to reduce TB severity and progression in badgers (Lesellier et al. 2006; Lesellier et al. 2011; Perrett et al. 
2018), but unable to offer complete protection (Buddle et al. 2011), and the duration of immunity under 
field conditions is unknown. From 2009–2013, a large-scale trial was conducted in County Kilkenny, 
Ireland, to assess the use of BCG in badgers as an alternative to culling (Aznar et al. 2011). This initial 
trial had favorable results and led to a second experiment across six counties (More and Good 2015). 
Vaccination of badgers has been officially included in Ireland’s bovine TB eradication plan (Good and 
Duignan 2017) as a result of these trials, but determining the efficacy of vaccination in managing TB 
levels in cattle will require evaluation of important confounding factors. 
One such factor may be the density of badgers. If M. bovis is transmitted in a density-dependent 
manner, high badger density areas may be considered at higher risk for TB breakdowns in cattle. Areas of 
Ireland where TB has been prevalent in cattle have often undergone repeated badger culling operations, 
drastically reducing badger densities. Low TB incidence in cattle in these areas may be an indirect result 
of low badger density, and badger density must be quantified to address its role in TB in cattle. Badgers 
can be expected to become more abundant as culling is reduced under the vaccination program, 
potentially increasing the risk of TB in cattle if vaccination of badgers is not effective in the long term. 
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Badgers are challenging to capture (Byrne, O’Keeffe, et al. 2012; Martin et al. 2017), as they are 
nocturnal animals and also spend a significant portion of time underground in shared burrow systems 
called setts (Roper 2010). Badger sett densities have been estimated using a variety of methods (Byrne, 
Acevedo, et al. 2014), but actual badger densities have been more difficult to estimate from capture data. 
Simulation models of badger management in Ireland showed that the success of vaccination depends in 
part on population density and the proportion of the population infected (Abdou et al. 2016), making 
density estimates valuable in predicting the performance of vaccination as a management strategy.  
Accounting for local badger density as a potential driver of cattle TB risk will be important for evaluating 
the efficacy of the vaccination program, and understanding changing disease dynamics as management 
evolves.  
Spatially explicit capture-recapture (SECR) methods provide an estimate of population density 
unbiased by edge effects and imperfect detection (Efford 2017a). This is advantageous for use in badgers, 
where trappability is known to be low (Byrne, O’Keeffe, et al. 2012) and movements can occur over a 
large spatial scale (Byrne, Quinn, et al. 2014). SECR methods are applicable in studies where individuals 
can be uniquely identified at known locations (Efford 2017b). Physically capturing badgers for 
vaccination has allowed for marking of individuals via passive integrated transponder (PIT) tags and 
tattooing, providing a dataset suitable for SECR analysis. SECR methods have been applied to trends in 
frequency-dependent disease (Lazenby et al. 2018), and could be applied similarly to density-dependent 
dynamics in badgers over time. 
Our objective was to use SECR methods to analyze available capture-mark-recapture data from a 
multi-year vaccination trial and develop an estimate of density for European badgers in County Kilkenny, 
Ireland. Our analysis provides a framework for estimating badger density in vaccination areas, which will 
allow for assessment of vaccine success in reducing cattle TB rates and influence on badger population 






5.3.1 Field Study Protocol 
The study site is located in northwest County Kilkenny, Ireland (Figure 5.1). During the Four 
Area Project from 1997–2002, sections of County Kilkenny were designated as removal areas, where 
badgers were systematically removed from all known setts; buffer areas surrounding removal areas where 
natural barriers to badger migration did not exist and additional badgers were removed; and reference 
areas where badgers were not removed (Griffin et al. 1999). The study methods for the vaccine trial have 
been fully described by Byrne et al. (2012). Briefly, setts were assessed for signs of activity as described 
by Martin et al. (2017). Each week approximately 30 active setts throughout the study area were trapped. 
Trapping was generally conducted in two week blocks, where up to 35 traps were laid at sett entrances 
and along paths four nights each week. Most traps used were stopped wire restraints designed specifically 
for adult badgers, with occasional use of cage traps. Traps were checked the following morning by 12 
PM. If a badger was captured, it was immobilized using a combination of 10 mg/kg ketamine and 0.1 
mg/kg medetomidine, then weighed, sexed, and had age class (cub, juvenile, adult, or old) determined by 
tooth wear. Each badger received a PIT tag subcutaneously, and had the last four digits of its unique 
number tattooed in the inguinal region. Each badger was injected with BCG vaccine or placebo 
intramuscularly and then released. All badger captures were conducted under license from the Irish 
Department of Health and Children, and the study was approved by the University College Dublin animal 
ethics committee. Badgers were trapped at 569 setts throughout the Kilkenny study area over a period of 
749 trapping nights from 2009–2013. Each sett was trapped for a total of 1–22 weeks throughout the 
study period. A total of 2295 captures of 1166 individual badgers were recorded. 
 
6.3.2 Density Estimation 
SECR methods (Appendix D) estimate maximum likelihood using data from capture locations 
and marked animals (Borchers and Efford 2008), and require files for trap layout and captures (Efford 




Figure 5.1: Map of the Kilkenny Vaccine Trial study area in County Kilkenny, Ireland, and setts where trapping 
occurred from 2009–2013. The extent of the 7 km buffer used to construct habitat masks for SECR models is shown 




(R Core Team 2017). The spatial modeling is then based on a habitat mask structured from habitat within 
a certain buffer of the detectors (Efford 2017c). 
A variable number of traps (1–35 restraints and/or cage traps) were laid at known badger setts 
during trapping efforts, but individual trap locations were not recorded. We classified the cluster of traps 
at a given sett as a “multi” detector type (i.e., a multi-catch trap) (Efford 2017d) in our models and used 
the sett Cartesian coordinates as the coordinates for the detector. We divided our dataset into multiple 
sessions to better meet assumptions of population closure within a trapping period. Sessions are assumed 
to be independent and recaptures are only considered based on captures within a session rather than the 
entire study period (Efford et al. 2009; Efford 2017e). Session length determines the number of recaptures 
recorded, and must be balanced to be long enough to accumulate adequate recaptures to perform an 
analysis but short enough to assume a stable population. We determined session length by looking at the 
percentage of setts each week that had been trapped in the previous week, and starting a new session in 
weeks where ≤ 50% of setts had been trapped in the previous week to minimize dependence between 
sessions, with a minimum session length of 10 weeks. We accounted for varying effort in trapping (Efford 
et al. 2013) within each session by recording a binary usage history of whether each sett was trapped on 
each occasion (trap night). We created a trap layout file for each session detailing all detectors (setts) 
used, their Cartesian coordinates, and their usage within the session. Badgers were uniquely identified by 
PIT tag number, or tattoo number if the full PIT tag number was unavailable or the tattoo was not 
matched to a PIT tag. We assigned each badger to a binary age class based on the recorded age class: 
juvenile, which included cubs and juvenile badgers, or adult, which included adults and “old” badgers. 
Our capture file included the badger’s identifier, the session and occasion of capture, the detector (sett) at 
which the badger was captured, and its age class at that capture. 
We chose to maximize the full likelihood to obtain density estimates directly (as opposed to 
derived estimates when maximizing the conditional likelihood), which allowed us to model heterogeneity 
in density according to habitat covariates (Borchers and Efford 2008). We estimated three parameters in 
multi-session models by maximizing the full likelihood using a Newton-Raphson optimization algorithm: 
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density (D), the intercept of the detection function (g0), and the spatial scale of the detection function (σ). 
We modeled a hazard rate detection function (Efford 2017d) as it has a long tail, which can accommodate 
occasional large-scale movements, consistent with what has been observed in badgers in Ireland (Byrne, 
Quinn, et al. 2014).  
We hypothesized that the observation model parameters (g0 and σ) might vary by three factors 
(Efford 2017b): a learned behavioral response (b) (Borchers and Efford 2008; Efford 2017d), resulting in 
a step change after the first detection (Borchers and Efford 2008); a site-specific learned response (bk), 
resulting in trap-happy or trap-shy behavior relative to a specific detector (sensu Royle et al. 2011); and 
individual heterogeneity (hcov), modeled here as a two-class hybrid mixture model (Borchers and Efford 
2008; Efford 2017f) of age class. If class is known for all individuals, as it was in our case, the mixture 
model is equivalent to a covariate (Efford 2017f). We hypothesized that learned responses would reflect 
trap-shy behavior (Roper 2010; Byrne, O’Keeffe, et al. 2012), and that juvenile badgers might range 
farther than adult badgers as a result of dispersal. Models fitted by maximizing the full likelihood can 
only handle a single individual-level covariate in the finite mixture model (Efford 2017f), so we opted to 
include age class, which has important management considerations: early vaccination of young badgers 
hopefully provides protection against TB before they are exposed, and badgers of a particular age class 
can be targeted by using different trapping methods (cage traps for young badgers, and stopped restraints 
for adult badgers). 
Initial test models were fitted using a mask with a buffer size of 4988 m (4σhalf-normal calculated 
using the RPSV function, using the largest σ value from all sessions), but retrospective checks of buffer 
size using the suggest.buffer() function and examination of plots of varying buffer width produced using 
the esa.plot() function indicated a larger buffer was needed (Efford 2017c). Long-tailed detection 
functions such as the hazard rate, which we used, require a large buffer for stable density estimates 
(Efford 2017c). A buffer of 7000 m was adequate based on visual inspection of a plot generated using 
esa.plot() from a fitted model using a hazard rate detection function. The final habitat mask was defined 
by buffering traps by 7000 m (Figure 5.1), with grid points spaced at 800 m across the mask.  
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We classified land within the habitat mask according to different covariates: Four AreasProject 
land classification, land cover, soil drainage, and soil texture (Figure 5.2). We used a shapefile of the Four 
Area Project study area to classify land as removal (which included the Four Area Project buffer areas), 
reference, or neither. We classified land cover based on the CORINE Land Cover 2012 database 
(European Union 2018). For simplicity, categories were collapsed into “artificial,” “arable/crop,” 
“pasture,” “forest,” “shrubs,” “peat,” and “water.” We used existing soil drainage categories 
“excessively,” “well,” “moderately,” “imperfectly,” “poor,” and “other” from the Irish National Soil 
dataset. We used exisiting soil texture categories “alluvial,” “coarse loamy,” “fine loamy,” “loamy,” and 
“peat.” Areas that were categorized as “artificial” (i.e., human development) or water were excluded as 
non-habitat from the habitat mask. Spatial files used to create the habitat mask were generated using 
ArcMap 10.4.2 (Environmental Systems Research Institute, Redlands, CA).  
We hypothesized that density might vary by land classification during the Four Area Project, land 
cover, soil drainage, or soil texture. We hypothesized that in models using Four Area Project land 
classification, density would be lowest in former removal areas because many badgers had been 
previously removed, highest in reference areas because culling was limited, and intermediate in areas 
outside the Four Area Project management areas. We hypothesized that in land cover models, density 
would be highest in forest and pasture areas because these would be associated with preferred badger 
habitat of field edges (Byrne, O’Keeffe, et al. 2012). Soil drainage is an important characteristic for 
badger sett-building preferences, and we hypothesized that density would increase as soil drainage 
improved based on preferences for well-drained soils (Byrne, Acevedo, et al. 2014). Soil texture has also 
been associated with badger sett preferences (Byrne, Sleeman, et al. 2012), and we hypothesized higher 
densities in areas of loamy soils over peaty soils to correspond to trends in badger sett building (Byrne, 















































Figure 5.2: Maps of covariates of interest within the Kilkenny study area and a composite 7 km habitat mask buffer. 
Actual habitat masks were constructed at lower resolution, using points spaced 800 m apart. A) Land classification 




We developed an a priori SECR model set and ranked candidate models using Akaike’s 
information criterion corrected for small sample size (AICc; Burnham and Anderson 2002), using 
differences in AICc scores between the top-ranked model and other models, and AICc weights. We used 
model averaging if the top model did not receive ≥ 0.9 of the model weight (Burnham and Anderson 
2002). All analyses were performed in R 3.4.3 (R Core Team 2017). We manipulated spatial files using 
package rgdal 1.2-16 (Bivand et al. 2017), performed SECR analysis using package secr 3.1.3 (Efford 
2017b), and generated certain figures using package ggplot2 2.2.1 (Wickham 2009). 
 
5.4 Results 
5.4.1 Live Captures 
The badgers captured were approximately equally distributed by sex (592 females, 574 males). 
Aprpoximately 80% of captures (443 females, 465 males) were categorized as adults at their last capture. 
The remaining badgers were categorized as juveniles (149 females, 109 males). The number of captures 
per badger ranged from 1–9; 568 badgers (48.7%) were recaptured at least once. The 749 capture nights 
in our dataset were divided into 13 independent sessions; each session contained 49–68 trap nights or 
occasions. The number of captures per badger within sessions ranged from 1–4, and there were 0–52 
spatial recaptures (0–20.3% total captures) per session. Distance moved between recaptures within 
sessions (Figure 5.3) ranged from 0 (recaptured at the same sett) to 10.8 km; the mean distance was 621.3 
m (SD 1370.4 m).  
 
 
5.4.2 Density Estimate 
A single model was selected as the top model, with 94.0% of the AIC weight (Table 5.2). This 
model included density varying by soil drainage (Figure 5.4), a behavioral trap response for g0, and the 
finite mixture model for σ. The estimated densities from the top model (Figure 5.5) were 0.80 
badgers/km2 (95% CI 0.68–0.93) in moderately drained soils, with estimates of 0.62 badgers/km2 (95% 
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CI 0.50–0.77) in poorly drained soils and 1.24 badgers/km2 (95% CI 0.97–1.60) in imperfectly drained 
soils, and estimates of 0.49 badgers/km2 (95% CI 0.35–0.69) in well drained soils and 0.80 badgers/km2 
(95% CI 0.68–0.93) in excessively drained soils. The estimated g0 was 0.141 (95% CI 0.110–0.179), and 
with the behavioral response, 0.046 (95% CI 0.038–0.055). The estimated σ was 442.6 m (95% CI 392.5–
499.1) for adults and 444.2 m (95% CI 382.7–515.6) for juveniles. The mixture proportion was adults = 




















Figure 5.3: Distances moved during spatial recapture events. 
 
Table 5.2: Candidate model set and results of AICc model selection. The log likelihood (-2LL), Akaike’s 
information criterion value corrected for small sample size (AICc), number of parameters (K), and Akaike weight 
(w) are presented for each model. 
Model Log likelihood AICc ΔAICc K w 
D~soil drainage, g0~b, σ~h2 -9581.287 19186.73 0 12 0.940 
D~Four Area class, g0~b, σ ~h2 -9587.104 19192.3 5.57 9 0.058 
D~soil drainage, g0~bk, σ ~h2 -9587.592 19199.34 12.61 12 0.000 
D~land cover, g0~b, σ~h2 -9591.734 19205.6 18.σ87 11 0.000 
D~Four Area class, g0~bk, σ ~h2 -9599.914 19217.92 31.19 9 0.000 
D~soil texture, g0~b, σ~h2 -9596.75 19219.69 32.96 13 0.000 
D~land cover, g0~bk, σ ~h2 -9600.242 19222.62 35.89 11 0.000 
D~soil texture, g0~bk, σ~h2 -9602.891 19225.78 39.05 10 0.000 
D~1, g0~1, σ~1 -9623.359 19256.75 70.02 5 0.000 





























































Our study is the first spatially explicit estimate of badger density in Ireland using empirical 
capture data. We examined the effect of behavioral, habitat, and management predictors on badger 
density and detection probability in a SECR analysis. Our best model indicated a density of 0.80 
badgers/km2 in the effective sampling area within and around County Kilkenny, with densities ranging 
from 0.49–1.24 badgers/km2 among different soil drainage quality. Detection probability was defined by a 
considerable behavioral response to trapping and neglible differences in the spatial scale of detection 
between age classes.   
Our results provide insight into the state of badger population management at the outset of the 
vaccination program. The Department of Agriculture’s Wildlife Unit had culled badgers to reduce 
densities from > 2 badgers/km2 to 0.2–0.5 badgers/km2 on 28% of the country’s agricultural land (Good 
and Duignan 2017). Prior crude estimates of density in the Kilkenny area, using non-spatial methods 
subject to edge effect bias, were approximately 0.5 badgers/km2 (J. O’Keeffe, unpublished data). Previous 
studies predicted main sett density in this area at ~0.2 main setts/km2 (Byrne, Acevedo, et al. 2014), 
combined with a crude mean group size estimate of 4.1 based on pooling prior studies throughout Ireland 
(Byrne, O’Keeffe, et al. 2012) for a rough estimate of 0.82 badgers/km2, which is remarkably close to our 
estimate of 0.80 badgers/km2 for most of the land in the study area. Using SECR methods to estimate 
density may be a more sensitive method to evaluate changes under the vaccination program if mean group 
size increases rather than the number of main setts increasing.  
Our top model was based on soil drainage, which is an important characteristic for badger sett-
building (Roper 2010; Byrne, Acevedo, et al. 2014) and correlated with soil type in the national soil 
dataset. Badgers tend to avoid wet and poorly draining areas (O’Corry-Crowe et al. 1996; Roper 2010) 
and prefer dryer soils that are easy to dig out (Hammond et al. 2001). Soil characteristics were also 
important in a SECR study of American badgers (Taxidea taxus), where density varied by soil depth 
(Gould and Harrison 2017). Our density estimates are reasonable for this area but did not scale exactly as 
expected with soil drainage. The lowest badger density occurred in well-drained soils, while the highest 
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badger density occurred in imperfectly drained soils. The estimate for imperfectly drained soils has a 
larger confidence interval than our other estimates (Figure 5.3), and the study area contained only small 
areas of this type of soil (Figure 5.2), and therefore should be interpreted with some caution. We assumed 
that soil drainage and other covariates were measured without error, but some degree of measurement 
error may have influenced our results. The lower estimate for well-drained soils is counterintuitive based 
on findings from previous studies and field observations where these soils are preferred for badger setts. 
Exploring this relationship using capture data from the other vaccination areas would be worthwhile, to 
better understand trends in badger density according to soil properties.  
Our top model indicated a marked trap response that affected detection probability. The baseline 
g0 estimate was 0.141, or a 14.1% probability of detecting a badger on a single occasion using a trap 
placed at its home range center. With the negative behavioral response, g0 is estimated to be 0.045, or 
about one third of the naïve estimate. This trap-wary response is supported by results from our descriptive 
analysis, which showed that while a small proportion of individuals were repeatedly recaptured, more 
than half of badgers were never recaptured during the study. Our analysis was limited by the fact that we 
used data collected from management activities rather than a study designed for spatial recapture analysis. 
Live-trapping generally results in fewer captures than non-invasive methods such as camera trapping or 
hair snares (e.g., De Bondi et al. 2010), and clearly a behavioral response impacted our ability to 
recapture badgers. Despite these limitations, we captured a large number of badgers over the course of the 
trial, and the precision of density estimates increases with > 20 recaptures (Efford et al. 2004),. 
Our observation model included a hybrid mixture model to describe σ. Mixture models may 
represent individual heterogeneity other than the covariate of interest, which can make biological 
interpretation challenging (Efford 2017f), but we hoped to account for heterogeneity in movement 
patterns if present. Our model had a 4:1 ratio between the two classes (adults: juveniles). We expected to 
have mostly adults in our dataset as trapping using stopped restraints is targeted towards capturing adults. 
Our model results indicate the spatial scale of detection for juveniles to be virtually identical to that for 
adults. Other studies have found sex differences in badger movements, including smaller home range 
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sizes for females and “super-ranging” behavior by a minority of males that may be related to mating 
(Gaughran et al. 2018). Ranging behavior has ramifications for intra- and interspecific transmission based 
on increased contact with other individuals (Gaughran et al. 2018), so sex may be an informative 
covariate to explore in future models of badger density.  
The scale of σ was smaller than expected. Movements ≤ 1 km were observed only 43% of the 
time in one previous study, with mean distance 2.6 km (Byrne, Quinn, et al. 2014). This finding may be 
an artifact of the trapping scheme and badger behavior. Badger trapping is specifically targeted at active 
setts rather than with traps randomly distributed throughout the landscape. Badgers have varying degrees 
of site fidelity to their setts (Stewart et al. 1999; Byrne, Quinn, et al. 2014), but badgers in our study were 
often recaptured at the same sett, which is not useful in a SECR framework that depends on spatial 
recaptures. Our σ estimates may be biased low by these non-spatial recaptures. While an altered sampling 
scheme might have increased the number of spatial recaptures, it would not have been feasible to conduct 
a live-trapping study over the same spatial and temporal scale outside of management purposes. Our 
inference about the top model is only in relation to the other candidate models examined our model set 
(Burnham and Anderson 2002). Other environmental or demographic factors that we did not test, such as 
sex and availability of preferred food sources, may play a role in badger densities. We think valuable 
inference can still be made from our data. 
Our findings have serious implications for TB management in badgers. Badger trappability is 
generally low (Byrne, O’Keeffe, et al. 2012), but the trap-shy behavioral response quantified in our model 
suggests a ~70% decrease in the baseline capture probability of captured badgers compared to naïve 
badgers. The current intramuscular formulation used in vaccine trials, BadgerBCG, has an unknown 
duration of immunity and is recommended for annual use (Brown et al. 2013). A parenteral vaccine used 
as part of the eradication program must deliver long-lasting immunity if a majority of previously captured 
badgers are unlikely to be recaptured to be revaccinated. The use of an oral BCG vaccine would 
ameliorate the problem of capture for vaccine delivery, although it raises other concerns about 
consumption of baits by non-target species, particularly cattle. Vaccination of cattle is currently 
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prohibited in the European Union (EU Council Directive 78/52/EEC), and consuming oral BCG vaccine 
can result in positive tuberculin skin test in cattle (Buddle et al. 2005). A DIVA (differentiating 
vaccinated from infected animals) vaccine and test are needed against TB but none are currently 
available. Despite these limitations, initial trials in badgers have demonstrated oral BCG vaccine efficacy 
(Chambers et al. 2017; Gormley et al. 2017), safety (Perrett et al. 2018), and bait palatability (Gowtage et 
al. 2017). 
Vaccination is becoming increasingly relevant as the management strategy of choice against TB 
in a number of systems (Buddle et al. 2013; Chambers et al. 2014), and other intramuscular BCG 
vaccination programs for badgers are underway in England and Wales (Brown et al. 2013; O’Connor 
2016). Understanding social changes that result from reduced culling and increased badger survival due to 
vaccination will be an important priority going forward. The social perturbation associated with culling 
badgers in the UK (Tuyttens et al. 2000; Woodroffe et al. 2006) has not been observed in badgers in 
Ireland (O’Connor et al. 2012). Social alterations that may result from vaccination remain to be seen. 
Vaccination also has long-term consequences on population dynamics by increasing survival, which may 
lead to higher population density (Tuyttens and Macdonald 1998), as will the reduction of culling. 
Monitoring density of populations undergoing vaccination is important to fully understand the ecological 
impacts of the management program. Future models could use diagnostic test data to define disease status 
in the finite mixture model covariate within secr, to estimate the density and movements of susceptible 
compared to infected badgers, and estimate the ratio of susceptible:infected badgers. Models using 
empirical data can inform management decisions within an adaptive framework management (Walters 
and Holling 1990) in response to disease intervention outcomes. 
Another consideration for changing disease dynamics under vaccination is the effect of BCG’s 
limited efficacy. Vaccinated badgers have shown decreased disease severity, progression, and bacterial 
shedding in laboratory studies (Chambers et al. 2011; Lesellier et al. 2011), and vaccinated free-ranging 
badgers have a reduced risk of infection (Carter et al. 2012). Encouraging preliminary results from the 
Kilkenny vaccine area showed a decrease in seropositive and clinically diseased badgers (Good and 
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Duignan 2017). Vaccinated badgers may maintain a less severe infection for a longer period of time and 
have reduced mortality compared to unvaccinated infected badgers, and the consequences of these factors 
for direct transmission are unclear. The role of environmental transmission has not been well-explored in 
TB, but both M. bovis and the BCG strain can persist in soil (Young et al. 2005), which could lead to 
increased environmental contamination from extended low-level bacterial shedding. Further exploring the 
changing badger population under vaccination, and the potential role of the environment will help to 
elucidate the complex transmission of M. bovis in this system. 
Our density estimates will be used in conjunction with cattle TB data to assess the impact of 
badger vaccination on bovine TB in Ireland. Including both hosts in a coordinated management approach 
is best for understanding and controlling the dynamics of a disease with multiple hosts. This study 
provides a framework for estimating wildlife population density in other vaccination areas, and over time 
as new data are collected from field operations to assess population-level impacts of vaccination. SECR 
models can also quantify behavioral responses – positive or negative – to trapping, which may influence 
managers’ decision-making about trapping objectives. Our study demonstrates the value of estimating 
density and detection probability of animals in disease management operations. Monitoring density of 
marked or uniquely identifiable individuals is a valuable tool for evaluating progress and success of 




CHAPTER 6: SURVEY OF ANTITUBERCULOSIS DRUG ADMINISTRATION AND ADVERSE 




6.1 Summary   
Tuberculosis, caused by Mycobacterium tuberculosis (M. tb), is a disease causing morbidity and 
mortality in elephants (Elephas maximus and Loxodonta africana) as well as free-ranging individuals. 
Elephants in North America, diagnosed with tuberculosis, are often treated with anti-tuberculosis drugs, 
unlike livestock species, which has necessitated the development of treatment guidelines adapted from 
recommendations for humans. There are few published reports describing empirical treatment, which may 
be complicated by poor patient compliance, interruptions in drug administration, and adverse effects. A 
survey of elephants in North America was conducted to compile information on treatment protocols, 
including drugs, dosages, and routes of administration, serum drug concentrations, and adverse effects of 
anti-tuberculosis treatment. Responses were received from 182 elephants, 12 of which were treated 
prophylactically or therapeutically with anti-tuberculosis drugs. Treatment protocols varied among 
elephants, and included various combinations of isoniazid, rifampin, pyrazinamide, ethambutol, 
enrofloxacin, levofloxacin, and ethionamide. Serum drug concentrations also varied considerably among 
and within individuals. Facility staff reported five elephants (5/12; 42%) that exhibited clinical signs that 
may have been associated with anti-tuberculosis drugs or treatment procedures. Anorexia, decreased 
water intake, constipation, depression, ataxia, limb paresis, and tremors were among the signs observed. 
Most adverse effects were reported to be moderate or severe, resulting in interruption of the treatment. 
The results from this survey provide veterinarians and elephant managers with valuable historical data to 







Infection with Mycobacterium tuberculosis (M. tb) is a growing disease concern for elephants. 
More than sixty elephants in the United States have been confirmed with tuberculosis (TB) since 1994, 
with a median point prevalence of 5.1% in Asian elephants (Elephas maximus) from 1997–2011 
(Feldman et al. 2013). Despite ongoing research, diagnosis and treatment of TB in elephants remain a 
challenge for veterinarians and animal managers (Mikota et al. 2001; Maslow, Mikota, Zhu, Isaza, et al. 
2005). The large size, complex anatomy, and unique physiological features of elephants confound 
application of commonly used methods to assess TB status. Adding to the diagnostic challenge is the fact 
that elephants can be infected with M. tb for years without showing any clinical signs of disease 
(Greenwald et al. 2009; Lyashchenko et al. 2012). 
As long-lived charismatic megafauna, elephants diagnosed with TB can be and often are treated 
for the disease. Veterinarians and elephant managers play an essential role in ensuring the health and 
welfare of these species, although knowledge gaps regarding effective treatment of TB still exist. The 
decision to treat elephants is contrary to management of TB in most species, such as cattle, which are 
typically culled if reactive to indirect screening tests or found to be infected. The lack of precedent for 
treating TB in animals has required the development of treatment guidelines extrapolated from human TB 
treatment protocols (United States Animal Health Association 2010). Treatment of TB in elephants 
commonly uses combination therapy with the first line drugs isoniazid (INH), rifampin (RIF), 
pyrazinamide (PZA), and ethambutol (EMB) (Maslow, Mikota, Zhu, Isaza, et al. 2005; Dumonceaux et 
al. 2011; Vogelnest et al. 2015; Stakeholders Task Force on Management and Research Priorities of 
Tuberculosis in Elephants 2017). However, determining appropriate doses for elephants may be 
complicated by inability to accurately determine body weight of some individuals in low-resource settings 
(Fowler and Mikota 2006; Mikota and Maslow 2011; Brock et al. 2014). Pharmacokinetic studies of anti-
TB drugs in elephants have been conducted for INH (Maslow, Mikota, Zhu, Isaza, et al. 2005; Egelund et 
al. 2016), EMB (Maslow, Mikota, Zhu, Riddle, et al. 2005), PZA (Zhu et al. 2005), RIF (Peloquin et al. 
2006; Egelund et al. 2014; Egelund et al. 2016), and all four in conjunction (Brock et al. 2014), using 
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small numbers of elephants. However these studies did not evaluate treatment efficacy; therefore the 
therapeutic drug serum levels for effective treatment in elephants are still unknown and are currently 
directly extrapolated from recommended human levels known to be curative (Maslow, Mikota, Zhu, 
Isaza, et al. 2005; United States Animal Health Association 2010).  
Other factors complicate appropriate treatment of TB in elephants in addition to determining anti-
TB drug dosages. Elephants may refuse to ingest medications (Lyashchenko et al. 2006; Simpson et al. 
2017), expel orally administered drugs or hold them in their mouths for prolonged periods of time without 
swallowing (Brock et al. 2014). Some drugs may be administered rectally to avoid problems with oral 
administration, but RIF does not reach recommended serum levels when administered rectally (Peloquin 
et al. 2006), and EMB results in mucosal irritation and expulsion of the drug (Maslow, Mikota, Zhu, 
Riddle, et al. 2005). In addition, administration of oral or rectal medications requires trained elephants 
and staff to ensure compliance (Stakeholders Task Force on Management and Research Priorities of 
Tuberculosis in Elephants 2017). Oral clearance (defined as the apparent volume of distribution in the 
systemic compartment divided by the first order absorption rate constant) (Zhu et al. 2005) or the 
presence of food in the gastrointestinal tract may influence drug absorption and make it difficult to reach 
targeted serum concentrations (Maslow, Mikota, Zhu, Isaza, et al. 2005; Zhu et al. 2005). Similarly, dose 
reduction to ameliorate adverse effects from treatment may compromise the ability to reach desired serum 
levels (United States Animal Health Association 2010).  
Achieving effective drug serum concentrations must be balanced with the individual elephant’s 
response to therapy and adverse effects from treatment. The criteria for effective drug serum levels may 
vary according to the goal of therapy and individual elephant. Since determining “cure” is difficult even 
in humans with TB, an achievable goal may be to sustain a consistent drug serum concentration that stops 
mycobacterial shedding in elephants without adverse effects. Since effective drug levels are unknown for 
elephants, targeted drug serum concentrations extrapolated from humans have been used. However, the 
guidelines for treatment of TB in elephants (developed under the auspices of the United States Animal 
Health Association) cited anecdotal evidence that some elephants could not tolerate anti-TB drugs at the 
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doses recommended to achieve targeted drug serum concentrations recommended for humans (United 
States Animal Health Association 2010). First-line anti-TB drugs have a variety of adverse effects in 
humans, including hepatitis, gastrointestinal intolerance, central nervous system toxicity, elevated liver 
enzymes, drug fever, rash, arthralgia, peripheral neuropathy, and optic neuritis (Yee et al. 2003; Zumla et 
al. 2015). Adverse effects documented in elephant case reports include inappetence (Mikota et al. 2001; 
Dumonceaux and Mikota 2006; Lyashchenko et al. 2006; Dumonceaux et al. 2011; Vogelnest et al. 2015; 
Simpson et al. 2017), depression/listlessness (Mikota et al. 2001; Lyashchenko et al. 2006; Dumonceaux 
et al. 2011; Simpson et al. 2017), epiphora (Dumonceaux and Mikota 2006; Dumonceaux et al. 2011; 
Vogelnest et al. 2015), blepharitis (Dumonceaux and Mikota 2006; Dumonceaux et al. 2011), 
hepatitis/liver toxicity (Mikota et al. 2001; Dumonceaux et al. 2011), diarrhea (Vogelnest et al. 2015), 
anemia (Dumonceaux et al. 2011), pica (Mikota et al. 2001), leukopenia (Mikota et al. 2001), trunk 
paralysis (Dumonceaux et al. 2011), elevated lactic dehydrogenase (Mikota et al. 2001), and stiff/sore 
limbs (Dumonceaux and Mikota 2006) associated with anti-TB treatment. The decision to deviate from or 
interrupt a treatment plan can interfere with consistent therapy but may result when elephants demonstrate 
adverse effects (Lyashchenko et al. 2006; Dumonceaux et al. 2011; Vogelnest et al. 2015; Egelund et al. 
2016). For example, one case report described two elephants with poor tolerance for daily INH, although 
dosing every other day was tolerated (Simpson et al. 2017). Because INH is recommended for use in all 
elephants being treated for TB, acceptance of this drug with minimal adverse effects is crucial to 
complete therapy (Stakeholders Task Force on Management and Research Priorities of Tuberculosis in 
Elephants 2017). Incomplete therapy may have serious consequences, including disease recurrence 
(Lyashchenko et al. 2006), emergence of multi-drug resistance (Dumonceaux et al. 2011), infection of 
herdmates due to continued exposure (Mikota and Maslow 2011), public health risk to elephant handlers, 
and euthanasia of the affected elephant (Lyashchenko et al. 2006; Dumonceaux et al. 2011). 
There is a paucity of literature on the response of elephants to TB treatment, except for 
information that can be gleaned from individual case reports (Dumonceaux et al. 2011; Vogelnest et al. 
2015; Egelund et al. 2016). The objective of this study was to report the drugs, dosages, routes of 
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administration, serum drug concentrations during therapy, and adverse effects from a larger pool of 
elephants under TB treatment to establish a baseline for the North American captive elephant population.  
The results from this survey can be used to inform future clinical decision-making and research priorities 
on this important zoonotic disease. 
 
6.3 Methods 
A cross-sectional survey study was conducted to evaluate the diagnosis and treatment of TB in 
elephants in North America. The population for distribution of the surveys included elephants listed in the 
Association of Zoos and Aquariums’ 2010 Asian (Keele 2010) and 2011 African (Olson 2011) elephant 
studbooks alive on January 1, 2010, for which contact information was available (365 animals). In order 
to preserve confidentiality, elephants were assigned a random code and questions were designed to avoid 
information that could be used to identify individuals.   
The survey was available on-line from June 2013 through November 2014 to maximize response 
rate.  A link to the survey was distributed via professional listserves, including the American Association 
of Zoo Veterinarians, Association of Zoos and Aquariums elephant group, Elephant Managers 
Association, and direct contact with veterinarians and elephant managers at individual facilities. Follow-
up reminders were sent through the same listserves and to individual veterinarians. 
Data were collected using an online survey website (SurveyMonkey©, San Mateo, 
California  94403, USA). Two surveys were distributed: one on potential risk factors for TB, along with 
general information about history of TB and TB treatment (Appendix B), and one on TB diagnostic test 
results and treatment protocols (Appendix C). The risk factor survey included demographic information 
(species, age, and sex); if a response was recorded for an elephant in both surveys, the demographic 
information was applied to the responses associated with this elephant in the diagnostics and treatment 
survey. The treatment portion of the diagnostics and treatment survey had 17 questions, including drop-
down lists and fill-in fields.  For treated elephants, fields for a list of commonly used anti-TB drugs (INH, 
RIF, EMB, PZA, fluoroquinolones, and amikacin) were presented and details on drug dosage (mg/kg), 
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frequency, route of administration, drug formulation, total doses received, duration, and purpose 
(prophylactic or therapeutic) of treatment were requested. Serum drug level values were also requested if 
they had been performed. If common adverse effects associated with anti-TB therapy had been observed, 
respondents were asked to record their severity, duration of single episodes, recurrence, and whether these 
caused an interruption in treatment. The survey specifically asked about the following adverse effects: 
decreased appetite/anorexia, decreased water intake, constipation, diarrhea, bloat, colic, ptyalism, 
depression/lethargy, agitation, generalized weakness, paresis of the limbs, tremors/muscle fasciculations, 
incoordination/ataxia, and photophobia. All adverse effects were subjective qualitative observations 
reported by the facility staff and not based on standardized criteria. 
 
6.4 Results 
There were survey responses for 182 elephants, 162 of which indicated that the elephant had not 
been treated with anti-TB drugs.  Four elephants had unknown treatment status, three surveys had no 
response to this question regarding treatment, and 13 elephants were reported to have been treated with 
anti-TB drugs at some point in their lifetime. One of these 13 elephants was reported to have been treated 
with isoniazid, but no further information was provided; the following results are based on data from the 
other 12 elephants. These 12 elephants came from five different facilities. Eight of these elephants also 
had demographic information available. All eight were Asian elephants, seven females and one male, 
ranging in age from 15–48 yr. The ages listed were the elephants’ ages at the time of the survey, not the 
time of anti-TB treatment. One treated elephant died in 2013, but cause of death was not reported.  
Of the 12 elephants treated for TB, eight were treated prophylactically (one for a herd history of 
TB, and seven for a reactive serological test result) and five were treated therapeutically after a positive 
M. tb culture (Table 1). One elephant was treated both prophylactically and therapeutically. The most 
frequently used drugs were INH (n = 12), PZA (n = 5), and enrofloxacin (n = 4).  In some cases, the same 
individual was treated with a different dosage, route, or formulation of the same drug; this is shown by 
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different rows for the same elephant in Table 6.1. A summary of the drugs, dosages, and frequencies and 
routes of administration are summarized Table 6.2. 
Twelve treated elephants had information about serum drug levels reported. Serum drug levels 
were reported for elephants treated with INH, PZA, RIF, EMB, and enrofloxacin (Table 6.3). Isoniazid 
serum levels from elephant 7 may have been affected by collecting samples in hot weather; INH 
dissipates quickly after blood collection and samples should be kept on ice (Mikota and Maslow 2011). 
The results in Table 6.3 show the large variability in serum drug concentrations at various time points, 
and even at the same time point when measured repeatedly in the same individual. 
Information about adverse effects attributed to TB treatment was reported for seven of the twelve 
treated elephants. No side effects were observed in two elephants. The other five of the seven elephants 
with survey responses to this question experienced adverse effects. Each of these elephants experienced 
two to five adverse effects during treatment, with at least one adverse effect being reported by facility 
staff as moderate or severe (Table 6.4). For four of the five elephants, at least one adverse effect resulted 
in interruption of treatment.  
The most commonly reported adverse effect from these five elephants was anorexia (n = 4). 
Single episodes were reported to last three days to one week (n = 2) or two weeks or longer (n = 1). Two 
elephants experienced multiple episodes of anorexia during treatment. Other commonly reported adverse 
signs were decreased water intake (n = 3) and depression/lethargy (n = 3). Single episodes of decreased 
water intake were reported to last three days to one week (n = 2), and sometimes occurred in multiple 
episodes (n = 2). Single episodes of depression/lethargy lasted two weeks or longer (n = 2), and occurred 
multiple times in one elephant. Two elephants were observed to have incoordination/ataxia. A single 
episode lasted two weeks or longer (n = 1) but did not recur. One elephant became constipated, lasting for 
three days to one week, and had multiple episodes. One elephant had tremors/muscle fasciculations, 
single episodes of which lasted for less than 24 hours. No elephants were reported to experience other 
signs listed in the survey such as diarrhea, bloat, colic, ptyalism, discolored feces, agitation, generalized 
weakness, paresis of the trunk, or photophobia. 
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Table 6.1: Complete prophylactic and therapeutic antimycobacterial treatment protocols used in elephants included in this survey. 
 
a P = prophylactic treatment, T = therapeutic treatment, NR = not reported.  
b Elephant 13 was treated with isoniazid, but no other data regarding dosing or frequency were provided. 
c INH = isoniazid; RIF = rifampin; PZA = pyrazinamide; EMB = ethambutol; ENRO = enrofloxacin; LEVO = levofloxacin. 
Elephantab Drugcd Dose range 
(mg/kg) 





1P INH 3–6 SID RE Powder  10–12 No None 
 RIF 10–11 SID OD Powder  10–12 No None 
 PZA NR SID RE Powder  0–3 No None 
2P,T INH NR TIW RE Powder  4–6 No Mild 
  NR TIW OD Powder  10–12 Yes Moderate 
 RIF NR TIW OD Powder  10–12 Yes No 
 EMB NR TIW OD Powder  4–6 No Moderate 
3P INH 1–5 TIW RE Powder  0–6 No None 
 PZA 20–31 TIW RE Powder  0–6 No None 
4T INH 2–6 TIW RE Powder/tablet  0–3 No Moderate-severe 
 PZA 30–40 TIW RE Powder  0–18 Yes None-moderate 
5T INH UNKf SID RE Powder  4–6 Yes Severe 
  UNK TIW RE Powder  22–24 Yes Severe 
 PZA UNK SID RE Powder  4–6 Yes Severe 
  UNK TIW RE Powder  22–24 Yes Severe 
 ENRO NR SID RE Powder  4–6 Yes Severe 
6T INH 2–5 TIW RE Powder  0–9 No None 
7T INH 5–6 SID RS Powder  0–3 Yes Moderate 
  5–10 EOD RS Powder  0–9 Yes No 
 PZA 29–30 SID RS Powder  0–3 Yes Moderate 
 Fluoroquinolonee 5–6 SID OF Powder  10–12 Yes None 
8P INH 4–5 SID OF Powder  10–12 No None 
 ENRO 9–10 SID OF Powder  10–12 No None 
9P INH 4–5 SID OF Powder  10–12 No None 
 ENRO 9–10 SID OF Powder  10–12 No None 
10P INH 4–5 SID OF Powder  7–9 No None 
 ENRO 9–10 SID OF Powder  7–9 No None 
11P INH 4–5 SID OF Powder  10–12 No None 
 ENRO 9–10 SID OF Powder  10–12 No None 
12T RIF 9–10 SID OD Powder  16–18 No None 
 Ethionamide 27–28 EOD OD Powder  0–3 Yes Yes 
 LEVO 19 SID OD Powder  0–3 No None 
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d Drugs are reported in multiple rows if there were multiple routes of administration or dosing intervals reported. 
e drug not specified.  
f UNK = unknown (entered by respondent). 
g EOD = every other day; SID = once daily: TIW = three times/week. 
h OD = orally, directly in mouth; OF = orally, on food; RE = rectal enema; RS = rectal suppository. 
 
 














a INH = isoniazid; RIF = rifampin; PZA = pyrazinamide; EMB = ethambutol; ENRO = enrofloxacin; LEVO = levofloxacin. 
b NR = not reported. 
c EOD = every other day; SID = once daily: TIW = three times/week. 
d OD = orally, directly in mouth; OF = orally, on food; RE = rectal enema; RS = rectal suppository. 
Druga Dosageb 
(mg/kg) 
Frequencyc Routed Did 
complications 
occur? 
INH 1–10 SID–TIW RE, RS Yes 
INH 4–5 SID OF No 
PZA 20–40 SID–TIW RE, RS Yes 
RIF 9–11 SID–TIW OD Yes 
EMB NR TIW OD Yes 
Ethionamide 27–28 EOD OD No 
ENRO NR SID RE Yes 
ENRO 9–10 SID OF No 
LEVO 19 SID OD No 
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Table 6.3: Summary of serum drug concentrations in elephants treated prophylactically or therapeutically for M. 
tuberculosis infection. 
Elephant Drug Dose 
range 
(mg/kg) 
Routea Time after 
administration 
(hr) 




1 INH 3–4 RE 1, 2, 4, other 0–1 12 
 INH 4–5 RE 2, 4, other 0–1 6 
 RIF 10–11 OD 2, 4 2–3; 3–4; 4–5 6 
    Other 0–1 3 
2 INH 3–4 OD 0.25, 0.5, 1, 2, 4, other 0–1 6 
 INH 4–5 OD 0.25 0–1; 2–3 2 
    0.5 0–1; 4–5 2 
    1 0–1; 3–4 2 
    1.5, 2, 3, 4, other 0–1 11 
 INH 7–8 RE 0.25, 0.5, 1 3–4 3 
 INH 10–11 RE 0.25 10–11 1 
    0.5 6–7 1 
    1 4–5 1 
 INH 12–13 RE 0.25 3–4 1 
    0.5 0–1 1 
    1 2–3 1 
 EMB 30–31 OD 0.25, 4 0–1 2 
    0.5 4–5 1 
    1 7–8 1 
    2 3–4 1 
 RIF 6–7 OD 1, 2 0–1 3 
    4 2–3; 3–4 3 
    Other 0–1; 2–3 6 
3 INH 3–4 RE 0.25 5–6 1 
    0.5 2–3 1 
    1, 2, 4 3–4 2 
 INH 5–6 RE 0.25, 0.5 2–3 1 
    1 0–1; 2–3; 3–4; 4–5 5 
    2 0–1; 2–3; 3–4; 4–5 5 
    4 2–3 1 
    Other 0–1 2  
PZA 20–21 RE 0.25 14–15 1 
    0.5 0–1 1 
    1 9–10 1 
    2, 4 10–11 2 
 PZA 30–31 RE 0.25, 0.5 0–1 2 
    1 4–5; 6–7; 7–8; 9–10; 22–23 5 
    2 7–8; 9–10; 11–12; 13–14; 20–21 5 
    4 9–10 1 
    Other 0–1; 8–9 2 
4 INH 5–6 RE 0.5 6–7 1 
    2 2–3 1 
    4 2–3; 3–4 1 
    Other 0–1; 2–3 4 
 PZA 30–31 RE 0.25 19–20 1 
    0.5, 1 26–28 2 
    2 25–26 1 
 PZA 39–40 RE 0.25 21–22 1 
    0.5, 2 30–33 2 
    1 21–22 1 
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6 INH 4–5 RE 0.25 2–3; 3–4; 7–8 3 
    0.5, 1 2–3; 3–4 6 
7 INH 10–11 RE 0.25 3–4; 7–8; 11–12 3 
    0.5 3–4; 7–8; 10–11 3 
    1 2–3; 5–6; 8–9 3 
    Other 4–5; 5–6; 8–9; 10–11 4 
 PZA 30–31 RE 0.5 30–33; 38–40 2 
    1 26–28; 30–33 2 
    1.5 25–26; 26–28 2 
    2 24–25 1 
8 ENRO 9–10 OF 2 2–3 1 
 INH 4–5 OF 2 0–1 1 
9 ENRO 9–10 OF 2 2–3 1 
 INH 4–5 OF 2 2–3 1 
10 ENRO 4–5 OF 2 3–4 1 
 INH 4–5 OF 2 3–4 1 
11 ENRO 10–11 OF 2 3–4 1 
 INH 4–5 OF 2 0–1 1 
12 RIF 9–10 OD 1 3–4 1 
    2 5–6 1 
    3 8–9 1 
    4 9–10 1 
a INH = isoniazid; RIF = rifampin; EMB = ethambutol; PZA = pyrazinamide; ENRO = enrofloxacin. 
b OD = orally, directly in mouth; OF = orally, on food; RE = rectal enema 
 
 
Table 6.4: Adverse effects, severity, and treatment interruption associated with antimycobacterial therapy in 
elephants. 
Elephant Adverse effect Severity Treatment 
interruption 
2 Decreased appetite/anorexia Severe Yes 
 Decreased water intake Severe Yes 
4 Decreased appetite/anorexia Severe Yes 
 Decreased water intake Severe No 
 Constipation Severe Yes 
 Depression/lethargy Moderate Yes 
 Incoordination/ataxia Mild NRa 
5 Decreased appetite/anorexia Severe Yes 
 Depression/lethargy Moderate Yes 
 Paresis/weakness of the limbs Moderate Yes 
 Incoordination/ataxia Moderate Yes 
7 Decreased appetite/anorexia Moderate Yes 
 Decreased water intake Moderate Yes 
 Depression/lethargy Moderate Yes 
12 Discolored urine Moderate No 
 Tremors/muscle fasciculations Mild No 





The results from this study represent the collection of treatment protocols, serum drug 
concentrations, and adverse effects from twelve elephants receiving TB treatment. Treatment of TB in 
elephants requires a significant commitment, both financially ($20,000–$60,000 per elephant) 
(Dumonceaux and Mikota 2006; Mikota 2008; Simpson et al. 2017) and in terms of time and effort to 
medicate and monitor an elephant for 12–18 months. These survey data provide a baseline of information 
for future research that can be used to develop treatment recommendations based on elephant data. 
It is not surprising that the responses for elephants treated for TB were all from Asian elephants, 
as in North America, TB is reported almost exclusively in this species rather than African elephants 
(Loxodonta africana) (Feldman et al. 2013). While the reported ages of the elephants do not correspond to 
their age at treatment (to protect confidentiality), most individuals with age data were older (> 30 yr), as 
would be expected in a chronic disease like TB. Most elephants in this survey had been treated on a 
prophylactic basis, which has been described anecdotally (Simpson et al. 2017), using recommendations 
in published guidelines (United States Animal Health Association 2010; Stakeholders Task Force on 
Management and Research Priorities of Tuberculosis in Elephants 2017). 
The 12 cases presented here demonstrate the variability in treatment plans for TB in elephants. 
The drugs used to treat an individual elephant depends on feasible routes of administration, individual 
compliance, and occurrence of adverse effects. Drug dosages and frequency of administration also may 
need to be altered until an acceptable regimen is found that achieves desired targeted serum drug levels, 
elephant compliance, and minimal adverse effects, while accomplishing treatment objectives (i.e., 
cessation of shedding, arrest of disease progression) (Zlot et al. 2015). Even then, elephants may need to 
be retreated if the first round of therapy does not achieve the therapeutic goal (Lyashchenko et al. 2006; 
Mikota and Maslow 2011; Simpson et al. 2017). 
The high variability in reported drug levels includes numerous concentrations below the 
published recommended serum concentrations for humans: 3–5 µg/ml for isoniazid, 8–24 µg/ml for 
rifampin, 20–60 µg/ml for pyrazinamide, and 2–5 µg/ml ethambutol (United States Animal Health 
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Association 2010). At least some of these lower levels are likely an artifact of measurements taken at 
times other than when drug concentrations were expected to be maximized (Stakeholders Task Force on 
Management and Research Priorities of Tuberculosis in Elephants 2017). Peak drug concentrations are 
reported to vary by individual elephant (Brock et al. 2014), thus even a measurement taken at the 
recommended time (Stakeholders Task Force on Management and Research Priorities of Tuberculosis in 
Elephants 2017) may not represent that individual’s peak drug concentration. Humans undergoing TB 
treatment also demonstrate similar variation in serum drug levels, with factors like age, sex, and genetics 
being consistently associated with higher or lower concentrations of certain drugs (McIlleron et al. 2006). 
In addition, drug penetration into infected tissues is influenced by pharmacokinetics and 
pharmacodynamics within lesions (Dartois 2014), which depend on factors like pH, active transport 
mechanisms, protein binding, and solubility (Prideaux et al. 2015). The high variability in serum drug 
concentrations, even within individuals, underscores the importance of individual therapeutic drug 
monitoring in elephants under treatment to determine appropriate dosing to achieve serum concentrations 
assumed to be effective for antimicrobial activity (Brock et al. 2014).  Simpson et al. (2017) describe 
changing a treatment protocol using EMB to enrofloxacin after monitoring serum concentrations, 
presumably due to inadequate EMB concentrations. Therapeutic drug monitoring is particularly crucial 
when modifying a treatment protocol as required by individual tolerance. It is important to keep in mind, 
however, that although cessation of bacterial shedding has been anecdotally reported, the lack of markers 
of disease progression in elephants limits studies on efficacy of the human-based target drug levels 
currently recommended (Stakeholders Task Force on Management and Research Priorities of 
Tuberculosis in Elephants 2017). 
Adverse effects of treatment are a serious concern for elephant welfare and ability to maintain an 
effective TB treatment plan. In humans, adverse effects from treatment resulted in termination of use of at 
least one drug in 23% of patients in one study (Schaberg et al. 1996), and in another, 14% of defaulters 
from TB treatment gave medication side effects as their reason for discontinuing treatment (Tekle et al. 
2002). Adverse effects of anti-TB treatment can be severe in some other animals as well; in Bactrian 
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camels (Camelus bactrianus), treatment with INH caused bone marrow toxicity resulting in mortalities 
(Bush et al. 1990). The survey responses in this study provide information about the severity and duration 
of adverse effects encountered during TB treatment of elephants. The burden of adverse effects reported 
in this study was substantial; elephants experienced multiple adverse effects, at least one of which was 
considered moderate or severe, and most of which resulted in interruption of treatment. Interruptions in 
treatment are suboptimal not only for a disease requiring lengthy treatment but for minimizing the risk of 
selecting for drug-resistant bacteria (World Health Organization and Stop TB Initiative 2010). Elephants 
being treated for TB should be closely monitored for adverse effects associated with treatment, and 
treatment plans should be adaptable to account for the elephant’s ability to tolerate drugs and 
interruptions that may prolong the treatment period. 
There were several limitations in the survey employed in this study. The survey was designed to 
protect confidentiality and avoid identifying individual elephants, which inherently limited the amount of 
information collected. The survey was directed towards attending veterinarians who could review medical 
records to provide responses to the survey questions, but respondents were not identified to maintain 
confidentiality. Information collected about treatment protocols did not extend to which drug doses were 
administered together or for exactly how long, exact drug formulations, or the sequence of therapy. The 
dates when therapy occurred were not requested to protect confidentiality since individual treated 
elephants may be identified by when treatment was administered. There were also no data collected on 
treatment outcomes since elephants may have been in various stages of treatment, and including animals 
at various times in or after treatment may bias results if insufficient time has passed. Other limitations are 
related to the information collected on adverse effects. Adverse effects reported were based on subjective 
observations, although respondents were able to provide information about the duration and repetition of 
episodes. It is possible that some of the observed side effects attributed to treatment were in fact age-
related changes in behavior, or a result of comorbid conditions. The results reported here still represent a 
baseline of multiple facets of treating TB in elephants, and provide a foundation for assessing future TB 
treatment data.  
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The treatment protocols, serum drug concentrations, and adverse effects reported for the 12 
elephants in this study represent a valuable addition to understanding the clinical picture of elephant TB. 
The unique challenges of treating a chronic disease in elephants, where high individual variability has 
been observed, demand flexibility and adaptation of treatment guidelines. Providing elephant managers 
and veterinarians with information on what protocols have been tried, their effectiveness in achieving 
desired serum drug concentrations, and the adverse effects encountered allows for more informed clinical 
management of treatment for TB in elephants. Similar information, as well as treatment outcomes, should 
be published for elephants treated under the most current recommendations so that they may be adapted 








Management of TB across humans and non-human animal species remains a challenging 
prospect. A One Health approach that incorporates data and techniques across disciplines to build a more 
complete picture of disease control is ideal for TB in wildlife. Both ecology and epidemiology can offer 
insight into the dynamics of infectious diseases in populations (Anderson 1991). My coauthors and I drew 
from ecology and epidemiology to implement a holistic approach to improving TB diagnosis and 
management in species of conservation concern: European badgers, and African and Asian elephants. Our 
results provide insight into the challenges of diagnosing and managing TB in free-ranging and captive 
wildlife, the benefits of a transdisciplinary approach, and areas in need of further investigation.  
 
7.1 One Health and the Role of the Environment 
The human-captive wildlife-free-ranging wildlife interface is rich with opportunities for pathogen 
transmission, with consequences for both human health and for conservation of free-ranging wildlife. 
Studies in Asia have revealed a troubling picture of TB exposure in working Asian elephants and their 
handlers (Angkawanish et al. 2010; Verma-Kumar et al. 2012; Ong et al. 2013; Paudel et al. 2014; 
Mikota, Gairhe, et al. 2015; Yakubu et al. 2016), with recent evidence of spillover into free-ranging 
elephants (Perera et al. 2014; Chandranaik et al. 2017; Zachariah et al. 2017). A case report of TB in a 
free-ranging African elephant in Kenya (Obanda et al. 2013) and evidence of M. tuberculosis in other 
southern African wildlife (Michel et al. 2013) highlight the risk to free-ranging wildlife throughout 
Africa. Human influences on ecosystems drive the level of disease risk at human-animal interfaces 
(Hassell et al. 2016). Our study in Zimbabwe provides support for the growing body of evidence of TB at 
high-risk human-wildlife interfaces in crucial conservation areas (Chapter 4; Rosen et al. 2018). The risks 
of this type of interface extend beyond TB to other pathogens; it is an ideal candidate for an integrated 
One Health approach involving screening of human handlers, monitoring of captive wildlife, and 
surveillance of free-ranging wildlife populations.  
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The environmental component of One Health is underrecognized, and therefore underutilized 
(Barrett and Bouley 2015), and the environmental component of the epidemiologic triad is often 
underinvestigated. Health research can benefit from introducing aspects of systems thinking from 
ecology, such as non-linear relationships (Zinsstag et al. 2011). Our studies in Ireland integrated 
environmental factors including precipitation, ambient temperature, and soil characteristics into 
assessment of the bovine TB management program (Chapter 3; Martin et al. 2017). Identifying conditions 
that are associated with desirable outcomes – trapping badgers – provides managers with data-based 
recommendations for focusing field efforts and resources to maximize impact. Similarly, exploring 
ecological drivers of badger density in conjunction with mark-recapture data can inform future predictive 
modeling of population densities across the country’s varying landscape where trapping data may not be 
available (Chapter 5). 
Environmental factors and transmission routes should be considered in TB and other infectious 
disease research as they can alter models of disease dynamics if, for instance, infectious pathogens can 
persist in the environment for relatively long periods of time (Almberg et al. 2011). Environmental 
transmission also impedes wildlife disease management by adding a potential source of infection that is 
challenging to eliminate (Miller et al. 2004; Miller et al. 2006). M. bovis has been shown to persist in soil, 
and even the BCG strain used in vaccines can remain viable in soil for months (Williams and Hoy 1930; 
Duffield and Young 1985; Young et al. 2005; Fine et al. 2011; Ghodbane et al. 2014; Barbier et al. 2017). 
Environmental contamination can result from unexpected sources: for instance, earthworms can 
disseminate M. bovis from cattle feces into soils and shed the bacteria for several days after moving to 
soils previously free of M. bovis (Barbier et al. 2016). Predation on earthworms by host species such as 
badgers could also represent an additional transmission pathway for M. bovis (Barbier et al. 2016). 
Pathogen sources outside of other vertebrate hosts need better incorporation into models of disease 





7.2 The Role of Imperfect Diagnostics in Management 
Diagnostic accuracy is critical for appropriately informing management decisions for culling, 
vaccination, and treatment strategies. The dynamics of theoretical SIR models will not accurately reflect 
those of a population if disease status is defined incorrectly. Test-and-cull schemes of cattle and wildlife 
depend on the ability to identify infected animals to cull. A vaccine superior to BCG, such as a more 
efficacious vaccine with DIVA capacity, may hold the key to controlling TB in wildlife and livestock, and 
ultimately eradication of the disease. Such a vaccine would depend on a reliable diagnostic test to 
differentiate vaccinated animals from infected animals to allow selective removal. Our elephant treatment 
study highlighted how the shortcomings of available diagnostic assays for elephants – with no method for 
confidently determining current infection status or cessation of bacterial shedding – impede the definition 
of successful treatment. All management interventions rely, in part, on diagnostic test results to 
characterize success in reducing the TB burden in wildlife. 
Making inference from diagnostic tests forms the basis for our understanding of disease incidence 
and prevalence in populations. Test characteristics such as sensitivity and specificity give an indication of 
the test’s performance, but not how reliably a test result under field conditions can be taken as a reflection 
of the animal’s true disease state (Dohoo et al. 2009). The negative and positive predictive values of test 
results are governed by sensitivity, specificity, and population prevalence (Dohoo et al. 2009), which 
makes test interpretation dependent on the underlying true prevalence in the population under study. 
Other mitigating circumstances, especially from the underappreciated environmental component of One 
Health, need to be considered when interpreting diagnostic test results. For example, environmental NTM 
infections can result in cross-reaction on diagnostic tests for wildlife, including the TST (Gcebe and 
Hlokwe 2017) and STAT-PAK (Greenwald et al. 2009). Our elephant serology study addressed the 
potential role of NTM and M. mungi, a newly emerging MTBC strain, in positive serological test results. 
We recognized that positive test results could be due to exposure to M. tuberculosis from humans, M. 
bovis from animal hosts, potentially M. mungi (another MTBC species present in the local ecosystem), or 
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NTM exposure (Chapter 4; Rosen et al. 2018) Test results should be evaluated with locally occurring 
MTBC and NTM species in mind rather than a single species of interest. 
 
7.3 Recommendations to Inform Management Using Field Data and Local Ecology 
TB has been studied and managed for decades, but unique features of each ecosystem can subtly 
alter the dynamics and management requirements (Miller and Olea-Popelka 2013). Bovine TB impacts 
badgers and cattle in the UK and Ireland, but similar management approaches through culling have had 
different outcomes in each country(O’Connor et al. 2012). In the UK, badger culling was believed to have 
“no meaningful contribution to cattle TB control” (Bourne et al. 2007) given observed increases in cattle 
TB after culling in some areas (Donnelly et al. 2005), while culling was shown to be effective in reducing 
cattle TB in Ireland (Ó Máirtín et al. 1998; Griffin et al. 2005; Olea-Popelka et al. 2009). White-tailed 
deer in Michigan are a persistent reservoir for M. bovis, while an outbreak in deer in Minnesota was 
successfully controlled and eliminated (Carstensen et al. 2011). Management programs would do well to 
consider the full host community, environment, and social factors in proposed control strategies.  
One method for incorporating local ecology and conditions into TB research is by building a 
complete picture of the host community, as well as highlighting differences from other related TB 
systems that may be important drivers of transmission. For instance, elephant management practices at the 
ecotourism facilities in our study in Zimbabwe are markedly different from those used for other 
populations of captive elephants. Practices such as humans and elephants sharing indoor facility airspace 
(Zlot et al. 2015), using pressure washers (Miller and Olea-Popelka 2013), and having an assigned 
handler (Lassausaie et al. 2014) were identified as risk factors in studies from other populations, but are 
not relevant in our study because none of these practices are in place at any of the facilities. Studies of TB 
in working Asian elephants have tended to focus on human-elephant contact (Ong et al. 2013; Lassausaie 
et al. 2014; Yakubu et al. 2016), without consideration of other wildlife or livestock hosts that may be 
involved in transmission. We documented other wildlife species with host potential, including warthogs 
(Woodford 1982) and banded mongoose (Alexander et al. 2010; Brüns et al. 2016), on and around 
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facilities, and considered these as possible sources for mycobacterial transmission in working African 
elephants. Our management guidelines for TB prevention specifically include measures to reduce direct 
and indirect contact with these potential host species (Chapter 4; Rosen et al. 2018).  
Social factors can also be important drivers and obstacles to management programs. Elephants’ 
size, longevity, and conservation status make them unsuitable as experimental research animals; TB 
management has been solely informed by the response of animals to natural infections. Privacy concerns 
in North American elephant facilities have limited data sharing about elephant TB. Our study of TB 
treatment in elephants provided a compilation of empirical data for elephant managers and veterinarians 
to use to inform clinical decision making. We found considerable variation in drug protocols and serum 
concentrations used to determine appropriate dosing, and a substantial burden of moderate or severe 
adverse effects (Chapter 6). These findings underscore the difficulty in treating elephants in a 
standardized fashion, and the need for improved diagnostics to more confidently identify when animals 
are no longer infectious. 
All management activities need metrics to determine progress in disease control. Our study of 
badger density in Ireland supports the Department of Agriculture, Fisheries and the Marine’s integrated 
program for TB management of cattle and badgers (O’Keeffe 2006; Good and Duignan 2017). One arm 
of this program involves badger vaccination as a management strategy (Good and Duignan 2017), which 
currently employs an intramuscular BCG vaccine. An oral vaccine formulation has the potential to reduce 
the labor intensity of vaccine delivery, which could prove valuable for effectively protecting elusive 
species such as badgers, or for vaccinating multiple target species, as in southern Africa. Until an oral 
vaccine is available for use in free-ranging wildlife, intramuscular vaccination will continue in Ireland, 
which requires a high rate of trapping success. Our results on weather and activity scores allow managers 
to best use resources by prioritizing field efforts under conditions when badger trapping is most likely to 
be successful. We also provided an estimate of badger density in one vaccination trial area derived from 
mark-recapture data, which may be more sensitive to subtle changes in density than estimates based on 
sett densities. Our results provide a baseline for using SECR models to assess badger densities over time 
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in an adaptive management framework (Walters and Holling 1990) that allows for the eradication 
program to be refined as new information becomes available. Our models can also be combined with 
culture data from badger mortalities to estimate densities of badger in different disease classes. 
Incorporating these badger population data with cattle testing results and slaughter surveillance can better 
inform understanding of the complex multi-host system of TB and accelerate progress towards 
eradication. These models could also be adapted for use in other free-ranging species undergoing disease 
management where host population density is important to estimate. 
Our results from Ireland highlight the difficulty in managing free-ranging wildlife using vaccines. 
The proportion of the population that must be vaccinated to eradicate a pathogen is 𝑝𝑝 > 1 − � 1
𝑅𝑅0
� 
(Anderson and May 1985), but in reality this number is higher in the case of TB in because BCG does not 
offer complete immunity. The low trapping success for badgers is a major obstacle to delivering enough 
vaccine to induce herd immunity. However, Ireland’s transition to vaccination has been designed as a 
non-inferiority approach, with the goal of demonstrating that a new intervention (BCG) is “not 
unacceptably worse” than culling, the current intervention (Schumi and Wittes 2011). Preliminary results 
from the trial have been positive, indicating that vaccination is not worse than culling for controlling TB 
in cattle, and the capturing effort for vaccine is not more resource intensive than for culling operations 
(Good and Duignan 2017). Our results will be used to assess the role of badger density as a confounder in 
cattle TB rates and the success of badger vaccination in controlling TB in cattle. The intramuscular BCG 
vaccine program may not be sufficient for TB eradication, but will promote badger conservation 
compared to culling in continued management efforts.   
BCG vaccine programs for free-ranging wildlife do have long-term impacts that must be 
considered as these plans are implemented. Vaccinated animals are not completely protected from 
infection and are therefore not truly resistant to infection as is assumed in a traditional SIR framework. 
Data from vaccinated badgers suggests lower levels of seroconversion and clinical disease in the field 
(Good and Duignan 2017), and laboratory studies found decreased bacterial shedding (Lesellier et al. 
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2011). It is unclear how increased survival but decreased transmission (β) associated with vaccination will 
affect TB prevalence in free-ranging populations. New vaccine development holds promise for an option 
with higher efficacy and ideally, DIVA capacity that would allow for use in both livestock and wildlife. 
Vaccination is becoming the future of TB management in free-ranging wildlife (Buddle et al. 2013), and 
closely studying populations where vaccination is being implemented will be informative to 
understanding the modified transmission dynamics under vaccine programs. 
In conclusion, my dissertation adds to our collective knowledge about the ecology and 
epidemiology of TB in wildlife. I integrated often-overlooked environmental aspects into my research to 
provide a broader scope beyond host and pathogen. My work underscores the limitations of current 
diagnostic tests and the need for interpretation in context of the local ecosystem. Lastly, I demonstrated 
the value of large and small datesets from field studies to conduct applied research that directly informs a 
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Country location: ____________________________________________ 
 




Elephant Unique Identification Number  




Name (if applicable): _______________________________________ 
 
 
2. What is the gender of this elephant? Please circle one. 
  








Other (please specify) 
_________________________________________________________________ 
 
4. Has this elephant reached puberty? Please circle one. 
 
     Yes 
     No 
Other (please specify): 
_________________________________________________________________ 
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5. Has this elephant reached breeding age? 
 
     Yes 
     No 
Other (please specify): 
_________________________________________________________________ 
 




    Other (please specify): 
_________________________________________________________________ 
 
7. How long has this elephant been managed by humans? 
 
  ___________________________________________ 
 
8. Has this elephant ever been kept  in a natural breeding situation (i.e., housed with a 













Note: For questions 9-11, if this is a female elephant, answer only questions related to 
pregnancies and live births; If this is a male elephant, answer only question related to breeding 
bull. 
 
9. In female elephants of breeding age, how many pregnancies have resulted? 
        
By natural breeding:  0 1 2 3 4         5        6 
 








10. How many live births have occurred? Please circle one. 
 
0, 1, 2, 3, 4, 5, 6 
 
Other (please specify) 
____________________________________________________________________________
____________________________________________________________________________ 
     
11. Has this male elephant ever been used as a breeding bull? 
 
By natural service:  Yes No Unknown 




12. How is this elephant currently managed? 
 
Unprotected physical contact handlers only  
 
Unprotected physical contact with multiple people 
 
Protected contact – only handled when there is a barrier or restraints (chains) 
 
Combination of unprotected and protected contact 
 





















14. If the management of this elephant has changed, how has the management of this 







15. How many elephants are housed in separate enclosures or barns (i.e., no physical 
contact) from this elephant? Please circle one. 
 
0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 10+ 
 





16. What is the approximate size of the current outdoor enclosure for this elephant 
















18. How has the size of the outdoor enclosure changed during the last 5 years? 
Unchanged 
Increased in size 
Decreased in size 
Unknown 






19. How many elephants are in the outdoor enclosure with this individual (including this 
individual)? Please circle one. 
 
1, 2, 3, 4, 5, 6, 7, 8, 9, 10,  
 




20. How many of the elephants in the outdoor enclosure are over 30 years of age 
(including this individual)? 
 
1, 2, 3, 4, 5, 6, 7, 8, 9, 10,  
 















22. What is the typical social grouping for this individual elephant when it is in the 
outdoor enclosure? Please circle one. 
  
Housed individually 
Housed with a single elephant (adult)  
Housed with more than one elephant (all adult group)  
Housed with more than one elephant (mixed age group  cow/calves)  
 




































































28. Does this elephant come into contact with wild elephant when free-ranging? 
 
Never  




Please specify an approximate number of encounters with wild elephants in the past month.   
 
___________/ month  
 
29. If this is a female elephant, has pregnancy occurred as a result of this female 











30. How is this elephant kept at night? 
 
Chained 
Penned singly  










32. When confined or restrained in an enclosure, or chained at night, can this elephant 
touch other elephant? 
 


























35. What is the origin of supplementary feed supplied to your elephant? 
 
Commercial bagged feed 
 
Fresh browse or hay cut in an area that other wildlife, including elephant, has access to 
 
Dried, baled hay 
 
Vegetables and other fresh feedstuffs which may have been extensively handled by persons not 














37. How many fulltime staff (trainers, handlers, keepers) are currently employed to 
provide daily care at the facility for elephants? 
  
- As Main handlers (every day) 
 
1–3, 4–6, 7–10, 10+ 
  




- As Back-up handlers (sometimes) 
 
1–3, 4–6, 7–10, 10+ 
  




38. What is the average duration of staff direct contact (in hours) per day with this 
elephant? 
 
(Direct contact is defined as interaction within a distance of less than 5 meters between the 
elephant and the person). 
 
0–1/2 hour, 1–2, 3–5, 5–8, 8+ 
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39. What is the average duration of public contact (in hours) for each contact? Please 
circle one. 
 
0–1/2 hour, 1–2, 3–4, 5–6, 6+ 
 
This elephant does not have public contact 
 




40. Approximately how many different members of the public touch and / or ride this 
elephant per month (average)? 
 
______________  people 
 
41. How many part-time staff (1 staff=20 hours/week) are currently employed to provide 
daily elephant care at this facility? 
 
1–3, 4–6, 7–10, 10+ 
  




42. How many volunteers (1 volunteer = average 5 hours/week) are used to assist with 
elephant care duties at this facility? 
 
1–3, 4–6, 7–10, 10+ 
  




43. How often do you require paid elephant staff to be tested for tuberculosis? 
  
At the time of hiring 
Semiannually (every 6 months) 
Annually 
Only if an elephant has a suspect/positive test for tuberculosis 
Never 







44. How often do you require volunteers involved with elephant care to be tested for 
tuberculosis? 
 
At the time of initial volunteering  
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AFB acid-fast bacilli 
AIC Akaike’s information criterion 
AICc Akaike’s information criterion corrected for small sample size 
BCG Bacille Calmette-Guérin 
CI confidence interval 
CFP10 10 kDa culture filtrate protein 
CFT caudal fold test 
CORINE Coordination of Information on the Environment 
DIVA differentiating infected from vaccinated animals 
DPP Dual-Path Platform 
EIA enzyme immunoassay 
ELISA enzyme-linked immunosorbent assay 
EMB ethambutol 
ESAT-6  6 kDa early secretory antigenic target 
HIV human immunodeficiency virus 
IS6110 insertion sequence 6110 
KAZA Kavango-Zambezi 
KNP Kruger National Park 
IFN interferon 
INH isoniazid 
LL log likelihood 
MAPIA multiantigen print immunoassay 
MBCF Mycobacterium bovis culture filtrate 
MDR-TB multi-drug-resistant tuberculosis 
MIRU-VNTR mycobacterial interspersed repetitive unit–variable number tandem repeat 
MPB protein purified from M. bovis BCG 
MTBC Mycobacterium tuberculosis complex 
MOT mammalian old tuberculin 
MOTT mycobacteria other than tuberculous mycobacteria 
NTM non-tuberculous mycobacteria 
OIE World Organisation for Animal Health (Office International des Epizooties) 
OR odds ratio 
OTF officially tuberculosis free 
PCR polymerase chain reaction 
PPD purified protein derivative  
PIT passive integrated transponder 
PPR peste des petits ruminants 
PZA pyrazinamide 
RBCT Randomized Badger Culling Trial 
RIF rifampin 
RFLP restriction fragment length polymorphism 
RPSV root pooled spatial variance 
SD standard deviation 
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SECR spatially explicit capture-recapture 
SIR susceptible-infected-recovered/resistant 
SIT single intradermal cervical test 
SICCT single intradermal comparative cervical test 
TFCA transfrontier conservation area 
TB tuberculosis 
TST tuberculin skin test 
WGS whole genome sequencing 
